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Astrocyte calcium activity mapping in behaving mice using an-
terograde axo-astrocytic AAV transfer
Astrocytes are considered active partners to neurons in information processing. Het-
erogeneous, bidirectional interaction between neurons and astrocytes alludes to circuit
specific communication. However, the role of astrocytes in information processing,
primarily established through ex vivo experiments, has been challenged by a series of
controversies that highlighted the importance of studying astrocytes under fully physi-
ological conditions in behaving mice. Astrocytes extend highly ramified processes that
cradle synapses. They form functionally independent microdomains where they exhibit
a rich repertoire of localized calcium signals. How astrocyte Ca2+ microdomain signals
relate to neuronal activity and behaviour in vivo is still unclear. My objective was to
investigate circuit specific, single-astrocyte Ca2+ microdomain activity in mice during
behavioural states and sensory stimuli. I found that adeno-associated viruses (AAVs)
can transfer anterogradely along thalamocortical projections to transduce cortical as-
trocytes and neurons. This axo-astrocytic AAV transfer enables the study of astrocytes
and neurons embedded in specific neuronal circuits. Intersectional approaches, using
anterograde axo-astrocytic AAV transfer in combination with membrane tagged genet-
ically encoded calcium indicators (GECIs), enabled sparse, high contrast labelling of
cortical astrocytes embedded in the somatosensory system of mice. Continuous imag-
ing with two-photon microscopy of single astrocytes for about ≈1 hour combined with
automatic, unbiased extraction of Ca2+ activity revealed a rich repertoire of subsec-
ond, µm scale, localized Ca2+ signals. The number, size and duration of astrocytic
Ca2+ signals were modulated with locomotion but not with intermittent whisker-touch
stimulation. Locomotion and whisker stimuli evoked rapid [Ca2+]i elevation in thalam-
ocortical axon boutons, whose activity was not correlated with nearby astrocyte Ca2+
microdomain signalling. Astrocyte fine processes exhibit heterogeneous, non-random,
Ca2+ signalling patterns giving rise to hotspots of higher activity that are stable over
time. Hotspot patterns allude to subcellular specialization. Our study: a) provides
a new toolkit for studying neuron-astrocyte interactions within brain circuits, b) ex-
tends our understanding of astrocyte Ca2+ microdomain signalling and relationship to
neuronal activity in behaving animals and c) suggests that there are astrocyte Ca2+
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Motivation
The human brain contains≈100 billion neurons, connected through trillions of synapses
involved in information processing. A tantalizing modern theory is that glial cells, such
as astrocytes, may be active partners to neurons in information processing through
active mechanisms supplementing their established homeostatic roles. This is a rev-
olutionary idea in our understanding of brain function. These traditionally thought
star-shaped cells arborize into nanoscopic processes that are in contact with synapses
and blood vessels giving them a characteristics spongiform, cloud-like appearance. Con-
sidering their proximity to synapses, are astrocytes involved in synaptic information
processing? Astrocytes possess receptors that can sense chemical signals in their envi-
ronment, including neurotransmitters and neuromodulators. A large body of evidence,
suggests bidirectional communication between neurons and astrocytes. Astrocytes can
respond to neuronal activity with Ca2+ signals that can in-turn drive mechanisms that
modulate neurons. Reported mechanisms include astrocytic release of chemical messen-
gers, termed "gliotransmitters". However, fast, bidirectional communication between
neurons and astrocytes under physiological conditions is controversial. On one hand
the spatiotemporal dynamics (whole astrocyte, multiple seconds) of Ca2+ signals are
not compatible with precise and fast signalling between synapses. The bidirectional
communication between astrocytes and neurons was also questioned on the grounds of
pathology, since most of the supporting evidence was accumulated from ex-vivo prepa-
rations. Since the identity and functions of astrocytes identity changes with pathology,
age and the conditions of their environment it is important to minimize their pertur-
bation in experimental preparations if we want to derive conclusions about physiology.
In-vivo preparations in awake, adult animals provides a more physiological platform
to test these ideas. Modern research, suggests that astrocytic function and Ca2+ sig-
naling are heterogeneous. For example, improved labelling techniques revealed a rich
repertoire of fast (hundreds of milliseconds) Ca2+ signals localized in thin astrocytic
processes that were previously unsampled. In addition, a heterogeneous and dynamic
identity of astrocytes within different neuronal circuits starts emerging where astrocytes
- neuron interaction exhibit circuit specificity. Therefore, functional tools for probing
neuron - astrocyte interactions within specific circuits under physiological conditions,
along with high spatiotemporal extraction of the rich Ca2+ activity at astrocytic thin
processes, are bound to revolutionize our understanding about the role of astrocytes in
information processing in the brain.
My aim was to develop a system for studying the function of astrocytes embed
within specific circuits, at high spatiotemporal resolution, in behaving mice. Then use
this system to investigate how Ca2+ signals in astrocytic fine processes are modulated
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by neuronal activity and characterize them.
Chapter 1
Introduction
1.1 What are astrocytes?
1.1.1 Historical perspective
Astrocytes are neuroglial cells. Rudolf Virchow (1858) coined the term neuroglia,
referring to the passive ‘connective tissue’ holding neurons together. About a decade
later Camillo Golgi (1873) stained this glia ‘goo’ with the ‘black reaction’ to reveal
its cellular attributes. The ‘star like’ subset of these glial cells was termed astrocytes
by Michael von Lenhossék (1891). Cajal’s pioneering modifications to the Golgi stain
with gold chloride demonstrated the morphology of astrocytes [107]. Interestingly, the
gold chloride stain targets intermediate filaments [178], consisting primarily of (GFAP)
today used as an astrocytic marker.
1.1.2 Distribution of astrocytes in the brain
The human brain consists of ≈1:1 glia to neuron ratio (GNR) [24]. The GNR ratio was
a controversial topic in neuroscience for decades [5] [163]. It was thought that there
were 10 times more glia than neurons until it was recently disproved by Herculano-
Houzel’s group using the isotropic fractionator method [24] [26]. The GNR generally
increases with brain size and varies between brain regions (Figure 1.1 A) and species
[24] [380] [371]. The majority of glial cells in the human brain are oligodendrocytes
(45-75%) followed by astrocytes (19-40%) and microglia (10%) [380]. Astrocyte tile the
entire brain with little overlap to each other (Figure 1.2 A, B, C), thus occupying dis-
tinct territorial domains [58]. They were classically divided based on their morphology
and astrocyte enriched proteins into: fibrous astrocytes of the white matter, protoplas-
mic astrocytes of the gray matter and specialized astrocytes. Specialized astrocytes
include: radial glia, retinal Muller cells, Bergman cells, velate astrocytes, tanycytes,
pituicytes, Gomori astrocytes, ependymocytes and surface associated astrocytes [373].
Some of these types of astrocytes are illustrated in Figure 1.1 C. Although this rough
classification of astrocytes was helpful, defining the heterogeneity of astrocytes is still a
work in progress. Astrocytes are defined by their morphology, molecular markers and
function. Here, we will focus on protoplasmic astrocytes.
3
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Figure 1.1: Heterogeneous distribution and identity of astrocytes in the
brain. A) The glia to neuron ratio (GNR) varies between brain areas. Illustration
of approximate number of neurons and glia in selected areas of the human brain. B)
Human astrocytes (right) are ≈2.5 times bigger in diameter (bottom, left) compared
to rodent astrocytes (top, left) as revealed by GFAP labelling. C) Astrocytes exhibit
different morphology and molecular markers depending on their locations in the brain.
Protoplasmic astrocytes are found in the gray matter, have radial morphology and are
in contact with synapses and blood vessels (top, left). Fibrous astrocytes are found
in the white matter, have elongated morphology and are in contact with myelinated
axons and oligodendrocytes (bottom, left). Bergman glia and velate astrocytes are
found in the cerebellum. Bergman glia extend long apical processes who wrap the
dendrites of Purkinje cells. Velate astrocytes are like protoplasmic astrocytes and
are found particularly around granule neurons (top, right). The lateral ventricles of
the subventricular zone are lined with astrocyte-like B cells(bottom, right). Different
astrocyte types differentially express molecular markers including GFAP, GLT1, Kir4.1,
AMPARs and vimentin. GFAP, Glutamate transporter 1 (GLT1), inward rectifying
potassium channel 4.1( Kir4.1). Panel A was modified from wikimedia commons based
on [24], panel B was modified from [254] and panel C was taken from [125].
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1.1.3 Morphology
The name astrocyte was derived based on the star-like morphology observed when
staining the GFAP enriched intermediate filaments [178]. However, more advanced
visualization techniques have now revealed that astrocytes exhibit a bushy, spongiform
morphology [299] [334] (Figure 1.2 A, B, C, D). Mouse protoplasmic astrocytes consist
of a cell body emanating into 4-10 main branches that arborize into thin, nanoscopic
processes often referred to as branchlets and leaflets that are devoid of GFAP. These
astrocytes have a diameter of ≈40-60 µm occupying a volume of ≈6.6x10µm3 mostly
composed of bracelets and leaflets (≈90-95% of volume). They also extend polarised
specialized endfeet that wrap around blood vessels [299] [58] [257] [175]. The terri-
tory of a single hippocampal astrocyte territory is estimated to encompass ≈140000
synapses [58] out of which ≈60% are juxtaposed to perisynaptic astrocytic processes
(PAPs) [396] [370]. The anatomical and functional relationship between synapses and
PAPs was consolidated into the concept of the “tripartite synapse” [14] or “astrocytic
cradle” [372]. The intimate relationship between PAPs and synapses allows astrocytes
to modulate a multitude of synaptic functions ranging from homeostasis to synap-
tic plasticity and information processing [14] [372]. PAP coverage of synapses is a
dynamic process [38] [280]. Synapses juxtaposed to PAPs tend to be larger [396], sug-
gesting a positive correlation between synaptic strength and PAP coverage of synapses.
PAP motility was reported to be enhanced in response to synaptic activity, increasing
synaptic coverage and stability [38]. For example, whisker stimulation in adult mice
increases astrocyte coverage of synapses in the barrel cortex [116]. In contrast, a recent
study [134] suggests that astrocyte processes might withdraw from mature synapses
following long-term potentiation (LTP) induction (at least 30-40 min following LTP)
thus enhancing glutamate spillover and cross talk between neighbouring synapses. The
mechanism, conditions and heterogeneity of PAP mobility is bound to be very impor-
tant for the functional relationship between astrocytes and neurons. The study of
nanoscopic PAPs (Figure 1.2 E, F) is not amenable to diffraction limited optical meth-
ods. While most studies so far relied on electron microscopy (often associated with
fixation issues [182] and static images), super resolution microscopy techniques [147]
[309] [130] and expansion microscopy [389] have potential to “expand” the field. The
size, diversity and morphological complexity of astrocytes varies across brain areas (i.e.
specialized astrocytes), within areas [194] and between species [253] [254]. For exam-
ple, human astrocytes occupy a volume 15-20 times larger than rodents (Figure 1.1
B), possess more elaborate processes and have unique astrocyte subtypes [253] [254].
However, the comparative biology of astrocytes between species is not well established
yet.
1.1.4 Molecular characteristics
There is still no systematic agreement on how to define astrocytes based on molecular
markers. GFAP was the first molecular marker associated with astrocytes. However,
GFAP is upregulated in pathology, not all healthy astrocytes express GFAP at con-
centrations detectable by immunohistochemistry and GFAP is also expressed in cell
types other than astrocytes. Thus GFAP expression alone is not sufficient or required
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Figure 1.2: Astrocyte morphology. Astrocytes tile the brain with little overlap to
each other shown by A) "Brainbow" expression in cortical astrocytes, B) Dye loading
of hippocampal, dentate gyrus astrocytes and C) "Traffic light labelling" (tdTomato
and eGFP) expression in cortical astrocytes. D) Fine astrocytic process architecture
revealed by high resolution optical image of a Lucifer yellow-filled astrocyte. Colour
scale represents fractal dimension. E) These nanoscopic processes exhibit high surface
area to volume ratio as shown by serial block-face scanning electron microscopy (SBF-
SEM) of perisomatic (top) and peripheral (bottom) volumes in Golgi-impregnated
astrocytes. F) Astrocyte processes (pink) wrap around presynaptic (yellow) and post-
synaptic (blue) synapses as shown by (SBF-SEM) in layer 6 and layer 2/3 of the
somatosensory cortex. Panel A was taken from [202]; B was taken from [394]; C is
from this thesis; D and E were taken from [334]; F was taken from [194].
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for astrocyte identification [175] [234]. Other molecular markers commonly associated
with astrocytes include: glutamate transporters GLT-1 and GLAST, connexins (Cx)
Cx30 and Cx43, inward rectifying Kir4.1 channels, aldehyde dehydrogenase 1 family
member L1 (Aldh1L1), glutamate synthetase, water channel aquaporin 4 (AQP4) and
the calcium binding protein S100B [373] [175] [234] (Figure 1.1 C). The protein expres-
sion profile of astrocytes shows variability within brain areas. For example, Cx30 and
Cx43 are enriched within the barrels of the primary somatosensory cortex (S1) com-
pared to septa [146] . Immunohistochemistry and transcriptome analysis revealed layer
specific heterogeneity in S1 astrocytes [31] [194]. Also, transcriptomic analysis revealed
molecular diversity of astrocytes between different areas [25] [59] [67]. The molecular
characteristics of astrocytes is likely regulated by neuronal activity. For example, as-
trocytes cultured with neurons change their expression of glutamate transporters [279],
glutamine synthase [222], connexins [185], and neuropeptide receptors [230]. Prolonged
whisker stimulation increases the expression of glutamate transporters in S1 astrocytes
[116]. Disturbance of neuronal layers in S1 abolishes the layer specific heterogeneity of
astrocytes [31] [194]. The molecular characteristics of astrocytes also change with age
[350] [85] and pathology [175] [125]. Therefore, the molecular identity of astrocytes is
heterogeneous and dynamic, changing in response to cues in their environment.
1.1.5 Astrocyte networks
Astrocytes interact with all cell types in the central nervous system (CNS). They are
connected to each other via gap junctions (Figure 1.3 A) composed primarily of con-
nexins of subtype Cx43 and Cx30 [240]. Cx43 / Cx30 double knockout mice do not
exhibit gap-junction mediated K+ [383] and metabolic [308] communication between
astrocytes. Connexins assemble into hemichannels. Hemichannels which dock to each
other form gap junctions [391] [56]. Unpaired hemichannels were reported to release
gliotransmitters such as ATP [346], glutamate [408] and D-serine [227] in the extra-
cellular fluid. Gap junctions (≈25%) also connect processes from the same astrocyte
[302] (reflexive gap junctions, Figure 1.3 A), potentially coupling different subcellular
compartments. Gap junctions allow rapid intercellular exchange of ions and small (≈1
kDa) molecules between astrocytes. This is critical for K+ buffering [383] and calcium
wave propagation [105] [143] [114]. Astrocyte gap-junction networks are not random.
For example, Cx30 and Cx43 are focused towards the center of S1 [146] (Figure 1.3
B) and olfactory bulb [68] (Figure 1.3 C) functional units [117]. Gap junction commu-
nication can be modulated by neurotransmitters and pathology [117]. Astrocytes are
also known to communicate to each other through the release of gliotransmitters such
as ATP [114].
Astrocytes communicate with microglia to mediate immune responses in the brain
[199] [156] and synaptic pruning [315] [46]. They communicate with oligodendrocytes
to modulate myelination [96] which could depend on neuronal activity [151]. Astrocytes
cooperate with pericytes and neurons to control blood flow in the brain [229]. Finally,
astrocytes communicate with neurons. While the interactions between astrocytes and
neurons was considered to be homeostatic, a large amount of evidence suggests that
astrocytes may be active partners to neurons in information processing in the brain
[14] [16] [312] [88] [104]. In this thesis we will focus on astrocyte - neuron interactions.
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Figure 1.3: Astrocytes are connected to each other via gap junctions. A)
Gap junctions connect contacting astrocytes to each other. Gap junctions are com-
posed of paired connexin (Cx) hemichannels. Same astrocyte process can connect with
each other forming reflexive gap junctions. B) In the somatosensory cortex, gap junc-
tion proteins (Cx30 & Cx43) are more highly expressed in barrel astrocytes (dark blue)
compared to septal astrocytes (light blue). C) In the olfactory bulb, glomerular astro-
cyte cell bodies are found in the periphery extending their processes to the center of
the functional unit. Images taken from [117].
1.2 Multifunctional role of astrocytes
1.2.1 Homeostasis
The most well accepted function of astrocytes is regulation of homeostasis. Astrocytes
maintain ion homeostasis, regulate the water volume of the brain, maintain the pH,
clear excess neurotransmitters (Figure 1.4) and provide metabolic support to neurons
(Figure 1.5). While these functions are well accepted, they shouldn’t be overlooked,
since they play critical roles in brain function and there is still a lot to be learned.
The spotlight of current research in astrocytes have been their emerging function as
elements of information processing mediated by Ca2+ signalling. However, the home-
ostatic functions of astrocytes are intimately linked to astrocyte Ca2+ signalling and
can influence neuronal activity.
1.2.2 K+ homeostasis
When neurons fire action potentials, they release K+ into the extracellular space which,
if not cleared, can result in neuronal hyperexcitability. Astrocytes express a high con-
centration of K+ channels and transporters that clear excess extracellular K+ through
uptake and spatial buffering (Figure 1.4 B, top). These include Kir4.1 channels, Na+/
K+ ATPases (NKA), inward rectifying, Na+/K+/Cl− (NKCC) co-transporters and
K+/Cl− co-transporters (KCC) [376] [35]. K+ uptake uses energy derived from the
breakdown of ATP (i.e. NKA) or the electrochemical gradient through co-transporters
(i.e. NKCC). Spatial buffering relies on passive transport of K+ ions from regions of
high [K+] to regions of low [K+] through Kir channels and the gap-junction coupled net-
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Figure 1.4: Astrocytes maintain homeostasis in the brain. A) The "astro-
cytic cradle" or "tripartite synapse" represents the functional and anatomical relation-
ship between astrocytes and neurons at synapses. Astrocyte processes wrap around
synapses and play important roles in the function, maturation, maintenance, isolation
and elimination of synapses. B) Astrocytes express a plethora of proteins involved
in the homeostasis of ions, neurotransmitters, metabolism, pH and reactive oxygen
species summarized in this schematic. C) They also express aquaporin (AQP) chan-
nels primarily located at their perivascular endfeet, allowing them to maintain water
homeostasis and clear waste accumulated in the brain through the glymphatic system.
Panel A & B images taken from [372]; C taken from [206].
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work of astrocytes [208] [35]. Disturbances to astrocyte mediated K+ homeostasis can
lead to epilepsy [80] and a range of other disorders summarized in [35]. Interestingly,
K+ uptake could also be actively regulated through [Ca2+]i dependent mechanisms. For
example, [Ca2+]i elevation can increase the activity of Na+/Ca2+ exchangers (NCX),
raising [Na+] that in turn activates Na+/ K+ ATPase mediated uptake of K+ and a
decrease in extracellular [Na+]. This leads to neuronal hyperpolarization, reduction in
excitatory synaptic activity and a decrease in synaptic failure [385]. Also computer
simulations suggest that NCXs are sufficient for the induction of microdomain [Ca2+]i
signals in PAPs [382]. These suggest that astrocytes may be able to modulate neuronal
activity through passive and active, [Ca2+]i dependent, regulation of K+.
1.2.3 Water homeostasis, aquaporins and the glymphatic sys-
tem
Astrocytes maintain water homeostasis and regulate extracellular volume in the brain
by virtue of high expression of aquaporin (AQP) channels. AQP4 is the most preva-
lent AQP in astrocytes, predominantly located at perivascular endfeet and, to a lesser
extent, processes around excitatory synapses [239]. AQP4 channels were also linked to
astrocyte [Ca2+]i elevations induced by osmotic stress [358]. AQP4 are also critical for
the operation of the glymphatic system [150] (Figure 1.4 C). The glymphatic system
clears cell waste accumulated in the brain. The system consists of a periarterial cere-
brospinal fluid influx route and a perivenous interstitial fluid clearance path, coupled
by convective flow facilitated by astrocytic AQP4 channels [155]. Interestingly, AQP4
isoforms (M23) regulate the motility of astrocyte process and glutamatergic synaptic
transmission [75]. The position of astrocyte processes in relation to synapses is likely
to have diverse effects on synaptic activity depending on the specific proteins expressed
at the respective processes (i.e. transporters, channels and receptors).
1.2.4 Neurotransmitter homeostasis
Astrocytes rapidly remove neurotransmitters released by synapses in the extracellular
fluid (Figure 1.4 B, middle), and constrain their spill over to nearby synapses [305]
(Figure 1.4 A). Astrocytes uptake the majority of glutamate released by synapses
(>80%) through high affinity excitatory amino acid transporters (EAAT) 1 and 2,
optimizing neuronal function and preventing excitotoxicity [213]. Considering that
astrocytes can also release glutamate [214] astrocytes may maintain homeostasis by
balancing the opposing functions of glutamate uptake and release [213]. Uptaken glu-
tamate is converted to glutamine through the enzymatic action of glutamine synthetase
that is expressed in astrocytes but not neurons [218], or used as energy by converting
it to a-ketoglutarate used in ATP synthesis [323]. Glutamine transported to neu-
rons is resynthesized to glutamate or gamma aminobutyric acid (GABA) and concen-
trated into vesicles to be released as a neurotransmitters. This is referred to as the
glutamate/GABA-glutamine cycle [28]. Similarly, astrocytes uptake GABA through
GABA transporters (GAT) 1 and 3 where it is converted to glutamine or metabolized
to succinic semialdehyde [106]. The number, position and distance of EAATs (and
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Figure 1.5: Astrocyte regulate the energy supply of the brain. Current model
on how astrocytes regulate energy supply. Astrocytes regulate the supply of nutrients
by modulating the contractility of pericytes. Astrocyte [Ca2+]i elevation activates an
enzymatic cascade that leads to prostaglandin release, relaxing pericytes and dilating
blood vessels. Glucose can be taken up by neurons and astrocytes directly and used in
glycolysis. In astrocytes glucose can be converted to glycogen for storage. Alternatively,
astrocytes can produce lactate and shuttle it to neurons through monocarboxylate
transporters (MCT) to use as energy source. For more detailed description of the
model see [252]. Image taken from [252].
other transmitter transporters) relative to synapses is likely to be important in synap-
tic modulation by controlling the spatiotemporal characteristics of neurotransmitter
concentration availability at the synapse. For example, surface diffusion of glutamate
transporters is modulated by synaptic activity and can influence synaptic transmis-
sion [237]. Similarly transient receptor potential cation channel subfamily A member
1 (TRPA1) mediated [Ca2+]i elevation in astrocytes increase GAT-3 insertion in the
membrane thus regulating GABAergic signaling [333]. Thus astrocyte [Ca2+]i elevation
could lead to insertion of transporters near synapses to modulate synaptic activity.
1.2.5 Metabolic support
The human brain consumes ≈20% of the body’s energy, mainly to reverse ion fluxes
involved in synaptic transmission [128]. Disruption in brain energy supply, quickly
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leads to cell injury and death. Therefore, it is important to dynamically match energy
supply to fluctuating demands. The response of increasing blood flow in response
to higher neuronal activity is termed functional hyperaemia [21]. Astrocytes cover
blood vessels with specialized endfeet [220] and enwrap synapses, the main energy
consumers of the brain, with their fine processes [6] (Figure 1.5). They are thus in
a privileged position to regulate functional hyperaemia. Early studies revealed that
astrocyte [Ca2+]i elevation led to dynamic control of microcirculation, mediated by
arachidonic acid derivatives [416] [236] [120] [353]. How astrocytes are involved in
functional hyperaemia is still under intense investigation and debate, but it seems to
involve the coordinated action between multiple cell types [252] (Figure 1.5). One
important issue was that somatic Ca2+ signals in astrocytes triggered by neuronal
activity were too slow to have a causative effect on neurovascular coupling. However,
neurovascular coupling might be mediated by faster, inositol trisphosphate receptor
(IP3R)-2 independent [Ca2+]i elevation. Astrocyte [Ca2+]i elevation (i.e. through
ATP-gated P2X1 channels) can trigger an enzymatic cascade leading to the release
of prostaglandin E2 acting on pericytes who can relax and dilate capillaries [229].
Diffused glucose then enters both neurons (via GLT3) and astrocytes (via GLT1) to be
used for glycolysis [226]. In astrocytes glucose can be converted and stored as glycogen.
Pyruvate produced by glycolysis can be used by mitochondria for ATP production or be
converted to lactate. According to the lactate shuttle hypothesis, lactate produced by
astrocytes can be delivered to neurons (via monocarboxylate transporters) as an energy
source [210] but the idea is still controversial [226]. Overall, astrocytes, along with other
glia and neurons, play important roles in the regulation of energy supply in the brain.
The discovery of fast Ca2+ signals in astrocyte processes and in vivo preparations may
help elucidate the functional role of astrocytes in functional hyperaemia [258]
1.2.6 Perspective
While Ca2+ mediated gliotransmission has gained enormous attention and popularity
as a means for astrocytes to modulate synaptic activity, the homeostatic functions of
astrocytes in regulating synaptic circuits shouldn’t be neglected. By mediating K+
uptake astrocytes control synaptic excitability. The motility of astrocyte processes
and recruitment of channels, exchangers and pumps in PAPs could modulate neuronal
activity by controlling the rate of transmitter and ion fluxes. Homeostatic processes
can also be actively mediated by astrocytic Ca2+ signals and in turn can influence
neuronal activity. It is thus possible that many of the effects attributed to the Ca2+
induced release of gliotransmitters may have been artifacts of astrocytes maintaining
homeostasis. Considering that astrocytes are the principal homeostatic cells of the
brain, would it be surprising if astrocyte Ca2+ signals often triggered by artificial
neuronal stimuli, are responses of astrocytes trying to re-establish homeostasis?
1.2.7 Control of synapse form and function
Beyond their homeostatic function, astrocytes are required for the formation and func-
tion of synapses. Seminal work by the Barres laboratory revealed that neurons grown in
co-cultures with astrocytes had seven times more mature, functional synapses compared
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Figure 1.6: Astrocytes control synaptic form, function and elimination. A)
Astrocytes induce the formation of structural synapses by releasing thrombospondins
(TSPs) and hevin. B) They can induce functional synapse formation through the
release of glypicans and C) eliminate synapses directly through MEGF10 and MERTK
mediated phagocytosis or indirectly by tagging synapses for elimination by microglia.
Image taken from [6].
to isolated neuron cultures [287] [365]. The role of astrocytes is synapse formation was
demonstrated across species and types of synapse [6]. Astrocytes control the formation
of synaptic structure, function and elimination by releasing different molecules. For
example, releasing thrombospondins [72] and hevin [189] induces structural synapse
formation (Figure 1.6 A). These synapses are presynaptically active but postsynap-
tically silent. Releasing the hevin antagonist SPARC inhibits synapse formation and
function [205] [4]. Astrocyte can enhance pre-synaptic function by releasing cholesterol
[221] and postsynaptic function by regulating the number (tumor necrosis factor alpha
(TNFα)) [343] and localization (Glypicans) [7] of AMPARs (Figure 1.6 B). Astrocytes
also regulate synapse elimination directly through phagocytosis [74] and indirectly by
tagging synapses for elimination by microglia [315] [46] (Figure 1.6 C). The hetero-
geneity of astrocytes and the mechanisms of synaptogenic signal release in the control
of synaptic development is currently an active frontier in the field. Interestingly, there
is in vitro evidence suggesting that astrocyte synaptogenic factor release can be reg-
ulated by ATP (thrombospondins) [362] and glutamate (SPARC, TNF-a) [159] [342].
Also, the effect on synaptogenic factors could have synapse specific roles [301]. Given
that astrocytes are known to respond to neurotransmitters (i.e. ATP and glutamate)
with [Ca2+]i elevations it will be interesting to determine if the release of synaptogenic
factors is calcium dependent and to elucidate the mechanisms and conditions of their
release in vivo.
1.2.8 Reactive astrocytes and pathology
Astrocytes are involved in the coordinated multicellular response to brain trauma, dis-
ease and inflammation. Astrocytes respond to pathological conditions and undergo a
spectrum of morphological and functional changes; collectively referred to as reactive
astrogliosis [338]. Reactive astrocytes were originally characterized by overexpression
of GFAP and hypertrophy [36]. It is now becoming evident that astrogliosis is not
a binary state, but rather a heterogeneous, graded continuum of context dependent
changes in gene expression, morphology and function [9] [228]. Recent collaborative
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work between the Barres and Steven laboratories [199] revealed two distinct types of re-
active astrocytes termed A1 and A2. A1 astrocytes are induced by activated microglial
secretion of Il-1α, TNF and C1q cytokines and are lethal to neurons and oligodendro-
cytes. In contrast, A2 astrocytes upregulate neurotrophic genes and promote neuron
survival. Considering the volatile nature of astrocyte identity, gene expression and
function during pathological conditions it is worth asking whether experiments assess-
ing physiological aspects of astrocytes in cultures, slices and maybe even in vivo are
investigating a reactive state of astrocytes. Indeed, Takano et al. [354] showed that
astrocytes in slice preparation exhibit observable reactive changes shortly (≈90 mins)
after acute slice preparation. Another intriguing question is how different types of
reactive astrocytes contribute to pathology and whether selective manipulation of as-
trocytes using pharmacology or gene therapy can be used to treat disease. Astrocytes
are involved in epilepsy, Alzheimer’s disease, Huntington’s disease, amyotrophic lat-
eral sclerosis, CNS trauma, stroke, infections, cancer, psychiatric disorders, and others
[338]. Reactive astrocytes also exhibit aberrant Ca2+ signalling generally character-
ized by increased amplitude, frequency and duration [336]. Astrocytes rapidly respond
with [Ca2+]i elevation to kainate induced epilepsy [138]. Reactive astrocytes display
high frequency Ca2+ signals and Ca2+ waves close to amyloid plaques in Alzheimer’s
disease model mice in vivo [90] [188]. The amplitude of Ca2+ signals was higher in the
ischemic core compared to the penumbra region in acute stroke models [94]. Addition-
ally, metabotropic glutamate receptors (mGluR5), often implicated in Ca2+ induced
gliotransmission [260], while normally downregulated with age [350], are upregulated
in reactive astrocytes [17] [366] [177]. Other receptors implicated in Ca2+ signalling
are also upregulated in reactive astrocytes. For example, purinergic P2Y1 receptors
[90] [187] [390] and TRP channels (TRPC4) [97] are upregulated during pathology.
Reactive astrocytes can in turn release gliotransmitters. For example, they can re-
lease tonic GABA though bestrophin-1 channels or GABA transporter reversal [158]
[401] [73] and release neurotoxic levels of glutamate [375] [306]. Reactive astrocyte
mGluR5 mediated [Ca2+]i signals may lead to thrombospondin 1 (TSP1) upregulation
which contributes to synaptic remodelling and plasticity [177]. Therefore, the reactive
state of astrocytes might be involved in Ca2+ mediated synaptic modulation by as-
trocytes. Similarly, the sensitivity of astrocytes to neuronal stimulation might depend
on pathology. For example, striatal astrocytes of wild type mice did not respond to
cortical stimulation while Huntington’s disease model astrocytes responded robustly
with Ca2+ signals [157]. Since every experimental preparation disturbs the system in
some way, different reactive responses might be induced in astrocytes, depending on the
specific experimental protocol. It is thus very important to maintain physiological con-
ditions in experimental preparations assessing the functions of (healthy/non-reactive)
astrocytes.
1.3 Astrocyte calcium signalling
Astrocytes, just like other glia, are electrically silent [190] as revealed by traditional
electrophysiology techniques. Since astrocytes were not amenable to electrophysiolog-
ical methods used to advance our understanding of neurons, the functional roles of
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astrocytes were neglected. This changed with the discovery and introduction of cal-
cium dyes that revealed chemical excitability of astrocytes in the form of Ca2+ signals
[79]. Astrocyte [Ca2+]i signals are now thought to act in synergy with neuronal activity
to process information in the brain [16] [32]. We will explore how Ca2+ provides the
substrate of astrocyte excitability and its role in information processing.
1.3.1 Calcium: the ubiquitous second messenger
In the furnace of red giants calcium was born through the fusion of helium and argon.
10 billion years after stellar nucleosynthesis and exploding stars, calcium found its way
into every cell. Cells evolved to separate their universe by charge, locally decreasing
entropy by parsing ions through semi-permeable membranes. Calcium was abundantly
available to them (3rd most common metal in nature). Cells possibly evolved to lower
intracellular concentration of calcium to avoid the formation of poorly soluble calcium
phosphate salts that would interfere with phosphate based bioenergetics. Once cells
developed the means to maintain low [Ca2+]i concentration (≈50-100nM) compared to
the extracellular space (≈20000 times higher) they gained an ideal signalling agent.
With the development of multicellularity, life already had the machinery available for
communication through calcium. As the complexity of signal transduction increased,
more numerous and elaborate systems developed to control [Ca2+]i [77].
The biophysical properties of calcium allow it to be readily accepted by protein
sites with irregular geometry. Within the cell, calcium binds to proteins carrying
EF hands such as Calmodulin and S100. The binding of Ca2+ induces conformational
changes in proteins, exposing hydrophobic patches on protein surfaces that allows them
to interact with targets. Ca2+ is involved in the control of a variety of enzymatic
cascades and thus acts as a universal signaling ion. A large number of transporters
and exchangers are involved to maintain Ca2+ homeostasis. Cytosolic calcium buffers
with high affinity to Ca2+ bind the ions and limit their diffusion. Ca2+ in the cell is
typically concentrated in the endoplasmic reticulum (ER) and other organelles such as
lysosomes and mitochondria. The movement of Ca2+ between the extracellular space
and the cell, or between and within intracellular components is referred to as: calcium
signals. Physical and chemical cues can trigger calcium signals [285] [49] [61][77] [60].
Mammalian life begins with a global calcium signal sweeping through the egg [233].
Since then, calcium is involved in many aspects of cellular life including embryonic
pattern formation, cell differentiation, cell proliferation, transcription factor activation,
chemical signalling, and apoptosis [40]. In astrocytes, Ca2+ signals are thought to also
be involved in the release of “gliotransmitters” i.e. (ATP, glutamate, D-serine) [16], the
motility of their processes [38] neurovascular coupling [258], receptor trafficking [333],
K+ homeostasis [385], and others. How can Ca2+ elevation regulate so many different
processes? The answer likely lies in the versatility of Ca2+ signalling mechanisms and an
extensive repertoire of calcium sensitive molecular signalling components. The spatio-
temporal patterning of calcium signals can recruit different combinations of messenger
molecules leading to distinct outputs and interactions with other signaling pathways
[40]. Cells use this versatility to regulate a diversity of cellular processes through precise
control of Ca2+ levels.
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Figure 1.7: Ca2+ sources and sinks. The [Ca2+]i of the cell is dynamically reg-
ulated through channels, pumps and transporters expressed in the plasma membrane
and organelles of the cell. High [Ca2+] from the extracellular space can enter the cell
through: ligand gated ion channels, voltage gated Ca2+ channels, TRP ion channels,
Orai channels and the reversal of Na+/Ca2+ exchangers (NCX). Low cytoplasmic [Ca2+]
can be maintained through the expulsion of cytoplasmic Ca2+ to the extracellular space
through plasma membrane Ca2+ ATPase (PMCA) pumps and NCX. Alternatively, cy-
toplasmic Ca2+ can be sequestered within organelles such as the endoplasmic reticulum
(ER), acidic organelles (i.e. lysosomes) and mitochondria; for example through plasma
membrane Ca2+ ATPaseas (PMCAs), mitochondrial calcium uniporters (MCU) and
Na+/Li+/Ca2+ exchangers (NLCXs). The same organelles can also act as sources of
cytoplasmic Ca2+. They can release Ca2+ into the cytoplasm through: indirect G-
protein coupled receptor (GPCR) mediated opening of inositol trisphosphate receptors
(IP3Rs), ryanodine receptors (RYRs), TRP melastatin channels (TRPM) and NCLX
among others. Together, Ca2+ sources and sinks control the flux of Ca2+ and mediate
Ca2+ signalling in cells. image taken from [335].
1.3 Astrocyte calcium signalling 17
1.3.2 Generation of Ca2+ signals
Cells generate Ca2+ signals using internal and external sources of calcium to increase
cytoplasmic [Ca2+] by an order of magnitude. They have mechanisms for increasing
(ON mechanisms) and decreasing (OFF mechanisms) [Ca2+]c (Figure 1.8 A, C). The
ON mechanisms rely on channels controlling the passage of Ca2+ from the extracellular
fluid (≈2mM) or intracellular stores (≈0.2-0.8mM) into the cytoplasm (≈150nM) [335].
Ca2+ influx into the cell can occur through: a) ligand-gated-ion channels such as ATP-
gated P2X channels [251], b) voltage-gated calcium channels [20], c) TRP channels
[374], d) store operated Ca2+ entry through Orai channels [193], mechanically gated
piezo channels [266] and e) Sodium-calcium exchangers (NCX)[378]. Alternatively,
stored Ca2+ can be released into the cytoplasm by organelles. One of the most well
studied mechanism is the G-coupled activation of IP3Rs of the endoplasmic reticulum.
This involves the binding of agonists on G-protein coupled receptors (GPCR). GPCRs
are classified into four families: Gs, Gi/o, Gq/11 and G12/13 [139]. We will focus on
the Gq/11 family. Agonist binding on Gq/11 GPCRs activates inositol triphosphate
(IP3) synthesis via the cleavage of phosphatidylinositol bisphosphate (PIP2) by phos-
pholipase C (PLC). IP3 diffuses and binds to IP3R receptors of the ER. Binding of
both IP3 and Ca2+ triggers IP3R opening and release on Ca2+ into the cytosol [50]
[39]. GPCR ligands include neurotransmitters and neuromodulators. In astrocytes
Gq/11 GPCRs include, noradrenergic receptors [93], muscarinic acetylcholine recep-
tors [356], and metabotropic glutamate receptors (mGluR1 and 5) [53]. Note however
that mGluR5 are downregulated with age [350] while other mGluRs found in astrocytes
such as the Gi/o mGluR3 that inhibits cyclic AMP production may raise [Ca2+]i in
astrocyte processes [129]. Once the ligand binds it can be amplified. Other organelles
and channels, such as mitochondria [2] and lysosomes are also involved in the intricate
control of intracellular calcium concentration [335] [295]. A summary of Ca2+ sources
and sinks in the cell is illustrated in Figure 1.7.
1.3.3 Spatiotemporal organization of Ca2+ signals
Once [Ca2+]i increases in the cytoplasm it binds to Ca2++-binding proteins that func-
tion as calcium effectors or buffers (Figure 1.8 A). Buffers (involved in OFF mecha-
nisms) with different kinetics and affinity to Ca2+ (i.e. calretinin, calbindin, parvalbu-
min), fine-tune the spatiotemporal properties of the Ca2+ signal [29]. The important
role of Ca2+ buffers in astrocyte Ca2+ signalling is not well explored yet. The small
portion of free cytosolic calcium remaining, binds to effector proteins such as calmod-
ulin, synaptotagmin, S100 or annexins [29]. These proteins amplify the diminutive size
of Ca2+ ions to the scale of proteins. For example, Ca2+ can bind to the EF-hand do-
mains of calmodulin (CaM) recruitment sites changing its shape [142]. Since hundreds
of proteins contain CaM recruitment sites who can undergo conformational changes
when CaM binds Ca2+ [77], it is easy to imagine the diverse influence of calcium on
cellular processes. Many Ca2+ signaling molecules are organized into complexes (Fig-
ure 1.8 D) where the effect of Ca2+ is localized. These complexes can operate as au-
tonomous units with different properties from their neighbours allowing calcium signals
to be spatially organized. The spatial organization of Ca2+ signals is very important
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for rapid responses [29]. The endoplasmic reticulum endowed with IP3Rs distributed
on its surface is an important contributor to the spatial organization of Ca2+ signals.
Stimuli of increasing strength can open single IP3Rs (blips), groups of IP3Rs (Puffs),
or trigger a chain reaction of opening neighbouring IP3Rs leading to a calcium wave
that can propagate between cells through gap junctions [40]. IP3R2 are enriched in
astrocytes [59] and have been the main focus of studying calcium signals in astrocytes.
Additionally, effector proteins operate over a wide temporal spectrum (Figure 1.8
C), ranging from microseconds (i.e. exocytosis) to hours (i.e. fertilization). Regula-
tion of transcription can extend the temporal reach of Ca2+ signals even further [29]
[77]. Cytoplasmic calcium is rapidly sequestered (OFF mechanisms) by mobile calcium
Figure 1.8: A diverse Ca2+ signalling toolkit allows versatile control of cel-
lular processes. (caption next page.)
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Figure 1.8: (previous page.) A) Ca2+ mobilizing signals (blue) often triggered by
stimuli acting on plasma membrane receptors (R) lead to increase in [Ca2+]i (ON
mechanisms; green). ON mechanisms can activate a variety of Ca2+ sensitive processes
(salmon-red) depending on the context and cell type. The transient elevation of [Ca2+]i
returns to baseline through the action of OFF processes (dark orange) that sequester
Ca2+ inside organelles or dissipate Ca2+ outside of the cell. B) The Ca2+ signalling
toolkit can interact with other signalling pathways such as the cyclic AMP (1) signalling
system, (2) nitric oxide (NO) synthesis system, (3) phosphoinositide 3-kinase (PI3K)
system, (4) Ca2+ positive and negative feedback interactions and (5) mitogen activated
protein kinase (MAPK) interactions. The type and nature of interactions enables
flexible, complex non-linear information processing by the cell. C) A tight balance
between ON and OFF processes enables Ca2+, acting through effector proteins to
influence cells dynamically over a large temporal scale, ranging from µs to hours. D)
Also, the components of different Ca2+ signalling systems are grouped together into
multimolecular complexes, allowing calcium to act differently in space depending on
the interacting complexes found there. Two examples of such systems are the NMDA
and Inositol trisphosphate receptor (IP3R) complex (top) and synaptic vesicle complex
(bottom) of neurons. The complex interaction of Ca2+ signals with effector proteins in
astrocytes is still in its infancy. Panels A & B were taken from [40]; C & D were taken
from [41].
buffers, extrusion from the cell, or through the elaborate network of calcium storing
organelles. For example, Ca2+ is extruded from the cell by plasma membrane Ca2+ AT-
Pase (PMCA) pumps, NCX or mobilized inside the ER by sarco-endoplasmic reticulum
ATPase (SERCA) pumps [40].
1.3.4 Diverse types of astrocyte Ca2+ signals
The spatiotemporal characteristics of calcium signals established through ON and OFF
mechanisms and a complex network of effector proteins are vital for the versatile con-
trol of cellular processes. Astrocytes display Ca2+ signals with a broad range of spa-
tiotemporal characteristics (Figure 1.9). These include: a) the predominant, sponta-
neous, highly localized microdomain Ca2+ signals observed in branches and branchlets
(Figure 1.9) [332] [333] [334] [274] [129] [344] [345] that are independent of neuronal
stimulation and are not abolished in IP3R2 KO mice [129] b) localized, microdomain
Ca2+ signals triggered by neuronal stimulation (Figure 1.10) [92] [261] [47] [344] [345]
c) local calcium waves that can occur spontaneously in major branches and somata
(Figure 1.9) [129] [157] d) global Ca2+ waves encompassing the whole astrocyte that
are largely mediated by IP3R2 receptors and can be triggered by intense neuronal
stimulation [129] e) synchronous, pan-astrocytic, Ca2+ signals triggered by locomotion
or startle responses driven by volume transmission of neuromodulators (Figure 1.11
C)[93] [249] [274] [341]. f) localized, mitochondria driven Ca2+ signals that can be
modulated by neuronal activity [2]. g) Ca2+ signals localized to astrocyte endfeet [347]
[102] [258] [345]. It is likely that astrocyte nanodomain signals represent another type
of Ca2+ signaling, however these remain largely unexplored at the moment because of
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Figure 1.9: Localized Ca2+ microdomains in astrocyte processes. Represen-
tative image of a hippocampal astrocyte (blue boundary) labelled with cyto-GCaMP6f
and traces from three predominant types of astrocyte signals: somatic (green), waves
(red) and microdomains (yellow). Astrocytes exhibit a range of Ca2+ signals. Image
taken from [341].
technical challenges. Astrocyte Ca2+ signals of different spatiotemporal characteristics
likely mediate diverse astrocyte mechanisms and responses yet to be discovered. While
astrocyte Ca2+ plays important roles in most aspects of cell and network physiology,
we will focus on its role in astrocyte - neuron interactions.
1.4 Astrocyte calcium responses to neuronal activity
1.4.1 Early studies revealed reliable astrocytic Ca2+ responses
to neuronal stimulation
The active role of astrocyte signalling in information processing was only recently ap-
preciated and actively investigated, largely because of technical developments. Appli-
cation of Ca2+ imaging techniques in the 1990s revealed that astrocytes display [Ca2+]i
elevation in response to neurotransmitters. Cornell-Bell et al. [79] showed that culture
hippocampal astrocytes from postnatal rats labelled with fluo-3 respond to glutamate
with cytoplasmic [Ca2+]i elevation in the form of propagating waves. This observation
raised the possibility that astrocytes might respond to synaptic glutamatergic activity.
Electrical stimulation of mossy fibers in organotypic culture slices triggered calcium
waves is CA3 astrocytes [87]. These findings were then supplemented by Porter and
McCarthy [291] in acute hippocampal slices loaded with the calcium sensitive dye Cal-
cium Green-1. Electrical stimulation of Schaffer collaterals resulted in [Ca2+]i elevation
in CA1 astrocytes that was inhibited by blocking neuronal activity and mGluRs. These
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experiments suggested that astrocytes can respond to neuronal glutamate with mGluR
mediated [Ca2+]i elevation. Astrocytes express a variety of transmitter receptors that
bind glutamate, GABA, adenosine, ATP, histamine, noradrenaline and acetylcholine
[352]. The natural next question was whether astrocytes respond to neurotransmitters
associated with these receptors.
A wave of discoveries revealed that astrocytes in brain slices of young rodents
respond with [Ca2+]i elevation to a variety of neurotransmitters released by neurons
such as glutamate [272], GABA [165], noradrenaline [192], and acetylcholine [15]. These
long lasting somatic Ca2+ elevations were triggered by GPCR activation leading to IP3
mediated Ca2+ release from the endoplasmic reticulum [276]. Furthermore, the synaptic
control of astrocyte Ca2+ signals was demonstrated in various brain areas, such as the
hippocampus [272] [43] [15]; cortex [282]; cerebellum [123] and retina [246]. A decade of
experiments by different groups using a variety of methods in different brain areas made
a convincing argument that immature rodent astrocytes reliably respond to neuronal
transmitter release with long lasting (10s of seconds) somatic responses ex vivo.
The next step was to confirm whether astrocytes respond to neuronal activity un-
der physiological conditions in vivo. Once again, this leap in experimental design
was enabled by advancements in imaging and indicator labelling; namely two photon
microscopy and the development of genetically encoded calcium indicators (GECIs).
First, two-photon microscopy combined with bulk loading of calcium dyes pioneered
the study of astrocyte signaling in vivo. The Nedergaard group [387] used two-photon
microscopy in anesthetized adult-mice to monitor Ca2+ responses in S1, L2, Fluo-4 AM
labelled astrocytes (bulk loaded with SR101 marker) to air-puff whisker stimulation.
They found reliable somatic [Ca2+]i responses in astrocytes following high frequency
(5Hz) whisker stimulation. The amplitude of these slow Ca2+ responses (peak at ≈9s,
with onset time ≈3s after whisker stimulus) were reduced with mGluR1 and mGluR5
antagonists, reinforcing the idea that astrocytes respond to glutamatergic signalling
with [Ca2+]i elevation. Similar results were observed by other groups. Hirase et al.
[140], found that increased neuronal activity was associated with enhanced [Ca2+]i ele-
vation in Fluo-4 AM labelled astrocytes of the rat barrel cortex (layer I/II). Schummers
et al. [325] found that ferret, visual cortex astrocytes loaded with OGB1 and SR101
respond to visual stimuli with spatial receptive fields tuned to feature orientation and
spatial frequency similar to neurons. Together, these findings suggested that dye la-
belled astrocytes respond to neuronal stimuli with robust somatic [Ca2+]i elevations in
anesthetized animals.
1.4.2 Do astrocytes respond with transient elevation of [Ca2+]i
to neuronal activity?
Recent studies have shown weak or a lack of astrocyte responses to sensory stimulation
of the somatosensory [93] [250] and visual cortex [274] [48] [18]. It was realized that
general anesthetics, used in previous studies, strongly suppressed cortical astrocyte
Ca2+ signals [359]. Interestingly, blocking synaptic activity (TTX, CNQX, AP5) in
the cortex had minor effects on somatic Ca2+ signals of astrocytes labelled with the
calcium indicator rhod-2 acetoxymethyl in awake animals [359]. It was also found that
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in awake mice, astrocytes (rhod-2 labelled) don’t respond to glutamatergic signals trig-
gered by sensory stimulation [93]. Instead they found that cortical astrocytes respond
with widespread Ca2+ activity to noradrenergic signals from locus coeruleus (LC) pro-
jections by activating astrocytic α1 adrenergic receptors [93]. The same observation was
also made in visual cortex (V1) and cerebellar GCaMP3 labelled astrocytes of awake
mice [274]. Interestingly, while V1 astrocytes rarely responded to light stimulation
alone, pairing the light stimulus with noradrenaline (NA) release enhanced astrocyte
Ca2+ responses to the light stimulus. These findings suggested that NA might shift
the gain of astrocytes to local synaptic activity. Similarly Bonder & McCarthy [48]
found changes in Ca2+ elevation in V1 astrocytes labelled with cyto-GCaMP3 and lck-
GCaMP6f in response to startle responses (air puff) but not with visual stimulation.
Also an extensive study using GECIs, glutamate indicators (iGluSnFR), pharmacoge-
netic and electrical modulation of neurotransmitter release in the hippocampal mossy
fiber astrocytes found no evidence of astrocyte Ca2+ microdomain responses to neuronal
activity or glutamate release [129]. Similarly, TTX had no effect on astrocyte calcium
signals (CA1 of hippocampus and dorsolateral striatum) [67]. Interestingly, the relia-
bility of astrocytic Ca2+ responses to electrical stimulation of input neurons increased
only during high frequency stimulation in the hippocampus but not in the striatum
[67]. In both regions astrocytes responded strongly to α1 adrenoreceptor agonists [67].
Together these reports questioned the role of sensory driven, neurotransmitter induced
astrocyte Ca2+ stimulation and pointed to neuromodulators as the strong influencers
of astrocyte activity. They also suggest possible heterogeneity of responses in different
astrocytes that may also depend on the stimulation frequency.
At about the same time, doubt of earlier findings started accumulating. The expres-
sion of mGluR5, the Gq-coupled metabotropic receptor commonly thought to generate
IP3 and Ca2+ release from the endoplasmic reticulum in response to neuronal activ-
ity, was found to decrease in mature astrocytes [59]. The mRNA expression of these
receptors was undetectable 3 weeks postnatally and mGluR5 agonists didn’t induce
somatic [Ca2+]i elevation in adult astrocytes [350]. However, mRNA level may not
predict protein level and mGluR5 may be found in astrocyte processes instead of so-
mata [195]. Also, EM studies cast doubt about whether there are calcium stores in thin
astrocyte processes apposed to synapses [273]; although these results could have been
confounded by fixation conditions. Together these findings questioned the mechanism
by which [Ca2+]i is raised. It was also becoming apparent that the speed of astrocyte
[Ca2+]i elevation was too slow to be involved in fast synaptic processing.
Astrocytes possess functionally independent subcellular compartments. Recent
work identified short duration Ca2+ signals localized within fine astrocyte processes
[123] [249] [332] [261] [92] [333] [334] [164] [18] [258] [341] [2] [47] [201] [344] [345].
Some of the earlier studies using patch mediated dye loading revealed Ca2+ transients
localized along astrocyte processes in response to supramaximal (bergmann glia [123])
or minimal synaptic stimulation [261] (CA1 of hippocampus). Spontaneous transmitter
release triggered brief, localized (≈0.7s, ≈4µm) transients in astrocyte processes while
action potentials triggered longer lasting, expanded (≈ 3s, ≈12µm) events. However,
patch loaded dyes dialyze and disturb astrocyte function [245] and they are difficult to
load. Patch loading of Ca2+ indicators can alter cell physiology [296]. The high dye
concentration often needed to study astrocyte microdomain signals [361] potentially
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buffers these signals. GECIs alleviate some of these challenges. Different strategies
have been developed to express GECIs in astrocytes to visualize microdomain Ca2+
signals. Kanemaru et al. [164] used transgenic mice expressing the ratiometric Ca2+
indicator yellow Cameleon-Nano in astrocytes to reveal localized microdomain Ca2+
signalling. Interestingly they also showed that microdomain Ca2+ signals were not
abolished in IP3R2 KO mice. The Ca2+ signals they detected were large (≈10µm) and
slow (≈40s to half peak). However, the duration might be an artifact of the indica-
tor used rather than a good estimate of intrinsic Ca2+ dynamics. Asada et al. [18]
used this ratiometric indicator in combination with 2 photon microscopy to investigate
the effect of visual stimuli in V1 astrocyte Ca2+ microdomain signals. Visual stimuli
didn’t change the frequency of Ca2+ microdomain events. Instead the size of these
events increased with visual stimuli and decreased with the application of TTX.
Single wavelength GECIs can be tethered to the astrocyte membrane (lck-GCaMP),
allowing the investigation of near-membrane Ca2+ activity [332] [333] [334], [341] [345].
This is important because astrocyte responses to synaptic activity are expected to oc-
cur near the membrane and it helps avoid large, global cytoplasmic signals that could
mask such responses. These membrane Ca2+ events were reduced (to 40%), but not
abolished in IP3R2 KO mice. This was in contrast to somatic Ca2+ responses which
were reduced by ≈90% in IP3R2 KO mice [341]. Removing extracellular Ca2+ reduced
the frequency of Ca2+ events at the processes (by 50-75%) but not at the cell body.
These findings suggest that the long duration signals observed in somata and thick
astrocyte processes are mediated through Ca2+ release from internal calcium stores
(i.e. ER) while the short duration events observed at astrocyte processes are largely,
but not exclusively, mediated by transmembrane entry of Ca2+ (i.e. through TRPA1
channels) [333]. Mitochondria are also thought to induce microdomain calcium tran-
sients in astrocytes [2]. Astrocyte microdomain calcium transients were colocalized
with the position of mitochondria. Microdomain Ca2+ transients were reduced with
mitochondrial permeability transition pore (mPTP) inhibition (CsA and rotenone)
and enhanced with mPTP opening (CAtr). These findings suggest that some astro-
cyte Ca2+ transients are mediated by mitochondria. Increasing neuronal activity with
picrotoxin (GABA-A receptor antagonist) increased the number (by ≈50%) and fre-
quency (≈60%) of microdomain Ca2+ transients who were mediated by mPTP opening.
These mitochondrial Ca2+ transients may be linked to local metabolic demand.
The idea that astrocytes respond with fast, micrometer scale Ca2+ transients to
neuronal stimulation in vivo is still on the forefront of astrocyte research today. In a
recent report, Stobart et al. [345] used a combination of GECIs to label barrel cortex
(layer II/III) neurons (RCaMP1.07) and astrocytes (GCaMP6f) simultaneously using
two photon excitation microscopy (2P) in awake mice. They revealed a subset (≈8%)
of microdomain Ca2+ signals that rapidly followed neuronal events (≈120 ms delay)
evoked by high frequency (90Hz, 8s) single whisker stimulation (Figure 1.10 B). These
events were IP3R2 and neuromodulator (acetylcholine, noradrenaline and serotonin)
activity independent. They were only found in preparations with membrane tagged
GCaMP (lck-GCaMP6f). Furthermore, advances in 3D imaging used in combination
with GECIs expressed in neurons and astrocytes of the adult mouse hippocampus (en-
torhinal cortex) during minimal or tetanic axon stimulation protocols revealed robust
astrocyte microdomain (≈60um3) Ca2+ responses blocked by TTX (Figure 1.10 A)
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Figure 1.10: Astrocytes responding to neuronal stimulation with Ca2+ mi-
crodomain signals. A) Minimal stimulation of a jRCaMP6f labelled axon (cyan
trace) within the vicinity of a GCaMP6f and SR101 labelled astrocyte with a quantum
dot (QD)-coated pipette (green) leads to synchronized Ca2+ responses in axons and
adjacent astrocytic microdomains in hippocampal slices that are abolished by TTX.
Orange arrows represent the onset of stimuli. B) Similar observations were made in
vivo, in L2/3 of the somatosensory cortex in response to long, high frequency whisker
stimulation (90Hz, 8s). A subset of fast Ca2+ microdomains (MDs; yellow ROIs; green
traces) in lck-GCaMP6f labelled astrocytes respond to whisker stimuli with a similar
onset latency as neurons (purple) labelled with RCaMP, as indicated by representative
traces during line scans (white arrow on image; middle traces) and frame scans (right
traces). Panel A was taken from [47] and panel B images were selected from [345].
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[47]. These modern studies support high responsiveness of astrocyte microdomains to
neuronal activity. They argue that the reason for conflicting reports was methodologi-
cal. For example, 2D studies may have missed actively responding regions to neuronal
activity that could be resolved in 3D imaging studies or without the use of membrane
bound GECIs. Interestingly, Ca2+ microdomain activity may be circuit specific. Opto-
genetic stimulation of paravalbumin or somatostatin expressing interneurons triggered
different Ca2+ responses in astrocytes [215]. This suggests that astrocytes may respond
distinctively to different neuronal populations. While the responsiveness of astrocyte
microdomains to physiological neuronal activity and neurotransmitter release is still
under debate, recent evidence in vivo support the idea that astrocytes respond to mini-
mal neuronal stimulation with fast (timescale of neuronal calcium signals) and possibly
circuit specific microdomain Ca2+ responses.
Figure 1.11: Neuromodulators modulate astrocyte Ca2+ signalling. (caption
next page.)
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Figure 1.11: (previous page.) A) The locus coeruleus (LC) sends noradrenergic
projections to the whole brain (with the notable exception of the basal ganglia). B)
Noradrenaline (NE or NA) can activate astrocytic α1 receptors that trigger a G-coupled
cascade leading to the release of Ca2+ from internal stores. Glutamate (Glu) may po-
tentiate the release of Ca2+ triggered by noradrenaline through activation of G-coupled
receptors or by slowing down the efflux of Ca2+ by Na+/Ca2+ exchangers (NCX). Other
plasma membrane channels such as TRPA1 and P2X1 and internal stores such as mi-
tochondria might contribute as well. [Ca2+]i elevation may then trigger the release
of gliotransmitters (i.e. ATP, D-serine, GABA and glutamate) and other mechanisms
involved that can modulate synaptic activity. C) Locomotion (green trace), associ-
ated with increased release of noradrenaline, evokes synchronized [Ca2+]i elevation in
astrocytes of different brain areas including the cerebellum and the visual cortex. D)
Enforced locomotion (green or running mouse) in combination with visual stimuli (blue,
LED, or light bulb) enhances Ca2+ responses in visual cortex astrocytes compared to
when these stimuli are presented alone. Note that astrocytes do not respond to visual
stimuli alone. E) Locomotion can also trigger Ca2+ microdomain signals in astrocytes
labelled with membrane tagged GCaMP3 that are not dependent on IP3R2 dependent
Ca2+ release from the endoplasmic reticulum. F) However, the number of spontaneous
microdomains and the frequency of Ca2+ events decreases in IP3R2−/− mice. During
treadmill rotation (TM), the frequency of event occurrence increased in IP3R2+/+ and
IP3R2−/− astrocytes but amplitude only increased in IP3R2+/+ astrocytes. G) Astro-
cytes ex vivo display distinct Ca2+ microdomain patterns in space to after application
of NE (red) and ATP (blue) suggesting different microdomains may be physiologically
distinct. H) NE promotes synchronized increase in Ca2+ microdomains. Panel A was
taken from [313]; B from [33]; D & D from [274] and E-H from [2].
1.4.3 Astrocytes respond reliably to neuromodulators
A less controversial idea is that astrocytes reliably respond to neuromodulators with
global, long lasting calcium elevations. Noradrenergic neurons in the brainstem locus
coeruleus project diffuse axon collaterals throughout the brain, providing a way to exert
control of global, brain states through volume transmission (Figure 1.11 A)[313]. Elec-
tric stimulation of the LC triggers broad [Ca2+]i elevation in mouse cortical astrocytes
in vivo [34]. Aversive stimuli (startle stimuli) and locomotion can induce widespread
[Ca2+] elevation in cortical astrocytes (Figure 1.11 C) mediated through α1 adrener-
gic receptors [93] [274]. The global release of noradrenaline is thought to increase the
gain of astrocytes to local release of synaptic transmitters [274]. Locomotion in com-
bination with visual stimuli synergistically enhances Ca2+ response in V1 astrocyte
networks (Figure 1.11 D) [274] [337]. Noradrenaline increases the number, size, dura-
tion and synchronicity of Ca2+ microdomains in single astrocytes (Figure 1.11 E-H) [2].
Noradrenaline is not the only neuromodulator involved in astrocyte Ca2+ signalling.
Electrical stimulation of nucleus basalis of Maynert (NBM) and medial septum, the
predominant sources of cholinergic afferents to the cortex and hippocampus, led to
muscarinic receptor (mAChR) dependent [Ca2+] elevation in astrocyte networks of the
cortex [356] [69] and hippocampus [243]. Dopamine [368] [154] [404] and serotonin
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[320] are also likely implicated in astrocyte Ca2+ signalling. Interestingly, ventral mid-
brain astrocytes respond to dopamine D2 modulation but not to noradrenaline [404]
suggesting heterogeneneous sensitivity of different astrocytes to the same neuromodu-
lator. Further work is needed to elucidate the synergistic role of neuromodulators and
neurotransmitters acting on astrocytes.
1.4.4 Perspective
A vast number of experiments conducted by different groups using a variety of meth-
ods demonstrate that astrocytes respond to neurotransmitters and neuromodulators
with [Ca2+]i elevation. Synthesis of the evidence suggests that astrocytes in ex vivo
preparations can respond to synaptic neurotransmitter release with [Ca2+]i elevation.
Whether this is the case in vivo and under what conditions is still controversial. Astro-
cyte responses to synaptic neurotransmitter release are likely to occur in the thin pro-
cesses in the form of fast microdomain Ca2+ transients instead of long lasting somatic
events. On the contrary, neuromodulators, especially noradrenaline seem to trigger
widespread, synchronous Ca2+ elevation in astrocyte networks that may increase the
gain of astrocytes to sensory stimuli.
It is becoming increasingly clear that the condition of the experimental preparation
used is very important to correctly assess astrocytic responses to neuronal activity. We
thus summarize the important parameter that an experimenter needs to pay attention
to, for studying neuron - astrocyte interactions: 1) Use high quality in vivo preparations
in awake animals when possible to minimize pathological conditions. 2) Use adult
animals to account for age dependent changes in receptor expression 3) Take into
account the fast [Ca2+]i microdomain activity at the fine astrocyte processes, not just
the slow [Ca2+]i activity of the soma. 4) Avoid loading astrocytes with Ca2+ dyes or
overexpressing GECIs to avoid cell damage, dyalisis and excessive Ca2+ buffering 5)
Limit the use of non-physiological perturbations as much as possible. For example, use
sensory instead of electrical stimuli. 6) Account for possible astrocyte heterogeneity.
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Astrocyte Ca2+ signalling is important because it is thought to act as a second mes-
senger who can trigger molecular cascades that in turn can modulate neuronal activity
and vascular tone. Shortly after the discovery of astrocyte calcium waves in response to
neurotransmitters [79], two seminal studies showed independently that [Ca2+]i increase
in cultured astrocytes can evoke [Ca2+]i elevation in adjacent neurons [267] [244]. Ex-
periments in slices and cultures then showed that astrocytes release glutamate when
their [Ca2+] was elevated [267] [272] [43]. These experiments suggested that astrocytes
could provide an additional layer in information processing in the brain mediated by
astrocytes. An expanded repertoire of signalling molecules released by astrocytes were
identified including glutamate, ATP, GABA, and D-serine [16]. These molecules were
termed gliotransmitters. The anatomical and functional interaction between astrocytes
and neurons was consolidated into the ’tripartite synapse’ [14]. Gliotransmission is one
of the most exciting and controversial topics in the field at the moment [111] [314].
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Figure 1.12: Current model of bidirectional communication between astro-
cytes and neurons. Fast, localized Ca2+ signals in astrocytic processes (1a) can be
evoked through Ca2+ entry from the extracellular space (2a) by the opening of (3a)
TRPA1 or neurotransmitter gated channels ,(2b) by release from organelles, (3b) ac-
tivation of mGluR2/3 receptors, or (3c) by reversal of Na+/Ca2+ exchangers (NCX).
Subsequently, Ca2+ signals may influence neuronal activity by modulating the release
of gliotransmitters through (4) ion channels (i.e. Best-1) and exocytosis, (5) alter-
ing the expression and mobilization of neurotransmitter transporters, and (6) lowering
of extracellular K+ indirectly through the action of NCX and Na+ pumps. (7) ATP
released from astrocytes may (7a) bind to P2X and P2Y receptors of the same astro-
cytes triggering widespread Ca2+ activity or (7b) is converted to adenosine that can
act on presynaptic A2A or A1 receptors that can increase or decrease neurotransmitter
release respectively. (8) Noradrenaline (NA) and acetylcholine (ACh) induce large,
synchronous [Ca2+]i elevation in astrocytes. Image taken from [32].
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1.5.1 Mechanisms of gliotransmitter release
The mechanisms of gliotransmitter release can be summarized in two groups, vesicu-
lar exocytosis and non-vesicular release. Non vesicular release of glutamate, ATP and
D-serine can occur by reversal of excitatory amino-acid transporters (EAATs), volume
regulated anion channels (VRACs), gap junction hemichannels (connexins and pan-
nexins) and ATP gated P2X7 receptors. These gliotransmitter can also be released
through P2X7 and VRACs in a Ca2+ dependent manner when astrocytes swell (i.e.
through [Ca2+]i elevation via ATP acting of P2Y and P2X7 receptors) [126]. Also glu-
tamate and GABA can be released through Ca2+ activated bestrophin-1 and TREK
channels [264] [198] [398] [409].
For vesicular exocytosis, astrocytes need to have mechanisms for storing gliotrans-
mitters in vesicles and the machinery to promote vesicle fusion to the plasma membrane.
Electron microscopy (EM) revealed 30-100 nm vesicles in hippocampal astrocytes re-
sembling those of synapses [45]. Immunostaining suggested that vesicles express vesic-
ular glutamate transporters (VGlut 1-3) [45] [126] and thus can accumulate glutamate.
Although astrocytes were shown to lack structurally organized release sites [45] [160],
some of the molecular machinery involved in neuronal synaptic transmission was also
found in cultured astrocytes (i.e. synaptobrevin II, cellubrevin, syntaxin and SNAP
23) [268] [135]. This suggested that astrocyte vesicles may form SNARE complexes
in-situ, similar to neurons. Following SNARE complex formation, a calcium sensor
is needed for exocytosis to initiate. Astrocytes express synaptotagmin 4, 7, and 11
[231] [412] [377], thought to trigger vesicular glutamate release in response to [Ca2+]i
elevation.
1.5.2 Modulation of gliotransmitter release
Multiple methods have been used to evoke or inhibit Ca2+ dependent gliotransmit-
ter release. Increasing [Ca2+]i in astrocytes via agonist (i.e. DHPG) activation of
metabotropic glutamate receptors (mGluRs) [108] [11], mechanical stimulation [186],
uncaging of Ca2+ or IP3 within astrocytes [108] [110] [277] or using strong depolar-
izing pulses [160] [165] modulated neuronal activity. These manipulations provide
indirect evidence for gliotransmission acting on neuronal circuits. Stronger evidence
for gliotransmitter release was provided by perturbations of the gliotransmitter release
machinery. Gliotransmitter release can be inhibited by buffering intracellular calcium
(i.e. using BAPTA) [13] [165] [160] [44] or enhanced by bypassing the Ca2+ dependent
step of exocytosis using a-latrotoxin [269]. Gliotransmitter release can be inhibited
by disturbing the SNARE complex in astrocytes using Botulinum and Tetanus Neu-
rotoxins (BoNT and TeNT) to cleave SNARE complex [160] [277] or by inhibiting the
formation of the SNARE complex in transgenic mice expressing dominant-negative do-
main of vesicular SNARE (dnSNARE) in astrocytes [413] [270]. Other, crude methods
to inhibit gliotransmission include the inhibition of the tricarboxylic acid (TCA) cycle
with fluorocitrine or fluoroacetate [10] [411]. Supplementary evidence in cultured as-
trocytes using total internal reflection fluorescence microscopy (TIRF) to track labelled
vesicles during exocytosis [262] [51] [45], capacitance measurements to assess changes
in membrane area during exocytosis [413], amperometric detection of dopamine loaded
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in vesicles carrying glutamate [71] and the use of sniffer cells expressing ATP or gluta-
mate receptors [262] [45] revealed both kiss-and-run and full-fusion exocytosis leading
to quantal-like release of transmitters. Together, these findings provide strong evidence
of gliotransmitter release, at least in culture astrocytes.
1.5.3 Role of astrocyte [Ca2+]i elevation and gliotransmission
in neuronal circuits
Astrocyte [Ca2+]i elevation is thought to trigger the release of gliotransmitters such
as glutamate, GABA, ATP and D-serine (Figure 1.13) that in turn bind to neuronal
receptors and modulate their activity. Some notable functions of glutamate released
by astrocytes include: a) evoke slow inward currents and thus increase neuronal ex-
citability and synchrony of postsynaptic neurons by acting on NMDARs [108] [11] b)
increase neurotransmitter release from presynaptic terminals by acting on extrasynap-
tic NMDARs [13] [160] or mGluRs [110] [277] , c) heterosynaptic depression and d)
modulation of LTP [243] and LTD [127]. GABA released from astrocytes is thought to
mediate postsynaptic slow outward currents [196] and tonic inhibition [198]. ATP is
converted to adenosine in the extracellular space and acts on presynaptic A1 receptors
to inhibit transmitter release [270] [329]. D-serine binds to the glycine side of NMDA
receptors acting as a co-agonist to glutamate. It is involved in the modulation of LTP
and LTD [407] [133] [356]. For an extensive review see [16].
Astrocytes embedded in the same circuit can release multiple gliotransmitters that
can exert diverse modulatory effects on neuronal circuits. For example, CA1 astro-
cytes can release glutamate [165] [108], GABA [196], D-serine [133] and ATP [411]
that in turn can have different effects on neuronal signalling. It is likely that individ-
ual astrocytes can release multiple gliotransmitters. For example, astrocytes express
synaptobrevin II and cellubrevin on distinct vesicle populations. Synaptobrevin II was
associated with the release of glutamate and the enhancement of synaptic signalling.
Cellubrevin was associated with neuropeptide Y secretion and tonic inhibition of basal
synaptic transmission [327]. Interestingly, in single hippocampal astrocytes, short or
low frequency stimulation triggers the release of glutamate while prolonged or high
frequency stimulation also triggers the release of ATP [81]. These findings suggest that
different gliotransmitters can be released from the same astrocyte depending on the
nature of neuronal input that in turn can differentially modulate neuronal circuits.
There is also evidence that astrocyte-neuron networks are circuit specific (Fig-
ure 1.14). Striatal and hippocampal astrocytes have different Ca2+ responses to Gi/o
GPCR agonists [67], while cortical astrocytes show differential Ca2+ responses to opto-
genetic activation of PV and somatostatin expressing interneurons [215]. Optogenetic
activation of visual cortex astrocytes results in differential modulation of PV+ and
SST+ interneuron activity (Figure 1.14 B) [278]. Ventral midbrain astrocytes respond
to dopamine D2 modulation but not to noradrenaline [404]. Subpopulations of dorsal
striatum astrocytes selectively respond to one type of medium spiny neuron type but
not the other and can release glutamate that acts on NMDARs in homotypic but not
heterotypic medium spiny neurons (Figure 1.14 A) [216]. Medial central amygdala
astrocytes release ATP in response to endocannabinoid signals to depress basolateral
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Figure 1.13: Functions of astrocyte Ca2+ elevation. A diverse array of excita-
tory (+) and inhibitory (-) signalling molecules can evoke [Ca2+]i elevation (left) in
astrocytes that precedes the release of different gliotransmitters (right) who may exert
excitatory or inhibitory effects in contacting neurons. Abbreviations correspond to re-
gions studied: Amy (Amygdala); BrSt (brainstem); CA1 (CA1 region of the hippocam-
pus); Ctx (cortex); DG (dentate gyrus); hHip (human hippocampus); Str (Striatum).
The symbol indicates studies describing functional changes to focal [Ca2+]i, instead of
global Ca2+ signals. Image taken from [124].
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Figure 1.14: Heterogeneity in astrocyte - neuron interactions. Astrocytes can
discriminate between different subtypes of neurons in a brain region and differentially
modulate their activity. For example, A) striatal astrocytes, selectively respond to
either neurons expressing D1 or D2 dopamine receptors. Stimulation of these neurons
evokes the release of endocannabinoids that activate specific astrocyte subpopulations.
Astrocytes then selectively modulate synaptic activity only in neurons expressing the
same dopamine receptor by releasing glutamate. B) Photoactivation of visual cor-
tex astrocytes increases the spontaneous firing rate of parvalbumin (PV) expressing
interneurons while increasing or decreasing the activity of somatostatin (SST) express-
ing interneurons. Image taken from [125].
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amygdala excitatory synapses (A1 activation) and enhance lateral subdivision of cen-
tral amygdala inhibitory synapses (A2A activation) [217]. These findings suggest that
astrocytes respond to neuronal activity with [Ca2+]i elevation in a circuit specific man-
ner that in turn can modulate distinct neuronal circuits.
In summary, modern findings suggest that astrocyte Ca2+ activity and gliotrans-
mitter release depends on the brain area and neuronal circuit they are embedded in,
as well as the regime of neuronal activity. A variety of gliotransmitters can be released
even by individual astrocytes under different conditions who can target distinct neu-
ronal receptors, leading to specific modulation of synaptic transmission and neuronal
circuits.
1.5.4 Controversies
The idea that neuronal activity triggers [Ca2+]i dependent release of gliotransmitters
by astrocytes to modulate neuronal circuits provides a paradigm shift in our thinking
on how the brain works. However, there are a lot of controversies challenging the
physiological nature and selectivity of methods used to reach such conclusions.
Assessing the role of gliotransmission requires methods that target astrocytes specif-
ically. The challenge is that neurons possess the same receptors as astrocytes. Drugs
assumed to evoke [Ca2+] elevation selectively in astrocytes (i.e. DHPG activation of
mGluR1 [108] [11]) also affected other cells. To date there are no drugs I am aware
of that selectively target astrocytes. Evoking [Ca2+]i elevation in astrocytes by Ca2+
or IP3 uncaging may activate Ca2+ gated K+ channels and the release of K+ in the
extracellular fluid that can depolarize neurons. Blocking gliotransmitter release by se-
questering Ca2+ (i.e. using BAPTA) dilutes basal calcium levels and perhaps other sig-
nalling molecules, while also inhibiting extracellular [K+] increase through Ca2+ gated
K+ channels. Using TeNT, BoNT or dnSNARE mice to block gliotransmitter exo-
cytosis may block the insertion of proteins mediating Ca2+ dependent non-exocytotic
release of transmitters [126].
mGluR5, suggested to trigger IP3 mediated [Ca2+] elevation and gliotransmitter
release are also expressed in neurons and are downregulated in mature astrocytes [59]
[350]. Additionally, mGluR5 agonists did not evoke [Ca2+] elevation in mature astro-
cytes [350] thus suggesting that the machinery thought to trigger transmitter release
from astrocytes was absent in adult animals. However, mGluR5 may be found in
astrocyte processes [195] [260] and mRNA expression doesn’t necessarily predict pro-
tein levels. These observations suggest that findings based on studies in immature
astrocytes do not necessarily generalize to adult astrocytes.
Knocking down IP3R2 greatly reduced somatic [Ca2+] responses in astrocytes but
had no effect on neuronal synaptic activity [286] and had no identifiable effect on
animal behaviour evaluated by an extensive battery of behavioural assays [286]. Fur-
thermore, evoking [Ca2+]i elevation with CNO in astrocytes expressing non-mammalian
Gq-coupled, designer receptors exclusively activated by designer drug (DREADD) had
no effect on excitatory synaptic activity or neurovascular coupling [112] [48]. These
findings suggest that the mechanism of Ca2+ elevation is crucial for gliotransmission.
A major innovation in suppressing vesicular release of gliotransmitters in vivo was
the generation of transgenic mice expressing dnSNARE in astrocytes [413] [270]. How-
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ever, Fujita et al. [115] found expression of the transgene also in neurons suggesting
that the effects attributed to gliotransmitter release could be reinterpreted to be neu-
ronal in origin. Although the topic is still debated and new evidence suggests astrocyte
specific expression of dnSNARE [348] [263], the controversy emphasizes the importance
of checking transgenic lines for specificity and “leaky” expression.
Interestingly, there is also doubt if there are vesicles associated with gliotransmitter
release in astrocytes at all. In a recent study [67] found vesicles in 139 hippocampal and
138 striatal synapses but not in astrocyte processes. Furthermore, they found no sig-
nificant RNA expression for Ca2+ sensitive synaptotagmins or VGluTs in hippocampal
and striatal astrocytes suggesting that astrocytes do not have the components neces-
sary for vesicular gliotransmission of glutamate.
Another common controversy is whether D-serine is a gliotransmitter. D-serine
synthesis requires the conversion of l-serine into d-serine by serine racemase (SR). The
development of SR KO mice [232][37] and other recent studies [397] suggest that it
is neurons who synthesized and release D-serine, not astrocytes. The advancement of
technology combined with a critical and open mind should clarify whether astrocytes
release gliotransmitters or not.
1.6 Methods for investigating astrocyte calcium sig-
nals
As we have seen in the previous sections the conditions and methods used to study
astrocyte physiology enabled both the greatest discoveries in the field but also fueled
most controversies. Any measurement is prone to the observer effect where even mere
observation of a phenomenon can disturb the system. Optimal method design relies
on disturbing a system just enough to enable measurement of the query of interest
without further, unnecessary disturbance. Too much disturbance to biological systems
is commonly referred to as pathology or non-physiological conditions. There is no
clear definition of what constitutes a physiological preparation or a pathological one,
however it should be viewed as a grating. There is no such thing as a fully physiological
preparation, but only better approximations of it. Therefore, we try to develop and
use the best tools available in optimal configurations to minimize the disturbance to
the system and maximize confidence in our measurements.
1.6.1 General principles for optical measurements of Ca2+ sig-
nals
Here we will focus mostly on how to measure astrocyte [Ca2+]i dynamics. The general
principle involves calcium binding to indicators, such as fluorescent proteins or organic
Ca2+ indicator dyes, that causes a state transition in said compounds (i.e. conforma-
tional change and increase in quantum yield) that can be detected using a fluorescent
microscope. The information collected is in the form of photons. The more photons
captured the higher signal to noise ratio (SNR) can be achieved for a given signal.
Theoretically, we can collect infinite photons by imaging a sample for infinite time.
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Figure 1.15: Multiscale spatiotemporal relationship between astrocytes and
neurons. Schematic of current perspective on the role of astrocytes at multiple scales.
A) Astrocyte - neuron interactions are thought to occur at temporal scales ranging
from seconds from minutes, influencing fast (millisecond timescale) synaptic output by
tuning the gain of synapses and promoting the synchronization of networks. B) At the
spatial nanoscale, perisynaptic astrocytic processes (PAPs) can modulate presynaptic
by changing the probability of transmitter release or alter the excitability of post-
synaptic terminals. C) At the spatial microscale, astrocytes can modulate multiple
synapses within its territory or within the spatial extent of functional microdomains.
D) At the syncytium scale, astrocyte networks connected via gap junctions can form
dynamic multi-astrocyte domains that can respond to and modulate local neuron net-
work activity. E) At the mesoscale, astrocytes co-ordinated by neuromodulators, such
as noradrenaline released from the locus coeruleus, may influence brain states, complex
behaviours and cognition. Image taken from [312].
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Besides the technical limitations of such a feat, the study of dynamic processes is lim-
ited by time. The faster the dynamics of interest the less time is available for collecting
photons. Similarly, the longer Ca2+ is bound to the indicator the more photons it can
emit. However, during binding, Ca2+ is buffered and becomes unavailable for cellular
processes. Also, longer binding of Ca2+ limits the temporal resolution of dynamics
that can be investigated. Another way to increase the number of photons collected is
the availability of higher concentration of indicators. However, the higher the concen-
tration, more Ca2+ is buffered, increasing disturbance to cell physiology. The number
of photons collected can also be increased using improved fluorescent indicators or by
increasing the power of excitation light. The latter is limited by potential phototox-
icity induced damage to the tissue. Alternatively, SNR can be improved by reducing
unwanted photons collected (noise). Effective experimental design is an optimization
problem taking into account all these variables and the condition of the sample. I
will introduce commonly used methods for probing astrocyte Ca2+ physiology, with
emphasis on the tools used in my study.
1.6.2 Organic Ca2+ indicator dyes
Organic Ca2+ indicators spearheaded the discovery and early work of astrocyte Ca2+
signalling. They are typically available in the form of water soluble, membrane im-
permeable salts (often dextran conjugated to minimise compartmentalization) or more
hydrophobic, membrane permeable acetoxymethyl (AM) esters. Membrane-permeable
dyes are typically bulk loaded into tissue to label a large population of cells while cell-
impermeable water soluble dyes are typically loaded inside single cells with a patch
pipette. Cell permeable dyes (i.e. Fluo4-AM and Oregon Green BAPTA1-AM) can be
easily bulk loaded into tissue to label a large population of cells. However, the labelling
is not selective to astrocytes thus requiring co-labelling with a cell specific marker, such
as sulforhodamine 101 (SR101) dye [248]. However, SR101 should be used with caution
since its specificity to astrocytes is questionable [149], it increases neuronal excitability
and LTP [166] [149] and can lead to seizures [297]. Furthermore, these bulk loaded
dyes are limited to labelling astrocytic somatata and thick processes, excluding their
fine distal processes thought to be involved in the tripartite synapse [299]. Hydrophilic
dyes can be loaded into single astrocytes (i.e. using a patch pipette), thus avoiding
the need of markers such as SR101. They also offer a number of advantages, including
precise control over the concentration of dye loaded. While they allow more precise
imaging of astrocyte branchlets they still ignore fine distal processes [92] [260]. At the
concentration needed to resolve astrocyte Ca2+ microdomain activity (up to 0.5mM)
they can disturb calcium signalling, dialyze the cell and possibly alter cell physiology
[174]. Also, dyes are not ideal for chronic experiments because they wash out over time
and need to be reapplied.
1.6.3 Genetically encoded calcium indicators (GECI)
GECIs provide a less invasive way of studying astrocyte Ca2+ activity in vivo and in
vitro and can be expressed in many cells without dialyzing them. GECIs are fluores-
cent proteins derived from GFP or its variant circularly permuted fluorescent proteins,
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fused with calmodulin and the M13 domain of the myosin light kinase (see figure 2).
Calmodulin binds to 4 Ca2+ ions undergoing a conformational change binding to M13
(Figure 1.16 C). This leads to rapid de-protonation of the chromophore and bright fluo-
rescence [386]. GECI genes driven by cell type specific promoters (i.e. GFAP or Aldh1l1
for astrocytes) can be selectively expressed in cell types of interest. Low GECI expres-
sion leads to low SNR while high expression increases SNR and baseline brightness, but
can disturb calcium homeostasis, reduce the signal change and affect cell physiology
[360]. Genetic manipulation of cells is usually achieved through viral vector delivery
or the generation of transgenic mice. GECI expression can be stable for months [410]
thus allowing chronic imaging of astrocytes in vivo. The most optimized GECI is the
GCaMP scaffold originally engineered by [242]. Variants of increasing sensitivity have
since then been developed [70] and used to study astrocytes, GCaMP2 [144], GCaMP3
[361], and GCaMP6 [341]. Additionally, GECIs can be engineered to target subcellular
compartments such as the plasma membrane by adding the Lck membrane tethering
domain [332] or other organelles [360]. New GECIs are continuously being generated
that have improved signal to noise ratio, varied spectral properties and different Ca2+
binding affinities promising a bright future for imaging astrocytes labeled with GECIs.
Their capacity to target specifically astrocytes, low photobleaching, high SNR, and
the capacity to let us non- invasively image Ca2+ activity from the thin processes of
astrocytes makes them indispensable tools.
1.6.4 Fluorescent microscopy: focus on two photon microscopy
The simplest objective of fluorescent microscopy is to excite fluorophores in a region
of interest and collect the emitted photons. When possible, living samples should be
studied in their natural habitat to better preserve their physiological characteristics.
Biological tissues, such as the brain, are composed of materials with different refractive
indices, causing scattering of photons. Scattering leads to the degradation of resolution
and contrast. Scattering increases exponentially with the imaging depth [91] [132].
Confocal microscopy partially overcomes some of these issues by introducing a detector
pinhole that rejects out of focus photons [78]. However, out of focus excitation is
unavoidable and can lead to photodamage. Photodamage refers to the combined effects
of photodestruction of the fluorophore (photobleaching) and photodynamic damage of
the entire sample mostly mediated by reactive oxygen species (photodamage). Also,
the pinhole excludes scattered signal photons emanating from the focus. At increasing
imaging depth, photons wasted because of the pinhole and scattering make confocal
microscopy prohibitively inefficient for deep tissue imaging [351].
Multiphoton microscopy alleviates a lot of the problems introduced by imaging
deep in high scattering tissues. In 2P microscopy, two low energy (infrared) photons
are simultaneously (within < 1fs) absorbed by the fluorophore (Figure 1.16 A, top). To
deliver the photon flux needed to induce two photon excitation, focused femtosecond
pulses (≈150fs) are used. The absorption rate is proportional to the second power of
light intensity. The intensity is highest at the focal point, leading to a diffraction-limited
focal volume and decreasing quadratically with distance (Figure 1.16 A, bottom) [91]
[132] [351]. A schematic of a two photon microscopy setup is illustrated in Figure 1.16
B.
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The sample can be scanned quickly using a galvo-scanning mirror, resonant scanning
mirror or an acousto-optical deflector. This allows measurements of dynamic signals
from many locations simultaneously and establishes the raw temporal resolution of
a recording. The light is delivered through an objective. Important factors include:
a) numerical aperture (N.A.), that determines the resolution and the angle of photon
collection, b) magnification and c) working distance.
Following excitation of the fluorophore, lower energy emitted photons are collected
by the objective. Since the excitation volume is limited to focus, emitted photons
that are scattered constitute useful signals. In 2P, emitted photons are collected by
the objective, separated by frequency through a band-pass filter and amplified using
detectors such as photomultiplier tubes (PMT) [91] [132] [351].
As a result, 2P minimizes photodamage by maximizing the probability of detecting
signal photons with excitation event and allows for high resolution imaging deep inside
tissues ( 1mm). These properties make 2P an excellent tool for studying astrocytes
and neurons in vivo. 2P can also be used to perform 3D imaging by vibrating the
Figure 1.16: Optical imaging. (caption next page.)
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Figure 1.16: (previous page.) A) Schematic comparison between the principle of
single photon (1P; left) and two photon (2P; right) excitation fluorescence microscopy.
In 1P, a molecule is brought to its excited state by absorbing a single photon (blue).
In 2P a molecule is brought to its excited state by simultaneously absorbing two near
infrared photons (red). Once in the excited state, vibrational relaxation brings the
molecule to its lowest excited state (black arrows), from where it returns to its ground
state (green) by emitting a photon of lower energy. 1P is limited by out of focus
fluorescence while the non-linear 2P effect minimizes this limitation (bottom). B)
Schematic of two-photon microscopy setup. A mode locked femtosecond titanium sap-
phire laser emits pulsed (100fs) near-infrared light (700-1050nm, red beam) at about
80MHz. The beam is reflected on a pair of computer controlled galvo-scanning mirrors
that change the position of the beam in the X-Y plane. The beam then passes through
a dichroic mirror to the objective lens and focused at the desired plane in the tissue.
The emitted light (yellow-green) is collected by the same objective and separated from
the excitation light via the dichroic mirror and a filter. The light is then directed to
photomultiplier tubes (PMTs) that amplify and detect the signal. C) Single fluorescent
protein, GCaMP indicators are composed of a circularly permuted fluorescent protein
(cpFP), calmodulin (CaM) and M13 domain of a myosin light chain kinase. When four
Ca2+ (red) bind to the CaM-M13 complex during excitation by fluorescence light (blue
arrows), the quantum yield of the cpFP increases (green arrows). D) Excitation and
emission spectra of GCaMP6f in a solution with free Ca2+ or bound to EGTA chelator.
Panel C was taken from [180]; D was taken from [335].
objective [118] [47] or holography [406]. The resolution limit of 2P is still diffraction
limited, limiting its use when dealing with nanoscopic structures like the thin processes
of astrocytes. Super resolution microscopy methods will likely provide new insights
into the nanoscopic world of astrocytes by bypassing the diffraction limit [317] [131].
Two-photon microscopy in awake animals requires head-fixation, thus restricting the
behaviour of the animal. Imaging during natural behaviour can be benefited with the
use of wearable endoscopes [152]. Such endoscopes (especially flexible endoscopes), red
shifted GECIs [86] and 3-photon microscopy [145] have the potential to increase the
imaging depth limit restricting 2P and thus allow optical investigation of deeper brain
structures without removing brain tissue.
1.6.5 Molecular toolkit for probing astrocyte physiology
Molecular manipulation of cells starts by incorporating foreign DNA into cells. This
is generally accomplished by generating transgenic mice or using viral vectors. To
generate transgenic mice, a linear DNA transgenic construct is injected into the male
pronuclei of a newly fertilized mouse egg. Foreign DNA can be inserted into the single
cell genome which then replicates with cell division into nearly all cells of the adult
mouse. Modified, fertilized eggs are then injected in the oviducts of pseudopregnant
female mice who have a chance of producing offspring that carry the transgene. Off-
springs are then selected for transgene expression (i.e. using PCR). Transgenic mice
offer a reliable way of introducing foreign DNA in vivo. It takes a long time ( 6-9
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months) to generate a stable mouse line, but after that it is mostly limited by the
reproductive vigor of mice. A faster, more flexible way of introducing transgenes, is
using viral vectors. Viruses have been evolving for billions of years to infect cells
and exploit their transcription machinery to replicate. Viral DNA can be modified
by replacing replication coding sequences with foreign DNA. The necessary viral com-
ponents are typically produced by cultured cells (typically immortalized HEK293T
cells) transfected with plasmids encoding these components. The replication deficient
viruses produced by these packaging cells are collected and filtered. These viruses can
be used to transduce cells of interest. Sufficient transgene expression typically takes
more than one week following delivery, the size of the DNA construct is restricted by
the size of the viral capsid and care must be taken regarding safety issues to scientists
and possible toxic effects on transduced cells. Typical viruses used in neuroscience
include adenovirus, canine adenovirus (CAV), herpes simplex virus (HSV), lentivirus
and adeno-associated virus (AAV) [62]. Both transgenic animals and viral strategies
have been used to deliver foreign DNA to astrocytes and neurons. The delivery of
genes encoding for fluorescent proteins allows visualization of cellular morphology and
function. The same strategy can be used to manipulate the function of cells by the
insertion of optogenetic receptors such as channelrhodopsin [52], halorhodopsin [393]
and melanopsin [224] or chemogenetic receptors such DREADDs [307] [212]. While
these approaches proved useful in neuronal manipulation, it is uncertain if they can
be trusted in mimicking physiological aspects of astrocyte signalling. These are just
some of the many available molecular tools that can be used to monitor and modulate
cellular activity. The tool used has to be matched to the problem by considering the
strengths and limitations. We will focus on the delivery of AAVs and their potential
for studying brain circuits.
1.7 AAV biology
AAVs are small (≈20 nm), icosahedral, non-enveloped, single stranded DNA (ssDNA)
parvoviruses often used for gene delivery. AAV is a dependovirus. It requires helper
virus genes (of adenovirus or herpes virus) for successful replication and assembly [238].
AAVs have a genome with≈4.7 kilobase capacity that contains two open reading frames
(ORFs). ORFs encode four replication proteins (Rep), three capsid proteins (Cap)
and an assembly activating protein (AAP) [3]. Rep and cap encode for replication
related proteins and capsid proteins (i.e. VP1, VP2, VP3) respectively. The viral
DNA is flanked by two T-shaped inverted terminal repeats (ITRs). ITRs are the only
requirements needed to package DNA into the capsid [403]. Recombinant AAV (rAAV)
vectors can be produced by replacing the wild type vector genes with genes of interest
flanked by ITRs [238]. As a result rAAVs can’t replicate. Pseudotyped rAAVs carry
ITRs of one serotype in the capsid of a different serotype [294]. For example, AAV2/1
is a pseudotyped rAAV carrying AAV2 ITRs in an AAV1 capsid. Different capsid
serotypes exhibit a range of tissue tropisms [19].
AAVs with different serotypes are attached to different cell membrane glycan recep-
tors who dictate their tropism. For example, AAV1 and 5 use sialic acid (SIA) binders
[400] [162] while AAV9 uses galactose binders [330]. All three serotypes use the newly
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Figure 1.17: Schematic of AAV transduction pathway. Adeno-associated
viruses are recognised and bound to glycosylated membrane receptors. This triggers
AAV internalization through clathrin-mediated endocytosis. AAVs travel through the
cytosol using the cytoskeletal network. Once they are inside the late endosome they
can enter the lysosome or tag on kinesin inside an unknown compartment for axonal
anterograde trafficking. AAVs escape from endosomes and lysosomes. They can un-
dergo proteolysis by the proteasome or enter the nucleus through the nuclear pore
where they are uncoated. There the single stranded DNA (ssDNA) carried by the
AAV is converted to double stranded DNA (dsDNA) that can undergo transcription.
Inter/intramolecular recombination of inverted terminal repeats (ITRs) leads to the
formation of circular episomal monomers, dimers and concatemers that can persist for
a long time in the nucleus. Vector genes can also be integrated in the host genome at
very low frequencies.
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discovered AAV receptor AAVR [349] [288]. AAVs enter cells through clathrin or
caveolae-mediated endocytosis [99] [324] [30]. Once inside endosomes AAVs are traf-
ficked through the cytosol using the cytoskeleton [402]. Following endosomal escape
AAVs enter the nucleus via the nuclear pore complex [170]. The capsid is likely un-
coated in the nucleus since fluorescent-labeled capsids were detected in cell nuclei [328]
[30]. The single stranded DNA (ssDNA) strands exposed undergo second strand synthe-
sis [414] and are converted to various forms of double stranded genomes. These include
extrachromosomal circular monomers that are converted to high molecular weight con-
catemers [405]. Concatemers persist in an episomal state and can provide long term
transgene expression in non-dividing cells [98] [100] [241]. Interestingly, concatemeriza-
tion of different independent vector DNA strands can be exploited to expand the small
packaging capacity of AAVs [101]. The wtAAV genome can also integrate into the cell
DNA because of sequence similarity found within the genomic locus AAVS1 and AAV
ITR and Rep [225]. Since the rep gene is removed in the rAAVs genome, integration
is vastly reduced [290]. A schematic of the AAV transduction pathway is illustrated in
Figure 1.17.
1.7.1 Cell specific gene expression using AAVs
AAVs have evolved to infiltrate cells and exploit the cell transcription machinery for
their own benefit. Their capsid serotype allows them to preferentially target different
cell types [19]. In rAAVs the rep and cap genes of the wtAAV genome are replaced
with artificial constructs [238]. These constructs typically contain a promoter region,
a gene of interest we want to express (sometimes flanked by LoxP sites), an enhancer
and a regulatory sequence. The promoter can be cell specific, i.e. human synapsin 1
(hSyn) and GFAP for expression in neurons [191] and astrocytes [55] respectively. A
promoter can also be general like the cytomegalovirus (CMV) promoter [121] and the
strong synthetic CAG promoter [161]. The endogenous diversity of transcription fac-
tors and RNA polymerases of different cell types allows these promoters to drive gene
expression in defined cell populations [82]. Some genes commonly used in neuroscience
research encode for fluorescent proteins such as eGFP, tdTomato or GCaMP allowing
researchers to visualise transduced cells. Others include genes encoding for enzymes
such as Cre recombinase (Cre). Because Cre can recombine with loxP sites it can be
used to selectively activate or inactivate the expression of genes [322]. A common strat-
egy involves the FLEX switch [322]. The FLEX switch (Figure 1.18C) uses separate
antiparallel loxP recombination sites that allow homotypic but not heterotypic recom-
bination [197]. Enhancer elements such as the woodchuck hepatitis post-transcriptional
regulatory element (WPRE) are typically used to enhance expression [179]. Terminator
sequences such as SV40 and rBG are used to terminate transcription [316].
In summary rAAV capsids of different serotypes can be selected to preferentially
enter specific cell types. Since their DNA is modified to contain genes of interest in-
stead of the rep and cap genes these viruses can’t replicate. Specific promoters can
be used to drive gene expression in specific cell types further enhancing the specificity
of expression. The Cre-Lox system can also be used to induce conditional activa-
tion/inactivation of genes. Continuous developments lead to a greater range of genetic
tools that can be delivered by AAVs to interact with cells.
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Figure 1.18: rAAV construct building strategy for cell specific gene delivery.
A) Rep and cap genes are removed from wild type AAVs. B) They are replaced by genes
of interest typically consisting of a promoter region (often cell type specific), a gene
of interest (i.e. encoding for a fluorescent protein), an enhancer sequence to enhance
gene expression and a terminator sequence to regulate gene expression. The gene of
interest can be flanked by loxP sites. C) Cre recognises loxP sites and initiates side
specific recombination between these sites. loxP sites have an orientation. If two loxP
sites are in the same direction the gene will be excised while if they face in opposite
directions Cre will induce continuous flipping. Cre recombinase recombines only with
two loxP sites with the same spacer sequences. Flanking a gene with a combination of
two pairs of loxP sites with different spacer sequences led to the development of the
FLEX switch. First recombination with a pair of loxP sites causes inversion of the
flanked gene. Next, recombination with the other loxP pair who is now in the same
orientation (orange) triggers excision. This results in the permanent rotation of the
gene of interest that can now be driven by the promoter. D) The engineered construct
is inserted in AAV capsids of specific serotypes to enable preferential entry into nuclei
of cell types of interest.
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1.7.2 AAVs exhibit anterograde and retrograde properties
AAVs are valuable tools in research and clinical applications because they can trans-
duce non- dividing cells and confer stable, long-term gene expression without causing
inflammation or toxicity [42] [119]. Because of these properties rAAVs can be very
useful tools for neuronal tracing studies. A very important viral property for tracing is
the ability of the vector to travel between synapses. Common viral tools used to map
neuronal circuits include the rabies virus that has retrograde transsynaptic properties
[392] and the herpes simplex virus that has anterograde transsynaptic properties [364]
[203]. However, these tracers are not ideal because they are neurotoxic and spread
uncontrollably across multiple synapses [203]. AAVs have been largely overlooked as
potential tracers.
AAVs have been known to exhibit anterograde and retrograde properties for about
two decades, transducing cells at substantial distance from the injection site [168] [169]
[57] [271] [293] [65] [66] [172] [76] [310] [63] [64] [415]. During retrograde transport,
viruses are taken up at axon terminals and are transported to the cell body. In antero-
grade transport viruses enter the cell body and travel through the axon to the terminals
where they are released. The released viruses then transduce new nearby cells.
Kaspar et al. [168] discovered that AAV2 injected in the rat brain undergoes retro-
grade transport. Injecting AAV2 carrying genes encoding for GFP in the hippocampus
and striatum resulted in infection of projection neurons in the entorhinal cortex and
substantia nigra respectively. They showed that AAV particles are found in entorhinal
cortex and substantia nigra neurons by conjugating a fluorophore (Cy3) to the AAV
capsid. They also detected viral genomic DNA in the retrograte areas using RT-PCR.
The retrograde transport properties of AAVs were later used to expand the range of
gene delivery to reverse pathology such as amyotrophic lateral sclerosis [169] and lyso-
somal disorders [271] [66] in animal models.
Provost et al. [293] detected vector DNA in the optic nerve following subretinal
injection of AAV 2, 4 or 5 and in the brain after intravitreal AAV 2 injection. Their
findings suggested anterograde transport of AAVs. Experiments were performed on
rats, dogs and primates suggesting that anterograde AAV transfer is unlikely to be
species dependent. Anterograde AAV transport of AAV 2 was also reported follow-
ing injection in the rat striatum [76] and primate thalamus [172]. Injecting AAV2
carrying genes encoding for glial cell line-derived neurotrophic factor (GDNF) in the
rat striatum led to GDNF expression in the substancia nigra, globus pallidus, entope-
duncular nucleus and subthalamic nucleus [76]. Similarly, AAV2 (GDNF and GFP)
injections in the primate thalamus led to GDNF and GFP expression in the cingulate,
pre-frontal, pre-motor, primary and secondary somatosensory and motor cortices with
highest expression in cortical layers III and IV [172].
Castle et al. [63] compared the anterograde and retrograde properties of AAV1, 8
and 9 and found that they exhibit both retrograde and anterograde properties. Using
microfluidic primary neuron cultures and dye conjugated AAV9 Castle [64] found that
AAV9 undergoes fast anterograde (≈2 µm/s) and retrograde transport (≈0.8 µm/s)
along axon microtubules driven by kinesin-2 and dynein respectively. Recently, Zingg
et al. [415] reported that AAV 1 and 9 can be used for anterograde trans-synaptic tag-
ging of neurons. They used four lines of evidence to claim trans-synaptic properties.
1.8 The mouse somatosensory system 45
They found labelled neurons only at the known upstream areas to the injection site, no
labelling was found in cells around axon bundles, no cells were GFAP+ suggesting no
transfer to astrocytes and labelled upstream cells were always functionally connected
to the neurons of the primary injection site. Zingg [415] also demonstrated that spe-
cific neuronal populations can be targeted using an intersectional approach and that
anterograde trans-synaptic tagging can be used in conjunction with optogenetics for
functional assays.
It is important to note that anterograde and retrograde transport of AAV is low.
Novel approaches using in vivo directed evolution allowed engineering of retrograde
functionality in AAV capsids [184]. This led to the development of rAAV2-retro that
could robustly act as a retrograde tracer [357].
In summary, multiple groups and lines of evidence reported that AAVs exhibit
anterograde and retrograde properties. These properties can be used for widespread
delivery of transgenes in the brain for the treatment of neurological disorders and
to facilitate experimental studies of neuronal circuits. There is very little research
or evidence suggesting intercellular transport of AAVs to astrocytes. This is quite
surprising considering the close proximity of astrocyte processes to synaptic elements
and that astrocytes can be directly infected with AAVs.
1.8 The mouse somatosensory system
Neuronal and astrocytic activity are naturally modulated by the behavioural state and
sensory experience of the organism. These physiological stimuli bypass the majority
of concerns regarding artificial modulation by optogenetics, chemogenetics or electrical
stimulation. We will focus on the mouse whisker system (Figure 1.19) as a model for
studying astrocyte-neuron interactions.
1.8.1 The whisker somatosensory circuit
Tactile information from facial whiskers allows dark dwelling mice to extract spatial
and textural information from their environment. Mice actively scan the environment
through back and forth ( 16Hz) movement of their whiskers (whisking)[339]. Whisker
deflection opens mechano-gated ion channels in trigeminal ganglion primary sensory
neuron distal axon endings innervating the hair follicles [283]. Trigeminal ganglion
neurons are pseudounipolar, with a proximal axon innervating the ipsilateral brain-
stem trigeminal complex (BTC) [209] and a distal axon innervating only one whisker
follicle [417]. Thus, whisker deflection depolarizes trigeminal ganglion neurons who in
turn send glutamatergic projections to the BTC. The BTC is divided into the prin-
cipal sensory nucleus (PrV) and the spinal nucleus (SpV) who is subdivided into the
oralis (SpVo), interpolaris (SpVi) and caudalis (SpVc) sub-nuclei [209]. BTC neurons
preserve the somatotopic organization of whiskers and form functional clusters termed
“barrellets” [369]. Principal trigeminal neurons send glutamatergic projections to the
ventral posterior medial (VPM) nucleus of the thalamus. The VPM is also somatotopi-
cally laid out into clusters termed “barreloids” [54]. VPM neurons send glutamatergic
projections to the primary somatosensory cortex (S1), forming distinct clusters in layer
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4, termed “barrels” separated by septa [399]. The majority of VPM axons project to
L4, but they also directly innervate L2/3 and the border of L5 and L6 (Figure 1.19
D)[395]. While whisker stimuli are detected reliably by the trigeminal ganglia, the
cortex responds with high variability to identical stimuli [12]. The S1 then innervates
other cortical and subcortical regions (Figure 1.19 C, E) [284]. The PrV - VPM - S1
circuit in termed the “lemniscal” pathway. An alternative circuit termed the “paral-
imniscal” pathway involves the interpolaris nucleus projecting to the posterior medial
(POM) thalamic nucleus which primarily innervates L1 and L5 of the S1 (Figure 1.19
D)[283]. Together these circuits transmit whisker, sensory information to the cortex
for sensorimotor processing (Figure 1.19 B).
1.8.2 Whisker touch increases neuronal activity in barrel cortex
The barrel cortex of the mouse is typically 1 mm thick and is classically subdivided
based on cytoarchitecture into six layers. L4 barrel receives the majority of input
from the VPM and sends inputs to L2/3 [284]. Whisker contact with an object evokes
rapid depolarization in L2/3 neurons but drives action potentials only in 10% of them
[84] suggesting sparse coding. This is likely because of fast recruitment of inhibitory
interneurons which provide feed-forward and feedback inhibition [284]. During active
whisking, inhibitory interneurons exhibit decreased firing rates which likely disinhibit
L2/3 excitatory excitatory neurons [363].
Natural whisker stimulation increases S1, L2/3 activity. Head fixed mice presented
with a pole show increased activity in L2/3 (and L4) neurons of S1 that is highly
correlated to the onset of touch [255] [84] [83] [141]. The larger the force exerted on
the whisker the higher the response [256] [281].
1.8.3 VPM drives cortical states
Changes in the activity of the VPM modulates the cortical state. Whisking increases
the firing of VPM neurons driving S1 into an active, desynchronized state [367] [235]
[292]. Optogenetic stimulation of the thalamus is sufficient to drive an active, desyn-
chronized state in S1 while pharmacological inactivation (muscimol) of the thalamus
enhances slow Vm fluctuations [292].
1.8.4 Locomotion modulates sensory responses
Sensory responses are also modulated by the behavioural state of the animal, such
as locomotion. For example, locomotion increases spontaneous and evoked activity in
the V1 [247] [22] and suppresses excitatory neuron activity in the auditory cortex [321]
suggesting that it can have modality specific effects. Using a tactile virtual reality setup
Ayaz et al. [23] found that locomotion (Figure 1.19 K) robustly increases S1 neuronal
activity (L2/3 and L5) more than whisker touch. Whisker touch during run increased
the amplitude and percentage of active S1 neurons more, compared to when these
stimuli were presented alone. This suggests modulation of sensory stimuli processing
by the behavioural state. L5 neurons respond transiently to whisker touch during run
while L2/3 neurons show sustained activity and more cells are recruited (Figure 1.19
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J). These suggests that L5 reports changes in touch conditions while L2/3 integrates
whisker stimuli continuously.
1.8.5 Astrocytes of the barrel cortex
It is no surprise that neurons in the S1 are involved in processing sensory information
from the whiskers. However, the cortex is also tiled with a network of astrocytes and
other glia. The astrocyte network in S1 is heterogeneous. Astrocytes within S1 barrels
are strongly coupled to each other through enriched expression of gap junction proteins
(Cx30 and Cx43) while astrocytes located in the septa are either weakly, or not coupled
to the astrocytic network [146]. They also exhibit layer specific morphological and
molecular characteristics [31] [194]. For example, L2/3 astrocytes had more extensive
process arborizations and ensheathed synaptic clefts more extensively compared to
L6 astrocytes [194]. Astrocytes exhibit differential gene expression patterns clustered
into layers who are divergent from neuronal laminae [31]. Layer specific diversity of
astrocyte is likely neuron dependent since they are abolished when neuronal layers are
disturbed in reeler and Dab1 conditional KO mice [194] [31].
Figure 1.19: Whisker somatosensory system of mice. (caption next page.)
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Figure 1.19: (previous page.) A) The whisker primary somatosensory cortex (wS1)
of mice is composed of somatotopically organized ’barrels’ (right), each representing
an individual whisker (left). B) Whisker deflection activates a cascade of neuronal ac-
tivity in trigeminal ganglia (1), brainstem (2), thalamus (3) and wS1. C) From there,
wS1 neurons project to many cortical and subcortical areas. D) wS1 neurons receive
thalamic input from the ventral posterior medial nucleus (VPM) and the posterior
medial nucleus (POm). The VPM primarily innervates layer 4 (L4) barrels but also
L3 and L6A (blue). The POm sends higher-order inputs to L1 and L5A. E) Extensive
excitatory microcircuits send projections between layers in the barrel column (vertical
arrows) and across barrel columns (horizontal arrows). F) Both excitatory neurons
and inhibitory interneurons receive input from the VPM and are strongly connected to
each other. G) The reciprocal connectivity between strong excitatory and inhibitory
synapses may mediate reliable, sparse coding in the wS1. H) Mice running on wheels
with systems embedded to trigger whisker touch can be used to study the somatosen-
sory system in awake animals. I) Upon whisking (periodic movement of whiskers)
onset only a tiny fractions of L2/3 and L5 neurons are activated. J) Both L2/3 and
L5 neurons display a sharp initial response to whisker touch. L2/3 neurons exhibit a
sustained response to continuous whisker touch while L5 neurons display a transient
response. K) Both L2/3 and L5 neurons display sustained activity with (slightly be-
fore) the onset of locomotion. APT (anterior pretectal nucleus); DLS, dorsolateral
striatum; DZ(dysgranular zone surrounding wS1); nRT(nucleus reticularis of the tha-
lamus); PPC (posterior parietal cortex); OFC (orbitofrontal cortex); PRh (perirhinal
cortex); SC (superior colliculus); Sp5 (spinal trigeminal nuclei); TeA (temporal as-
sociation cortex); wM1 (whisker-related primary motor cortex); wM2 (whisker-related
secondary motor cortex); wS2 (whisker-related secondary somatosensory cortex); POm
(posterior medial nucleus of the thalamus); VPM (ventral posterior medial nucleus of
the thalamus); V2 (P,PP) (secondary visual area). Panels A-G were taken from [284];
H-I from [23].
Recently, astrocytes were also reported to respond to whisker stimulation with
[Ca2+]i elevations in L2/3 of S1 [387] [356] [200] [201] [344][345] but see ([93] [250])
suggesting that they might be involved in aspects of sensory processing. Astrocyte
responses were more reliably observed in spatially clustered sensory maps like the
mouse S1 compared to V1, suggesting that some of the controversies might be sensory
modality dependent [204]. Calcium changes might be different across layers [355] but
this remains to be confirmed and better characterized. Slice experiments indicated that
L2/3 astrocytes specifically respond to L4 neurons [319] suggesting that astrocytes can
discriminate between inputs within anatomical circuits. S1 astrocytes were also shown
to exhibit heterogeneous Ca2+ responses to optogenetic stimulation of PV+ and STT+
inhibitory interneurons in vivo [215]. Stimulating whiskers in mice for 24h doubles
the expression of GLT1 and GLAST in the respective barrel column and increases
astrocyte enveloping of excitatory dendritic synapses [116]. Therefore, neuronal activity
can change functional, molecular and morphological features of S1 astrocytes. The






It has been recently realized that astrocytes are heterogeneous cells that may be dif-
ferentially involved in different neuronal circuits [216] [278]. Viral tracers have been
widely used to study neuronal circuits. I hypothesised that viral tracing can be used to
label astrocytes embedded in specific neuronal circuits. Recombinant adeno associated
viruses (rAAVs) are capable of anterograde and retrograde transport through axons,
and have been used to study neuronal circuits [63] [64] [415]. Even though astrocytes
are in tight contact with neuronal synapses and can be efficiently transduced by AAVs,
the ability of AAVs to transfer through axons to astrocytes was so far unexplored. The
objective of this chapter is to investigate the potential of intercellular AAV transfer
from neurons to astrocytes.
2.1.1 Hypothesis
• AAV1 injected in the VPM can transfer to the cortex through axons to infect
2nd order astrocytes and neurons in the somatosensory cortex.
2.2 Methods
All experimental procedures were approved by the OIST Institutional Animal Care
and Use Committee (IACUC) in an Association for Assessment and Accreditation of
Laboratory Animal Care (AAALAC International) accredited facility.
2.2.1 Animals
Male, 1 - 3 month old C57/BL6 mice were used. Mice were housed under reverse
light/dark cycle.
49
50 Anterograde axo-astrocytic AAV transfer to astrocytes
Figure 2.1: Hypothetical schematic of trans-synaptic AAV transfer to as-
trocytes and neurons. 1) AAVs enter neurons at the injection site by endocytosis.
2) Some AAV particles transport to the nucleus through the cytoskeleton. 3) They
enter the nucleus and release their ssDNA which is converted to dsDNA concatemers.
The transgene is transcribed and then translated into proteins. 4) A small number
of AAV particles are transported anterogradely along the axons to the terminals. 5)
They are then released and enter adjacent postsynaptic dendrites and perisynaptic as-
trocytic processes (PAPs). Then they enter the nuclei of 6) neurons and 7) astrocytes
and release their ssDNA which eventually leads to protein synthesis.
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2.2.2 Surgery
Mice were anesthetized by intraperitoneal injection of 0.1 ml/10g 3-mixture anesthetic
(Medetomidine: 0.3mg/kg, Midazolam: 4 mg/kg, Butorphanol: 5 mg/kg diluted in
0.9% saline solution). Carprofen (5 µg/g; intraperetoneal), Dexamethasone (2 µg/g; in-
tramuscular) and Buprenorphine (0.1 µg/g; subcutaneous) were administered to reduce
inflammation, immune response and pain respectively. Following anesthesia induction
the mouse eyes were protected by covering them with mycochlorin eye ointment (Sato
Pharmaceutical Co., Ltd). The head hair were removed with a hair trimmer and hair
removal cream (Veet). The head of the animal was fixed on a stereotactic apparatus
and its skin was sterilized with iodine. If further anesthesia was needed, 1% isoflurane
was administered.
A single midline sagittal incision of the skin (head) was performed. The exposed
skull was cleaned with the local anesthetic lidocaine. The skin was then pulled and
dry fixed with compressed air. Bregma and lambda were used to level the skull. The
injection co-ordinates in reference to Bregma were based on the Paxinos reference Atlas
[275] and previous calibration injections. The skull was thinned at the desired coor-
dinates using a diamond drill. A sterile glass pipette with a broken tip was used to
puncture the thinned skull at the precise coordinates established to minimize the ex-
posure of the brain. Using separate glass pipettes (10-15 µm tip diameter), AAVs were
injected in the VPM (1.8 mm posterior, 1.7 mm lateral, 3.5 mm deep) and sometimes
in the somatosensory cortex (1.8 mm posterior, 3.2 mm lateral, 0.5 mm deep) as well.
AAVs were pressure injected at ≈70 nl/ 5 minutes and the pipette was left to rest in
the brain for at least 5 minutes before and after injection. After injections, the cut skin
was glued back together. Animals were housed individually and allowed to recover for
at least one week, unless otherwise stated.
2.2.3 Adeno associated viruses
To assess whether AAV1 tags astrocytes anterograde the injection site, 140 nl (1:1 ratio)
AAV2/1.CMV.P1.Cre.rBG (1.2×1013 GC/mL) and AAV2/1.hSyn.TurboRFP.WPRE.rBG
(3.9×1013 GC/mL) (University of Pennsylvania Viral Vector Core) were co-injected in
the VPM and 100 nl AAV2/5.GFaABC1D.Flex.Lck.GCaMP6f.WPRE.SV40 (1.0×1013
GC/mL) (Sirion Biotech) was injected in the somatosensory cortex.
To assess if a similar intersectional strategy can be used to label neurons, the same
combination of AAVs was injected in the VPM, while 100 nl AAV9.Syn.Flex.GCaMP6f.
WPRE.SV40 (2.8×1013 GC/mL) (University of Pennsylvania Viral Vector Core) was
injected in the somatosensory cortex.
To assess whether a cortical injection is necessary and what aspects of the AAV vec-
tor are needed to label 2nd order cells; 140 nl (1:1 ratio) of different rAAV combinations
were injected only in the VPM:
• AAV2/1.hSyn.TurboRFP.WPRE.rBG and AAV2/1.CAG.GCaMP6f.WPRE.SV40
(1.33×1013 GC/mL) (University of Pennsylvania Viral Vector Core).
• AAV2/1.CMV.P1.Cre.rBG and AAV2/1.CAG.Flex.eGFP.WPRE.bGH (9.16×1012
GC/mL) (University of Pennsylvania Viral Vector Core).
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• AAV2/1.CMV.P1.Cre.rBG and AAV2/1.CAG.Flex.tdTomato.WPRE.rBG (4.65
×1013 GC/mL) (University of Pennsylvania Viral Vector Core).
A combination of AAVs that induced high contrast, “brainbow”-like labelling, an-
terograde the injection site were used for cell quantification experiments to aid in the
counting of cells, particularly those inside dense thalamocortical projections in layer 4
of S1. I termed this effect ’Traffic light labelling’, and it was induced by injecting 70 or
140 nl (1:1:1) AAV2/1.CMV.P1.Cre.rBG, AAV2/1.CAG.Flex.eGFP.WPRE.bGH and
AAV2/1.CAG.Flex.tdTomato.WPRE.rBG in the VPM.
2.2.4 Slice preparation and immunohistochemistry
Two weeks after injection (unless otherwise stated) the animals were deeply anes-
thetized with the 3-mixture anesthetic and transcardially perfused with PBS followed
by PLP (4% paraformaldehyde, 0.2% periodate and 1.2% lysine in 0.1M phosphate
buffer) fixation. The brains were extracted and stored in PLP at 4oC for a minimum
of 48h.
Brains were sliced after all procedures and prepared for confocal microscopy. A
vibratome (VT1000S, Leica) was used to cut 100 µm thick coronal brain sections. The
slices were mounted on glass slides with Mowiol and stored at 4oC.
I used immunohistochemistry to track AAV capsids by tagging them with an anti-
AAV1 antibody. For immunohistochemistry preparation the brains were cryoprotected
using 20% sucrose solution in PBS overnight. The brains were then trimmed and em-
bedded in optimal cutting temperature (OCT) compound (Tissue-Tek). The samples
were frozen at -80oC for 1 hour. A cryotome (Leica CM3050 S) was used to cut 50 µm
thick coronal slices at -15oC which were immediately transferred in wells filled with
PBS. The sections were washed in PBS and then incubated in 20% normal goat serum
in permeabilization solution (0.3% Triton-X-100, 0.05% sodium azide, PBS) for 1 hour.
The serum was replaced with 1:20 mouse Anti-AAV1 monoclonal antibody (Antibodies-
online, ABIN933221) diluted in permeabilization solution. The slices were incubated
for 24h at 4oC. The samples were washed with PBS and incubated in goat anti-mouse
polyclonal secondary antibody Alexa Fluor 488 (abcam, ab150113) 1:200 (diluted in
permeabilization solution) for 2-3 hours in the dark at room temperature. The brain
slices were washed with PBS, mounted on glass slides with DAPI (VECTASHIELD)
and stored at 4oC.
2.2.5 Confocal imaging and analysis
LSM 510 META ConfoCor3 and LSM 710 (Carl Zeis) confocal microscopes were used to
image fixed brain slices. LSM 510 was used to capture all images except for antibody-
labelled capsid samples in the cortex. For immunostained AAV capsid imaging, LSM
710 was used because an objective with high numerical aperture (N.A.) was needed for
high resolution.
For LSM 510, a 488 nm argon laser and a 561nm Diode-Pumped Solid-State (DPSS)
laser were used to excite green fluorophores (eGFP, GCaMP6f, Alexa Fluor 488) and
red fluorophores (tdTomato, TurboRFP) respectively. A 405 nm Diode was used to
excite DAPI.
2.2 Methods 53
All data was analyzed using Matlab (R2015b). The normality of distributions was
assessed using Kolmogorov-Smirnov test (kstest) with a significance threshold set at
p = 0.05, and a straight line of the quantile-quantile (QQ) plot (qqplot). Normal
distributions from independent samples were compared using an unpaired, two tailed
t-test (ttest2) with the significance threshold set to p < 0.05.
To compare the relative intensity of the eGFP and tdTomato component of ’Traffic
light labelled’ cells, confocal images in 100µm thick coronal brain slices from 2 mice
were acquired. The intensity parameters of the argon (488nm) and DPSS (561nm)
laser were standardized for consistency and to avoid saturation. ROIs of all labelled
cells were manually selected in Fiji [318]. The average red and green channel intensities
from these ROIs was extracted. ROIs containing saturated pixels were discarded. 1019
cells were used. The extracted red and green ROI intensities were normalized to the
minimum and maximum value of the respective channel and set to 0 (minimum) and
1 (maximum) respectively. The values of the red (R): green (G) normalized intensity
ratio (G / R + G) for each ROI (cell) where calculated. For example, 0 and 1 means
a given ROI is only red (tdTomato+) or green (eGFP+) respectively.
For cell number quantification, 3 image stacks were acquired per mouse composed of
40, 16 bit images with a 409×409 µm field of view, interspaced 1 µm from each other at
1 Airy Unit (AU) using a Plan-apochromat 20x/N.A. 0.8 objective. The 3 stacks were
taken from 3 brain slices (1 at the z-plane of the injection tract± 1) and standardized to
be ≈1700 µm lateral of the injection track centered on the barrels. All cell bodies were
manually counted. The number of cells in all 3 slices were averaged for each mouse.
Normal distributions from independent samples were compared using an unpaired, two
tailed t-test (p < 0.05). 9 brain slices from 4 mice were used to manually count all
astrocytes and neurons in ’Traffic light labelled" samples and categorized. Astrocytes
were identified and separated from neurons based on their characteristic spongiform
morphology. Ambiguous cells were discarded. The remaining classified astrocytes and
neurons (n = 595) were used to estimate their relative proportions.
For capsid puncta quantification in the cortex tdTomato positive cell bodies of as-
trocytes and neurons ≈1700 µm lateral of the injection site were randomly selected
from 3 brain slices per mouse (n=3). A 63x /N.A. 1.46 a-Plan-Apochromat Oil objec-
tive was used to acquire 3D image stacks of 67.48×67.48µm field of view (16 bit, 1024
x1024 pixels), 0.7 µm interspaced from each other at 0.84 AU and averaged 8 times.
Alexa-fluor 488 and tdTomato were excited using a 488 nm Argon laser and 543 nm
Helium-Neon laser respectively. For control, 3D stacks with the same parameters were
also taken in the opposite site cortex (1 hour after injection in its ipsilateral VPM).
To quantify the number of capsid puncta, images were converted to 8 bits and a 3D
gaussian filter of 1 pixel was applied. Standardized brightness, contrast and threshold
parameters were established empirically. Fluorescent puncta of 0.1 - 0.5 µm2 in size
were automatically counted using Fiji (analyze particles). The size range parameter
was based on empirical observations of puncta sizes since they could be easily identified
by eye. Unpaired two tailed t-tests were used to compare the puncta density between
a) S1 cell bodies (n=15) vs local background to these cells (n=12; 12 days after in-
jection in ipsilateral VPM) and b) local background vs background of the opposite S1
cortex (n=10), devoid of cell bodies (1 hour after injection in its ipsilateral VPM).
The sampling volume was calculated to be equal to the ROI area×(0.7×Number of
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Z sections). Puncta density was calculated to be the number of puncta / sampling
volume. The significance threshold was set to p < 0.05 for all statistical tests.
2.2.6 Whisker removal
To test the hypothesis that AAV transfer to 2nd order cortical cells is activity de-
pendent, the contralateral whiskers to the injected VPM were removed to deprive the
mouse of sensory input to the somatosensory circuit. Mice (n=10, 2 months old)
were separated into a control (n=5) and an experimental group (n=5). The ipsilateral
whiskers to the injected VPM were removed in the control group. All contralateral
whiskers to the injected VPM were plucked in the experimental group. Whiskers were
first removed right before surgery. Whisker were removed by periodic plucking using
tweezers. Whisker regrowth was monitored and any regrowing whiskers were plucked
under 1% isoflurane anesthesia. The animals were perfused two weeks after injection.
The mean number of S1, ’Traffic light labelled’ cells between the two groups was com-
pared using an unpaired, two tailed t-test.
2.2.7 Exosome inhibition
To test if AAV anterograde tagging is exosome dependent I used a protocol based on
Dinkins et al. [95] to inhibit exosome production. Dinkins et al. [95] showed that ad-
ministration of 100 µg GW4869 daily for 5 days in wild type mice reduced the number of
exosomes in the brain (detected by the exosome markers Alix and Tsg101). They then
reported that injecting 60µg of GW4869 every 2 days for 6 weeks in an Alzheimer’s dis-
ease mouse model (5XFAD) reduced brain amyloid concentration, serum exosomes and
several ceramides. I used Dinkins et al. protocol [95] with modifications in the percent-
age of DMSO used to dilute the drug. GW4869 (N,N’-Bis[4-(4,5-dihydro-1H-imidazol-
2-yl)phenyl]-3,3’-p-phenylene-bis-acrylamide dihydrochloride; molecular weight 577.5
g/mol; Santa Cruz Biotechnology) was diluted and stored in DMSO at 4 mg/mL in
4oC. Mice (n=10, 2 months old) were separated into a control (n=5) and an exper-
imental group (n=5). The control group was injected with 200 µl of 7% DMSO in
0.9% saline. The experimental group was injected with 200 µl GW4869 diluted to 0.3
mg/mL in 0.9% saline (≈ 60 µg/mouse). Mice in both groups were injected intraperi-
toneally every day for the first 5 days and then every 48 hours for 2 weeks total (9
injections). The first injection was performed right before surgery. All injections were
performed under isoflurane anesthesia. No obvious health problems were observed.
The animals were perfused 2 weeks after AAV injection. The mean number of S1,




2.3.1 AAV1 vectors injected in the VPM mediate astrocytic
and neuronal labelling in S1
The long range, thalamocortical projections from VPM to S1 provide a good model to
test whether AAV1s transport anterograde through axons to 2nd order astrocytes and
neurons. First I tested if injecting AAV1.CMV.Cre in the VPM and AAV1.GFaABC1D.
flex.lck.GCaMP6f in the cortex can label astrocytes. In this preparation, AAV1.hSyn.
TurboRFP was also co-injected in the VPM as a marker for the projection path-
way, to assess if there was any damage at the injection site and check if there are
TurboRFP+ cell bodies in the cortex (Figure 2.2 A). The injection co-ordinates were
confirmed based on the Paxinos Brain Atlas and by the distinct, dense, barrel like pro-
jection pattern of VPM neurons observed in layer 4 of the somatosensory cortex (Fig-
ure 2.2). This injection strategy resulted in labelling of S1 astrocytic membranes with
lck.GCaMP6f (green; Figure 2.2 A) revealing their cloud like morphology. While dense
TurboRFP+ thalamocortical axons could be seen innervating the S1 (red; Figure 2.2 A),
no TurboRFP+ cell bodies were found in S1. GCaMP6f+ S1 astrocytes were sparsely
distributed in L3 and more densely distributed in L4. A small number of cells with non-
astrocytic like morphology were also observed predominantly in layers 5 and 6. Using a
similar Cre-Flex intersectional strategy, I tested whether S1 neurons can be selectively
labelled. Instead of using the astrocyte specific GFaABC1D promoter, I used AAVs car-
rying the gene encoding the neuron specific hSyn promoter. Injecting AAV1.CMV.Cre
and AAV1.hSyn.TurboRFP in the VPM and AAV9.hSyn.Flex.GCaMP6f in S1 led only
to neuronal labelling with GCaMP6f in the cortex (green, Figure 2.2 B). GCaMP6f+ S1
neurons were most densely found in L4 and L6A. I didn’t observe TurboRFP labelling
in cortical cells.
I then asked whether: a) a double injection strategy (VPM and cortex), b) Cre re-
combinase or, c) the specific fluorescent protein expressed are needed to label astrocytes
and neurons in the cortex . Injecting AAV1.CAG.GCaMP6f and AAV1.hSyn.TurboRFP
(Figure 2.2 C) or AAV1.CMV.Cre and AAV1.CAG.flex.eGFP (Figure 2.2 D) in the
VPM results in second order cortical astrocytes and neurons labelled with GCaMP6f
and eGFP respectively. Therefore, a double injection strategy is not necessary, Cre re-
combinase is not required and the fluorescent protein expressed doesn’t affect whether
second order astrocytes and neurons are labeled. Although a double injection strategy
is not necessary for the labelling of cortical cells following AAV injection in the VPM,
the gene encoding for the fluorescent protein must be driven by a strong promoter (like
CAG) for cortical cell to be labelled with a single AAV injection only in the VPM.
Once again, the highest density of labelled cortical cells was observed in L4.
Through the above strategies and more than 300 injections with a variety of AAVs
I observed reliable (≈100%) labelling of cortical cells following thalamic injection with
certain AAV mixtures (i.e. ones demonstrated here). Sparse labelling of cortical cells
suggests a small number of AAVs are transferred. Intersectional Cre-FLEX strategies
with different promoters can be used with AAVs for anterograde, cell type specific
labelling of astrocytes and neurons. AAV1 injected in the VPM led to second order
cell labelling in the cortex. However the strong promoter CAG was necessary. The
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Figure 2.2: Intercellular AAV transfer injection strategies. Inject-
ing AAV1s carrying genes encoding for fluorescent proteins in VPM results in
sparse labelling of astrocytes and neurons in the projecting somatosensory cor-
tex. A) AAV1.CMV.Cre and AAV1.hSyn.TurboRFP injected in the thalamus and
AAV5.GFaABC1D.Flex.lck.GCaMP6f injected in S1 cortex. Thalamocortical ax-
ons are labelled with TurboRFP and cortical astrocyte membranes are labelled
with GCaMP6f. B) AAV1.CMV.Cre and AAV1.hSyn.TurboRFP injected in the
thalamus and AAV9.hSyn.Flex.GCaMP6f in the somatosensory cortex. Thalamo-
cortical axons are labelled with TurboRFP and cortical neurons are labelled with
GCaMP6f. C) AAV1.hSyn.TurboRFP and AAV1.CAG.GCaMP6f injected in the VPM
labels neurons and astrocytes in the somatosensory cortex. D) AAV1.CMV.Cre and
AAV1.CAG.Flex.eGFP injected in the VPM labels neurons and astrocytes in the cor-
tex. Thalamic injections of AAV1.hSyn.TurboRFP label VPM neurons but not any
cortical cells. All images were taken from fixed brain slices of mice sacrificed two week
after injections.
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majority of labelled cortical cells were in layer 4, the major projection target of the
VPM. A smaller number of labelled thalamocortical axons and cortical cells was found
in layers 5, 6 and 2/3. The highest concentration of labelled cells was far (≈1.5 mm)
from the injection tract and injection site. Taken together these observations suggest
that a small number of AAVs are transferred through thalamocortical axons to cortical
astrocytes and neurons.
2.3.2 AAV capsids are found in astrocytes and neurons in the
cortex following VPM injection
The next question was whether indeed a small number of AAVs transduce cortical cells
following thalamic injection. To test that I tracked AAV capsids periodically using an
anti-AAV primary antibody to tag the AAV capsids and a secondary antibody carrying
Alexa Fluor 488 to detect where primary antibodies were bound.
First I tested if the antibody labels capsids reliably, and how AAV capsids are
distributed at the injection site (VPM). If the anti-VP1 antibody binds to the AAV
capsids, then I would expect Alexa Fluor 488 lebelling at the injection site immedi-
ately after injection of AAV1. Indeed, injecting an AAV mixture (AAV1.CMV.Cre
and AAV1.CAG.Flex.tdTomato) in the VPM of mice followed by perfusion within 1
hour resulted in green, cloud like fluorescence (≈radius = 250 µm; 140nl) only at the
injection site. A macroscale and a microscale example can be seen in Figure 2.4 B and
Figure 2.3 B respectively. Therefore, in all future experiments using anti-VP1 anti-
body, two injections were performed in the same mouse: one control (within 1 hour
before perfusing the animal serving as a positive control for antibody labelling) and one
experimental. Absence of green fluorescence at the control injection site indicated that
something went wrong during the experiment and the sample was discarded. A second
injection in the opposite VPM to the control was performed to investigate the distri-
bution of AAVs in the VPM 24 hours (Figure 2.3; n = 3 mice) or 12 days (Figure 2.4;
n=3 mice) after co-injection of AAV1.CMV.Cre and AAV1.CAG.Flex.tdTomato.
Immediately after injection (≈1h), AAV particles are distributed like a cloud at
the injection site (Figure 2.4 B) but do not co-localized with DAPI labelled cell nuclei
(Figure 2.3 B). However, 24 hours after AAV injection the opposite picture emerged.
Green fluorescent puncta representing AAV capsids (or clusters of capsids) were pri-
marily co-localized with DAPI labelled cell nuclei (Figure 2.3 C). These observations
suggested that a large number (not quantifiable) of AAV capsids enter the nuclei of
cells within 24 hours after injection.
I then hypothesized that green fluorescent puncta would be present in the cell bodies
of tdTomato labelled cells in the cortex following VPM injection of AAV1.CMV.Cre
and AAV1.CAG.Flex.tdTomato. A period of 12 days was chosen for this experiment
(in contrast to 24 hours of the previous experiment)(Figure 2.4 A) in order to give
enough time for tdTomato to be expressed in the cortex, to decrease the chance of
any possible damage in the VPM due of prolonged expression and to have relatively
low tdTomato expression in the cortex to minimize possible cross talk of the red and
green detection channels. The same injection strategy as before was performed. High
resolution confocal imaging revealed a small, countable, number of green fluorescent
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Figure 2.3: AAV capsids enter thalamic cells within 24 hours after injection
A) Experimental procedure: AAV1.CMV.Cre and AAV1.CAG.Flex.tdTomato were in-
jected in the left VPM of mice (n=3; Day 0). Following 24 hours of rest (Day 1),
the right VPM of the same mouse was injected with the same virus mixture (control)
followed by perfusion of the animal within 1 hour from injection. Immunohistochem-
istry (IHC) was used to label AAV capsids with anti-VP1 antibody in brain slices. B)
Confocal images of VPM 1 hour after AAV injection there. Nuclei are stained with
DAPI (blue) and AAV capsids are tagged with anti-VP1 antibody (Alexa Fluor 488;
green). AAV capsids form a cloud at the injection site but they don’t co-localise with
cell nuclei. C) Confocal images of VPM 24 hours after AAV injection. AAV capsids
(green) co-localize with cell nuclei (blue).
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Figure 2.4: AAV capsids are found in cortical astrocytes and neu-
rons 12 days after injection in the thalamus. A) Experimental procedure:
AAV1.CMV.Cre and AAV1.CAG.Flex.tdTomato were injected in the left VPM of mice
(n=3; Day 0). Following 12 days of rest (Day 12), the right VPM of the same mouse
was injected with the same virus mixture (control) followed by perfusion of the animal
within 1 hour from injection. Immunohistochemistry (IHC) was used to label AAV
capsids with anti-VP1 antibody in brain slices B) Confocal image of coronal brain
slices labelled with tdTomato (red), DAPI (blue) and anti-VP1 antibody (green). 12
days after injection, tdTomato is expressed in the left but not in the right VPM (con-
trol). Anti-VP1 antibody tagged AAV capsids in both right and left VPM. C) Confocal
images of a S1 astrocyte (left, mid) and neuron (right) in the left cortex labelled with
tdTomato (red) and anti-VP1 antibody (green). Green fluorescent puncta can be seen
in both astrocytic and neuronal cell bodies (see white arrow). D) Green fluorescent
(Alexa Fluor 488) puncta density (number of puncta/ 10µm3) in the 1 hour background
(mean = 8.1 ± 1.0 CI, 1.6 SD, n=10), 12 day background (mean = 19.6 ± 3.0 CI, 5.3
SD, n=12) and tdTomato+ cell bodies (mean = 39.8 ± 4.7 CI, 9.2 SD, n=15) of the
cortex. Data is represented as mean ± 95% confidence interval (CI). SD = standard
deviation. Unpaired two tailed t-test was used with significance threshold set to p <
0.05. *** = p < 10−5.
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puncta in the cell bodies of tdTomato+ S1 astrocytes and neurons (Figure 2.4 C).
Quantification of puncta density (number of puncta / 10 µm3) from 3D stacks revealed
that the mean density of puncta in the cell bodies (mean = 39.8 ± 4.7 CI, 9.2 SD, n =
15) was higher (≈2x; p < 10−5) than their local (12d) background (mean = 19.6 ± 3.0
CI, 5.3 SD, n = 12) (Figure 2.4 D). No tdTomato+ cells or distinct green fluorescent
puncta clusters were observed in the opposite S1. The mean puncta density of the
opposite S1 background (1h background) was significantly (p < 10−5) lower (mean =
8.1 ± 1.0 CI, 1.6 SD; ), n = 10) than the 12d background (Figure 2.4 D) The 1h
background puncta density is more representative of the actual signal noise. The 12d
background also contained green fluorescence puncta clusters in tdTomato− cells and
possibly puncta accumulated inside neurites. Also some homogenous labelling of what
looked like blood vessels was observed throughout the brain using this antibody that
was ignored in the analysis. The data was compared using unpaired, two-tailed t-test
with the significance threshold set to p < 0.05. (CI = 95% confidence interval, SD =
standard deviation).
"Traffic light labelling"
These findings suggest that following AAV injection in the VPM a small number of AAV
capsids transport to the ipsilateral cortex and accumulate into neuron and astrocyte
cell bodies. Considering that ≈1 week is needed for fluorescent proteins to be produced
at visible levels following AAV transduction, anterograde AAV1 transport most likely
occures within the first 5 days of VPM injection.
2.3.3 Mechanisms of intercellular AAV transfer
The mechanism of intercellular AAV transfer in unknown. Possible mechanisms might
involve exosome release (Figure 2.6) or neuronal activity dependence (Figure 2.7). The
general idea was to inhibit exosome production using the drug GW4869 or inhibit
glutamatergic input to the VPM by plucking all contralateral whiskers. If these per-
turbations reduced the number of AAVs transferred from the VPM to the cortex I
would expect a reduced number of labelled cells.
First I developed an AAV injection strategy to improve cell counting accuracy.
Since the same fluorophores expressed in the VPM are also expressed in the cortex
with the highest cell density in the regions of most thalamocortical axon projections
(layer 4) it can result in low contrast and therefore high counting errors. I found that
injecting AAV1.CMV.Cre, AAV1.CAG.Flex.eGFP and AAV1.CAG.Flex.tdTomato in
the VPM leads to a spectrum of sparse, bright green, red and yellow (green + red)
astrocytes and neurons (Figure 2.5 B, C). I termed this pattern of labelling “Traffic
light labelling” (TLL). Brain slices from 2 mice infected with TLL AAV mixture (VPM,
70nl 1:1:1) were used to test the relative contribution of eGFP and tdTomato in the
labelling of cortical cells. Mice were perfused 2 week after AAV injection. All visible
cell bodies were manually selected (n=1019 ROIs). Their respective red (R) and green
(G) intensity values were extracted and normalized to their respective minimum and
maximum (Figure 2.5 E; top, middle). I then calculated the G/(G+R) values of these
cells and plotted their probability histogram (Figure 2.5 E; bottom). This analysis
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Figure 2.5: “Traffic light labelling” Injecting a mixture of AAV1.CMV.Cre,
AAV1.CAG.Flex.tdTomato and AAV1.CAG flex.eGFP in the VPM results in bright
red, green and yellow (red + green) astrocytes and neurons in the cortex. I term
this effect “Traffic light labelling”. A) Schematic of AAVs injected in the VPM. B)
Confocal image of “Traffic light labelled” neurons and astrocytes embedded in yellow
thalamocortical axons projecting from the VPM in a fixed brain slice two weeks after
injection. C) Confocal (top) and in vivo two-photon microscopy image (bottom) of
“Traffic light labelled” red and green astrocytes shows their minimally-overlapping do-
mains in the cortex. D) Estimated percentage of astrocytes compared to neurons in the
somatosensory cortex using “Traffic light labelling” (n = 595 cells). E) Histogram of
the normalized green (G; eGFP; top) and red (R; tdTomato; middle) channel intensity
values of labelled cortical cells. G/(R+G) histogram (blue; bottom) of “Traffic light
labelled” cells (0 = cell is 100% red, 1 = cell is 100% green). 1019 cells from brain
slices of 2 mice.
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revealed that some cells are purely red while some others are purely green. However the
majority of cells expressed a combination of tdTomato and eGFP. The flat G/(G+R)
probability distribution further suggests that a small number of virus particles are
delivered to cortical cells from the VPM.
Sorting astrocytes and neurons based on morphology (595 cells, 9 slices, 4 mice),
I estimated that 13% of “Traffic light labelled” cells in the somatosensory cortex were
astrocytes (Figure 2.5 D). Because of the wide spectrum of colours in the cortex “Traffic
light labelling” offers high contrast (to yellow thalamocortical axons) that can be used
to count cells in the cortex. “Traffic light labelling” was used to study the exosome
(Figure 2.6) and activity dependence (Figure 2.7) of AAV transfer.
Exosome mediated AAV intercellular transport
Exosomes are ≈ 40 - 150 nm diameter extracellular vesicles secreted by most cells. Ex-
osomes are thought to play roles in waste removal [27] and intercellular communication
(i.e. they carry proteins, mRNA, lipids) [298]. Their membranes are rich in lipids such
as ceramide, sphingolipids and cholesterol [89]
Maguire [211] showed that under normal conditions of AAV production a fraction
of AAV particles are associated with exosomes in cell culture media. These exosome-
associated AAVs were termed exo-AAVs or vexosomes (vector exosomes). Interestingly
exo-AAVs had higher transduction efficiency and showed resistance to neutralizing
antibodies compared to conventional AAVs. Maguire’s lab later demonstrated that
exo-AAVs are capable of efficient transduction in brain astrocytes and neurons [148].
Exosome and AAV pathways are similar. AAVs enter the cell through endocytosis,
transfer to the early endosome (EE) followed by entry in the late endosome (LE)/ mul-
tivesicular body (MVB) and trans-golgi network (TGN). rAAVs released by endosomes
can enter the nucleus through the nuclear pore complex (NPC). AAVs in MVBs can
also be targeted for degradation in the lysosome [324]. Similarly, exosomes are formed
by the maturation of the early endosome into MVBs. During this process the endo-
somal membrane invaginates to generate intraluminal vesicles. The vesicles are then
released as exosomes through fusion of MVBs to the plasma membrane or targeted for
degradation in the lysosome [137].
In neurons, the maturing late endosome can be anterogradely transported along the
axon or converted to an MVB. The MVB then fuses with the cell body or dendritic
membrane to release intraluminal vesicles as exosomes. MVBs are present in both
axons and presynaptic terminals but there is no evidence of its MVB transport along
the axon. It is postulated that the maturing late endosome is converted to MVB during
its transport [379][181][8][153].
It is likely that viruses would evolve ways to hijack intercellular cargo transport
mechanisms for their own proliferation. Other viruses are known to hijack the exosome
pathway to aid their spread, infection and pathogenesis [311][176]. Therefore, consid-
ering that AAVs can associate with exosomes and that they share similar pathways
inside the cell led to the hypothesis that inhibiting exosome production would decrease
rAAV intercellular transfer. A summary of this hypothesis is illustrated in Figure 2.6
A.
To investigate if AAV intercellular transfer is exosome dependent I used the neutral
2.3 Results 63
Figure 2.6: Number of labelled 2nd order cells in S1 was not affected by
the exosome inhibitor GW4869. A) Schematic of question: Does inhibiting exo-
some production using GW4869 reduces the number of 2nd order labelled astrocytes
and neurons by intercellular AAV transfer? B) Schematic of experimental procedure:
“Traffic light labelling” AAV mixture, is injected in the left VPM of mice (n=10) who
were separated into a GW4869 group (n=5) and a control group (n=5). GW4869 or
saline mixtures were injected every day for 5 days followed by every 2 days thereafter
for 2 weeks in each mouse group respectively. C) The mean number of cortical cells was
calculated based on the number of labelled cells found in pre-determined areas (area
≈6.7×106 µm3 /slice; 3 slices) of the S1. D) Comparison between the mean number
of cortical cells GW4869 (GW; 108.8 ± 52.5 CI, 59.9 SD) and control (103.6 ± 19 CI,
22.1 SD). Unpaired, two-tail t-test (p = 0.87). SD = standard deviation, CI = 95%
confidence interval. Data is presented as mean ± CI. Significance threshold set to p <
0.05).
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sphingomyelin inhibitor GW4869 to inhibit the ceramide-mediated inward budding of
MVBs and the release of mature exosomes [183]. I used a protocol based on the work
of Dinkins et al. [95] where they tested the effect of the drug in the adult mouse brain.
GW4869 was injected in mice (n=5) every day for 5 days (expected time interval of
AAV transfer) followed by 2 day intervals for 14 days total (Figure 2.6 B). Mice were
then perfused and their brains were sliced and imaged. I counted and averaged the
number of labelled cells in 3 slices per mouse in a cubic area ≈6.7×106 µm3, ≈1700
µm lateral the injection site centered on layer 4 (Schematic shown in (Figure 2.6 C).
Comparison between the mean number of labelled cortical cells in the GW4869 group
(108.8 ± 52.5 CI, 59.9 SD) and control group (103.6 ± 19 CI, 22.1 SD; n=5) revealed
no significant difference between the two means (unpaired two tailed t-test, p = 0.87)
(Figure 2.6 D). This suggests that GW4869 had no significant effect on the number of
cortical labelled cells.
Neuronal activity mediated AAV intercellular transport
Another possibility is that intercellular AAV transfer is related to the activity of the
infected neurons. I thought that a simple way to chronically decrease the activity
of neurons in the VPM is to remove the sensory input (whiskers) associated with it.
Early work by Durham & Woolsey [103] using the autoradiographic 2-deoxy-D-glucose
showed that whisker plucking in rats results in decreased metabolic activity in the
barrel cortex. This can be interpreted as a reduction in neuronal activity. Kelly et
al. [173] expanded these findings using extracellular unit recordings of the rat barrel
cortex showing that removal of principle whiskers leads to decreased activity in the
associated barrel column.
To assess whether intercellular AAV transfer is activity dependent (Figure 2.7 A) I
plucked all the whiskers (Figure 2.7 B) contralateral or ipsilateral (control) the injection
site (VPM injected with TLL mixture) in two groups of mice (n = 5 each) respectively.
Two week later the mice were perfused. Confocal imaging of their brain slices revealed
no significant difference (p = 0.35) between the control (98.6 ± 30.2 CI, 34.3 SD) and
experimental group (73.6 ± 31.7 CI, 36.1 SD) (Figure 2.7 D).
2.4 Discussion
2.4.1 A small number of AAV particles is anterogradely trans-
ferred to transduce 2nd-order astrocytes and neurons
First, I showed that AAV1s injected in the VPM enter thalamic cell nuclei within 24
hours of injection (Figure 2.3). I demonstrated this using anti-AAV antibodies instead
of conjugating a dye to the viral capsid to avoid any possible interference to the natural
intracellular and intercellular movement of the virus.
Second, using the same antibody I found punctated antibody labelling inside tdTomato+
cell bodies of cortical astrocytes and neurons 12 days after vector injection in the VPM
(Figure 2.4). These findings suggest that AAVs are transferred to the cortical cell bod-
ies. Since cortical cells were tdTomato+ within 12 days of injection, AAVs must have
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Figure 2.7: Number of labelled 2nd order cells in S1 was not affected by con-
tralateral whisker removal A) Schematic of activity dependent hypothesis of AAV
transfer. Removal of contralateral whiskers decreases sensory input to the trigeminal
nuclei who in turn projects to the injected VPM. The hypothesis is that the num-
ber of viruses transferred from the VPM to the cortex following thalamic injection
will decrease with lower neuronal activity resulting in less labelled second order cells.
B) Experimental schematic: two groups of mice had either their ipsilateral (n = 5;
control) or contralateral (n=5) whiskers to the injected VPM ("Traffic light labelling"
AAV mixture) plucked for 2 weeks, followed by perfusion. C) The mean number of cor-
tical cells was calculated based on the number of labelled cells found in pre-determined
areas (area ≈6.7×106 µm3 /slice; 3 slices) of the S1. D) Comparison between the mean
number of labelled cortical cells in the contralateral whisker removal group (73.6 ± 31.7
CI, 36.1 SD; n=5) and ipsilateral whisker removal control group (98.6 ± 30.2 CI, 34.3
SD; n= 5). Unpaired two-tail t-test, p = 0.35. SD = standard deviation, CI = 95%
confidence interval. Data is presented as mean ± CI. Significance threshold set to p <
0.05).
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transferred soon after infecting VPM neurons to allow time for dsDNA synthesis and
tdTomato expression. This is in agreement with findings by Cearley & Wolfe [66] who
showed that anterograde and retrograde transfer of dye conjugated AAV9 to second
order neurons can occur within less than 24 hours. The early onset of AAV transfer
suggests that it didn’t take place because of overexpression induced neuronal death at
the VPM. The small number of puncta detected in cortical cell bodies compared to
the dense antibody labelling in the VPM suggests that only a small number of AAV
particles are transferred. It is possible that the puncta detected are capsid fragments
that don’t carry any DNA. Fluorescence labelling of second order cells suggests that
either fluorescent proteins or genetic material (mRNA, DNA) was transferred. Con-
sidering the strong expression of fluorescent proteins observed in a minority of cells,
DNA transfer through a small number of viral particles seems to be the most likely
explanation.
Third, I showed that co-injection of AAV1.CMV.Cre, AAV1.CAG.Flex.tdTomato
and AAV1.CAG flex.eGFP in the VPM results in bright, "brainbow" like labelling
of S1 astrocytes and neurons (Figure 2.5). Because of the colour pattern observed
(red, yellow, green) I termed this effect "Traffic light labelling" (TLL). TLL provides
another indication that a small number of AAV particles is anterogradely transferred
to 2nd-order cells based on the relative expression of tdTomato and eGFP in these
cells (Figure 2.5 E). Thalamocortical axons are co-labelled with tdTomato and eGFP
(yellow) suggesting a large amount of eGFP and tdTomato protein delivered there.
If intercellular labelling occurred because of protein transfer I would expect a large
amount of protein to be delivered to 2nd-order cells so they are detectable with fluo-
rescent microscopy. Unless the cell has a way of sorting out tdTomato from eGFP I
would expect that the majority of 2nd-order cells will be co-labelled (yellow). Instead
we can observe a mosaic of red, yellow and green cells (Figure 2.5 B, C). Most cells
express both eGFP(G) and tdTomato(R) at different proportions resulting in a flat
G/(G+R) probability distribution. A gaussian distribution centered on G/(G+R) =
0.5 would be expected if a large number of DNA or proteins were delivered. These in-
direct observations, also support the idea of elevated protein synthesis through a small
number of DNA delivered to cells.
2.4.2 Axo-astrocytic AAV transfer offers a flexible toolkit for
studying brain circuits
Fourth, I showed a set of injection strategies that can be used for labelling 2nd or-
der astrocyte and neuron of the somatosensory cortex (Figure 2.2). AAV1.CMV.Cre
injected in the thalamus and AAV5.GFaABC1D.Flex.lck.GCaMP6f in the somatosen-
sory cortex primarily (a small number of unidentified cell bodies were also detected)
labels cortical astrocytes (Figure 2.2 A). Using a similar intersectional approach with
AAV9.hSyn.Flex.GCaM6f injected in S1 led to neuronal labelling exclusively (Fig-
ure 2.2 B). These observations suggest that intersectional approaches can be used for
cell type specific manipulations. Both astrocyte and neuronal labelling is sparse using
these strategies even though a large amount of vectors (Flex.GCaMP) are delivered in
the cortex. This suggests that Cre recombinase (protein or via AAV mediated DNA
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expression) is delivered from VPM thalamocortical axons to astrocytes and neurons.
Only a small amount of Cre recombinase is needed to recombine with the FLEX sys-
tem and drive gene expression [340] [381]. Therefore, even if a few AAV Cre encoding
vectors transduce cell nuclei, we can still expect strong fluorescence protein expression.
I also found that 2nd order astrocyte and neuron labelling can occur with a single
AAV1-injection in the VPM. However a strong general promoter was necessary (CAG).
For example AAV1.hSyn.TurboRFP injection in the VPM doesn’t induce obvious la-
belling of cortical cells. It is possible that a large number of ssDNA copies carrying
relatively weak promoters are needed for detectable amounts of protein production to
occur. In the case of the strong artificial CAG promoters even a small number of ssDNA
copies carrying them could be sufficient in producing detectable amounts of fluorescent
proteins. This observation is in contrast to what Zingg et al. [415] reported. In their
case, injection of AAV1.CAG.eGFP in V1 didn’t results in 2nd order cell labelling.
This might imply that the propensity of intercellular AAV transfer might depend on
the brain area injected (i.e. neuronal subtypes infected and types of synapses involved).
Interestingly, Zingg et al. [415] reported no 2nd order astrocyte labelling (using GFAP
marker) in the pons and corpus callosum following AAV1.CMV.Cre injection in the
V1 of Ai14 (Cre-reporter) mice. This is strange, because Ai14 mice should act as Cre-
reporters for astrocytes, since crossing Ai14 mice with hGFAP-CreERT2 mice leads to
astrocyte labelling [265]. Again, this might imply that anterograde AAV1 transfer may
be neuron type and area specific. I also observed no astrocyte labelling along white
matter axon tracts. Instead astrocytes (and neurons) are labelled at the projection
sites of these axons (Figure 2.2). For instance we observe more dense neuronal and
astrocytic labelling in L4 compared to L2/3 of the somatosensory cortex following AAV
injection in the thalamus or an intersectional approach. Also the highest density of
2nd order cell labelling was far (>1mm) from the injection site and injection tract.
Therefore, intercellular AAV transfer most likely takes place at axon terminals and
is not an artifact of diffusion. It is thus not surprising that Zingg et al. [415] found
no astrocyte labelling in the corpus callosum. My results indicate that second order
cortical astrocyte and neuron labelling in the cortex by AAVs doesn’t require Cre re-
combinase or a specific fluorophore delivered to the thalamus (Figure 2.2 C, D). This
work contradicts the conclusions of Zingg et al. [415] that AAV spread is highly re-
stricted to neuronal structures close to axon boutons since astrocytes are also labelled
(at least in the somatosensory cortex). However, my observations reinforce their find-
ing that AAV1 spread is anterograde since astrocytes do not send projections to the
VPM, and thus can’t be labelled by retrograde AAV transport. Further work is needed
to elucidate whether anterograde AAV1 transfer to astrocytes is area and neuron type
specific.
Using “Traffic light labelling" I estimated that 13% of labelled cells in the cortex
are astrocytes (Figure 2.5 D). This is probably an underestimate since I categorized
the cell type based only on morphology. It is likely that some astrocytes were mis-
labelled as neurons because their distinctive cloud like morphology might have been
saturated by the intense thalamocortical axon projections to the barrels despite the
use of “Traffic light labelling”. This estimate is likely to be different depending on
the serotype and promoters used or the area of injection. The density of neurons and
astrocytes in the mouse cortex is estimated to be ≈92000 cells/mm3 [326] and ≈15696
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cells/mm3 (S100-beta [122]) respectively [171]. Astrocyte cell density is thus ≈15% of
the total astrocyte and neuronal cell density (107700 cells/mm3). Therefore, the cell
type labeling pattern observed (13%) reflects the expected percentage of astrocytes to
astrocytes and neurons in the cortex (15%). This suggests that AAV1 released by tha-
lamocortical axon terminals enter both neurons and astrocytes in the somatosensory
cortex with about equal probability.
Using “Traffic light labelling” (AAV1, 140nl in VPM), ≈100 neurons and astro-
cytes are expected in 6.7×106 µm3 of somatosensory cortex (mostly in layer 4) to be
labelled, which approximates to a density of 15000 cells/mm3. Compared to the es-
timate of ≈108000 astrocytes and neurons/mm3 expected in the mouse cortex [171]
I estimate that only 14% of neurons and astrocytes are labelled by “Traffic light la-
belling” in the somatosensory cortex 2 weeks after AAV1 injection in the VPM. The
result is sparse labelling of astrocytes and neurons with highest density in layer 4,
the primary projection area of the VPM. Also the number of cortical cells labelled
will most likely depend on the injection volume in the thalamus, AAV serotype, titer
and vector constract (i.e. promoter, fluorophore, enhancer regions, size). Future AAV
capsid discovery and engineering (i.e. directed evolution, rational design, new AAVs
discovered and in silico design) has the potential to customize these vectors to optimize
their potential to spread and target specific cell types [384], including astrocytes. Such
innovations can revolutionize gene therapy and experimental neuroscience targeting
astrocytes.
2.4.3 The mechanisms involved in anterograde AAV transfer
remain unknown
The mechanisms of AAV release from thalamocortical axons to the cortex remains
unidentified. I tested whether AAV transfer could be affected by exosome inhibition
(Figure 2.6) or neuronal activity (Figure 2.7). For these experiments I made the as-
sumption that a decrease in AAV transfer from thalamocortical neurons to 2nd order
cells in the cortex will result in lower number of labelled cells. To inhibit exosome
production I used the drug GW4869 and followed the protocol of Dinkins et al. [95].
I made a few modifications to the original protocol to improve the solubility of the
drug (increased DMSO). I wanted to keep the protocol as close to that of Dinkins
et al. [95] because I didn’t have the means of quantifying the exosome reduction in
the tissue following GW4869 administration. Since this important control is missing I
can’t be confident that my intervention led to the reduction of exosomes. Reduction
expectation of serum exosomes and ceramide concentration using GW4869 was based
on controls done by Dinkins et al. [95]. In their controls, the normalized percentage
of Alix levels (exosome marker using immunoblot) in serum was ≈4 times lower than
control. If this is true, I should expect a reduction in labelled cells (not necessarily 4
fold). However the baseline variability in the number of labelled cortical cells (standard
deviation ≈60% of mean) is too high to allow accurate assessment of GW4869 induced
effects (Figure 2.6 D). A larger sample size is required to accurately assess the effect
of exosome inhibition in anterograde AAV transfer. I thus conclude that these results
are preliminary and inconclusive. However, I think that this is a promising avenue for
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further investigation.
To test whether anterograde AAV1 transfer is activity dependent I assumed that
chronic whisker removal will lead to lower excitatory input to the contralateral VPM.
I didn’t use any methods (i.e. electrophysiology) to assess if whisker removal actu-
ally decreased neuronal activity in the VPM. I didn’t expect to eliminate entirely the
activity of VPM neurons following contralateral whisker removal. There is a lot of
spontaneous activity in the brain and the VPM receives other inputs as well (i.e. neu-
romodulators). I found that there was ≈25% reduction in the mean number of labelled
cortical cells in the contralateral whisker removal group compared to control. While
this reduction could be attributed to reduced neuronal activity in the VPM it can also
be explained by random chance (standard deviation ≈50% of mean). A larger sample
size and appropriate controls are necessary to more precisely assess the effect of neu-
ronal activity of AAV1 transfer. I thus conclude that the results of these experiments
are inconclusive. Further experiments should elucidate the mechanisms of intercellular
AAV transfer. Possible mechanisms beyond the ones explored might include: direct
phagocytosis of synapses carrying AAVs by astrocytes [74], microvesicle release [223],
tunneling nanotubes [259] [1] or cytonemes [331].
2.4.4 Summary
AAV1s injected in the VPM transfer to 2nd-order astrocytes and neurons in the so-
matosensory cortex of mice. AAV capsid immunolabelling, sparse cell labelling and the
heterochromatic nature of “Traffic light labelling” suggest that only a small number of
rAAVs are transferred to these 2nd order cells. Since cortical astrocytes are labelled it
suggest that AAV transport is anterograde from the VPM instead of retrograde. AAV
transfer most likely takes place at synaptic terminals because most labelled 2nd-order
cells are found in layer 4 of the somatosensory cortex (main projection site of VPM,
barrel cortex) and no labelled cells are found along the thalamocortical tract. It is
unlikely that AAVs spread by diffusion because most labelled cortical cells are found
far away (>1mm) from both the injection site and injection tract. It is likely that a
strong promoter is required to induce high gene expression in 2nd-order cortical cells
with AAV injections only in the VPM. Direct AAV injection in the VPM has the ad-
vantage of labelling 2nd order cortical cells without injection close to the imaging area,
thus minimizing damage there. Using Cre-Flex intersectional approaches with cell spe-
cific promoters (i.e. GFaABC1D and hSyn) I can leverage the property of AAVs to
transport anterogrately to label specific 2nd-order cell types (astrocytes and neurons)
without a very strong promoter (i.e. CAG). The mechanism of AAV transfer remains
unknown.
Our findings suggest that anterograde AAV1 transfer can be used to study neuron-
astrocyte and neuron-neuron interactions embedded in defined circuits (at least in the
thalamocortical - somatosensory circuit). It also provides a way to sparsely label cor-
tical cells for high contrast in vivo imaging. A notable implication of these findings
is that care should be taken when using AAVs to manipulate cells locally in the brain
since the intended effect is likely to spread to distal connected 2nd order astrocytes and
neurons. For example chemogenetics is emerging as a popular tool for cell manipula-
tion [307]. Local AAV delivery of genes expressing chemogenetic receptors (i.e. hM4Di,
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hM3Dq) in neurons locally followed by systemic injection of clozapine N oxide (CNO)
will likely also affect astrocytes and neurons in distal connected regions. This may
have unintended consequences that may lead to incorrect conclusions. This challenge
can likely be alleviated by using AAV serotypes with weak CNS tropism. On the other
hand it opens possibilities for anterograde targeting of astrocytes with chemogenetics
and optogenetics. The sparse labelling of 2nd order cells limits its application to ma-
nipulations targeting a small number of cells. One such application is single astrocyte
two-photon in vivo imaging. Because of sparse labelling and the lack of fluorescence
in superficial cortical layers it should allow for high contrast single cell recordings.
2.5 Summary of findings
• rAAVs injected in the VPM can sparsely transduce astrocytes and neuron in the
somatosensory cortex.
• A small number of AAV capsids are found in somatosensory cortex neurons and
astrocytes following AAV injection in the VPM.




mapping in behaving mice
3.1 Motivation
Astrocytes are thought to respond to neuronal activity with [Ca2+]i elevation mostly
ex vivo [92] [261] [47] and in vivo [387] [200] [345]. Astrocyte Ca2+ signals in-turn may
modulate neuronal activity [16] and local blood flow [229]. The bidirectional commu-
nication between neurons and astrocytes suggests that astrocytes may participate in
information processing in the brain. However, it is controversial whether astrocytes
respond with fast [Ca2+]i signals to sensory stimuli [93] [250] [274] [48] [18] and dy-
namically modulate neuronal activity [111] [314] [32] under physiological conditions.
Interestingly, some of these studies reported more pronounced astrocyte [Ca2+]i re-
sponses to state dependent, neuromodulatory signalling compared to sensory stimuli
and suggested that neuromodulation may increase the gain of astrocytes to local cir-
cuit activity [69] [93] [274]. Astrocyte Ca2+ signalling is altered with pathology [336]
and anesthesia [359]. It is therefore important to preserve physiological conditions.
While most studies focused on global, cytosolic calcium signalling, modern studies us-
ing membrane tagged genetically encoded calcium indicators (CECIs), revealed a rich
spectrum of Ca2+ signals primarily at thin astrocytic processes [341] [345] [2]. The spa-
tiotemporal characteristics of [Ca2+]i signals and their interactions with multimolecular
complexes are crucial for the versatile role of Ca2+ in cells [40] [77]. Therefore, it is
important to account for the spatiotemporal characteristics of astrocytic Ca2+ signals
since they may elicit different responses. It is also reported that astrocyte signalling
may be circuit specific [216] [217] [67] [215] [404] and may be able to release different
“gliotransmitters” under different conditions [81] [327]. It is thus important to under-
stand the conditions and constraints of astrocyte calcium signals and their subsequent
effects taking into account the conditions of the preparation and the heterogeneity of
astrocyte signals, identity and relationship to local neuronal circuits.
Anterograde transfer of rAAVs from neurons to astrocytes (axo-astrocytic transfer;
see chapter 2) offers a unique opportunity to investigate neuron astrocyte interactions
within a given circuit. Sparse labeling of astrocytes with GECIs enabled by axo-
astrocytic AAV transfer, should allow high contrast in vivo imaging. My aim was to
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use this method to study single-astrocyte Ca2+ dynamics in the behaving mouse to
help elucidate the calcium code of theses cells under physiological conditions, in vivo. I
chose to study astrocytes embedded in the whisker somatosensory system of the mouse
because it is a well studied system [284] and astrocytes were reported to respond to
whisker stimuli there [387] [356] [200] [201] [344] [345] [204].
3.1.1 Hypotheses
• Anterograde axo-astrocytic AAV transfer can be used to study single-astrocyte
Ca2+ microdomains in vivo.
• Barrel cortex astrocytes respond to whisker touch stimulation with transient
elevation in Ca2+ microdomains.
• Barrel cortex astrocytes respond to locomotion with prolonged, synchronized
elevation in Ca2+ microdomains.
• Barrel cortex astrocyte Ca2+ microdomains are correlated to thalamocortical
axon activity.
• Astrocyte fine processes exhibit heterogeneous Ca2+ activity hotspots that are
stable over time.
3.2 Methods
All experimental procedures were approved by the OIST Institutional Animal Care
and Use Committee (IACUC) in an Association for Assessment and Accreditation of
Laboratory Animal Care (AAALAC International) accredited facility.
3.2.1 Animals
Male, 1 - 6 month old, C57/BL6 wild type mice (n = 6) were housed in reverse
light/dark cycles. All experiments were performed during the dark cycle.
3.2.2 Surgery
Mice were anesthetized by intraperitoneal injection (i.p) of 0.1 ml/10g 3-mixture anes-
thetic (Medetomidine: 0.3mg/kg, Midazolam: 4 mg/kg, Butorphanol: 5 mg/kg diluted
in 0.9% saline solution). Carprofen (5 ug/g; i.p), Dexamethasone (2 ug/g; intramuscu-
lar) and Buprenorphine (0.1 ug/g) were administered to reduce inflammation, immune
response and pain respectively. Following anesthesia the eyes of the mouse were pro-
tected by covering them with mycochlorin eye ointment (Sato Pharmaceutical Co.,
Ltd). The head hair was trimmed and removed with a hair trimmer and hair removal
cream (Veet). The animal’s head was fixed to a stereotactic apparatus and its skin was
sterilized with iodine before cutting it to expose the skull. The skull was cleaned with
the local anesthetic lidocaine and leveled by aligning Bregma and Lambda. If further
anesthesia was needed, 1% isoflurane was administered.
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For chronic window implantation surgeries, a region above the somatosensory cor-
tex and injection site (typically a circle of ≈ 2mm radius) was marked. The skull
surrounding it was thinned with a drill. Instead of using forceps to remove the skull,
I glued the base of a wooden cotton swab on the bone above the intended craniotomy
and gently pulled it to expose the dura without damaging it [303]. Any bleeding was
cleared carefully with Carprofen soaked gelfoam (Pfizer). AAVs were injected in the
VPM only (n=3) or both VPM and somatosensory cortex (n=3) using glass pipettes
(10-15 µm tip diameter). The injection coordinates used were based on the Paxinos
brain atlas [275] and previous experiments (see chapter 2) measured from bregma.
VPM: 1.8 mm posterior, 1.7 mm lateral, 3.5 mm deep, S1 cortex: 1.8 mm posterior,
3.2 mm lateral, 0.5 mm deep. AAVs were injected at ≈70 nl/ 5 minutes by air pressure
application and the pipette was left to rest in the brain for at least 5 minutes before
and after injection. A 5 mm diameter glass coverslip was placed directly on top of the
craniotomy and fixed to the bone with a thin layer of super glue. A rectangular alu-
minum head plate was mounted above the glass window and fixed with dental cement
(Super-Bond). Super-Bond was also used to cover any exposed skull. The animals
were individually housed and allowed to recover for at least one week.
3.2.3 Adeno-associated viruses
To label somatosensory cortex astrocyte membranes with GCaMP6f, I injected 140nl
AAV2/1.CMV.P1.Cre.rBG (1.2×1013 GC/mL; University of Pennsylvania Viral Vector
Core) in the VPM and 140nl AAV2/5.GFaABC1D.Flex.Lck.GCaMP6f.WPRE.SV40
(1.0×1013 GC/mL; Sirion Biotech) in the somatosensory cortex.
To label thalamocortical axons and somatosensory cortex astrocytes, I injected
120nl (1:1:1 ratio) AAV2/1.CMV.P1. Cre.rBG (1.2×1013 GC/mL), AAV2/1.CAG.Flex.
GCaMP6f.WPRE.SV40 (1.33×1013 GC/mL) and AAV2/1.hSyn.TurboRFP.WPRE.rBG
(3.9×1013 GC/mL) (University of Pennsylvania Viral Vector Core) in the VPM.
3.2.4 Two photon imaging in awake animals
One week after surgery animals were habituated by periodic handling and exposure to
head-fixation on a vertical, foam treadmill (r = 7.4cm) platform. A whisker stimulus
was incorporated to the rotating treadmill in the form of a wooden rod (toothpick)
inserted in the foam treadmill so as to periodically intercept the whiskers contralat-
eral the injection site as the animal runs. Animals were briefly anesthetized with
2-3% isoflurane before head fixation and left to rest and recover from anesthesia for
≈10 minutes before two-photon (2P) imaging. 2P in vivo microscopy was used to
study calcium signalling ≈2 - 3 weeks after injection (depending on the expression
of GCaMP6f). A sCMOS camera and infrared light source were used to record be-
havioural activity (focused on the whisker pad of the animal) and whisker stimulation
by the wooden rod. Since the wooden rod intercepting the whiskers also intercepted
the light path to the sCMOS camera, the sharp change in light intensity detected by
the camera was interpreted as a whisker stimulus. A second infrared camera (Sony)
was used for online monitoring of animal behaviour during the experiment. A rotary
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encoder (E6A2, Omron) synchronized to the imaging setup was used to record the
rotation of the treadmill.
In vivo imaging was performed using a custom-built combined wide field and two-
photon (2P) microscope (MOM, Sutter Instruments) with a 25x/ N.A. 1.05 water im-
mersion objective with 2 mm working distance (Olympus). A Ti:sapphire femtosecond-
pulsed laser (Vision II, Coherent) was used to excite fluorescence at 950 nm (power
measured after the objective < 60mW). The back aperture of the objective was under-
filled to give an elongated point spread function (PSF) of ≈4mm. A resonant scanner
was used to acquire images at 30.9 Hz. Fluorescence was detected by two GaAsP
photomultiplier tubes (Hamamatsu) in the spectral range of 490–560 nm (green) and
570–640 nm (red) separated by a 565-nm dichroic mirror (Chroma). Commercial soft-
ware (MScan, Sutter Instruments) controlled the microscope, analog channel acquisi-
tion, and behavior camera acquisition. Imaging was done 200 - 300 µm below dura (L
2/3) in the somatosensory cortex with 512×512 pixels and 94×94µm2 field of view.
In order to image the same astrocyte repeatedly, I used a 5x/N.A. 0.25 air objective
(Zeiss) followed by the 25x objective to map the blood vessel pattern directly above
the astrocyte of interest. I used the blood vessel pattern on the brain surface to locate
the x, y coordinates of the astrocyte of interest. I could find the same astrocyte by
2P scanning of the z-plane at the x, y coordinates established over consecutive days.
This was relatively easy because of sparse labelling and since the approximate depth of
the astrocyte was known. I then used the local autofluorescent puncta patterns, shape
of astrocyte cloud perimeter and blood vessel perforation of the astrocyte cloud as
references to accurately locate the imaging z-plane (1 - 3 days after the first recording).
3.2.5 Data analysis
Behavioural data extraction
To record whisker stimulation, I used the fact that the wooden rod intercepted both
the whiskers and the IR light path to the camera (sCMOS). The momentary change
in light intensity detected by the camera at the region of the whisker pad contralateral
the injection side was translated to a signal. The whisker pad region was manually
selected as a ROI in Fiji [318]. I binarized the thresholded light intensity extracted
with the sCMOS (0 = no whisker interception, 1 = whisker interception) to detected
whisker stimulation events.
The state of the animal was determined as a binary signal: running or resting.
Movement of the mouse on the treadmill was extracted from the analog signal of the
rotary encoder. If the running mouse stopped moving for less than a threshold of
1.5s and then continued running I considered it a state of continuous running. If the
mouse moved less than threshold, its state was defined as at rest. If the wooden rod
intercepted the whiskers (manually selected ROI), it was defined as a whisker stimulus.
Most often the animal was running when the wooden rod intercepted its whiskers. I
define this state as whisker stimulation. Sometimes, the animal would stop and explore
the wooden rod with its whiskers during rest. I define that state as whisker exploration.
3.2 Methods 75
Preprocessing
Two-photon microscopy movies (30.9 Hz), rotary encoder analog signals and animal be-
haviour movies were synchronously recorded using MScan software. Proprietary video
format files (MDF, Sutter Instruments Inc.) were converted to Tiff using commercial
software (MView, Sutter Instrument). Time lapse recordings were preprocessed using
Fiji. Movement artifact x, y drift was corrected using the TurboReg plugin (using stiff
translation) and a custom macro to automate the process. Videos were then visually
inspected to confirm movement artifact correction. A 1 pixel 3D gaussian filter was
applied to all 2P image stacks (Fiji). A moving average (bin size = 3) was used to
average the recorded video (30.9 Hz) down to 10.3 Hz to increase signal to noise ratio
(≈ 1.7x increase).
AQUA processing
AQUA (Automatic Quantification and Analysis) [388] was used for unbiased iden-
tification and characterization of astrocyte Ca2+ microdomain signals AQUA applies
machine learning techniques to model calcium events in a ROI independent, data driven
way that does not impose a priori assumptions about the data. All preprocessed time
lapse movies used for AQUA processing had a nominal spatial resolution of ≈0.18 µm
/pixel (optical resolution based on the PSF of the microscope: 1.0 µm; therefore, 5-fold
oversampling) and a temporal resolution of 10.3Hz (0.097 seconds/ frame). AQUA per-
formed further preprocessing by applying a Gaussian filter (smoXY = 2 SD). AQUA
estimated the standard deviation of the noise (sigma). A conservative ∆F/F thresh-
old was set for signal detection equal to 4 times sigma (thrARScl = 4). Also events
with lower ∆F/F than 20% of peak ∆F were discarded (minShow1 = 0.2). AQUA
excluded any calcium signals composed of >6 pixels (minSize = 6 pixels) and < 0.2s in
duration (seedRemoveNeib = 2). Any events <2µm2 (2×PSF) were also subsequently
filtered out. No pixels were removed close to the imagining boundary (regMaskGap
= 0). A temporal threshold (thrTWScl = 2) was set to discriminate between several
events occuring in the same spatial location (defined as delta = thrTWScl×sigma).
Voxels (x, y, t) with higher values compared to their spatial and temporal neighbours
are termed seeds. To determine whether neighbouring pixels to each seed are similar
enough to be included in the signal a growing z-threshold relating to noise is used
(thrExtZ = 2). The assigned pixels to seeds form super voxels which in turn can be
combined to form super events. This is classified by AQUA using three parameters:
rising time uncertainty (cRise = 2), slowest delay propagation (cDelay = 2) and prop-
agation smoothness (gtwSmo = 1). A z-score threshold was set to distinguish events
from noise (zThr = 2). AQUA also compensates for possible bleaching that can oc-
cur during long recordings. This is done by cutting the video into sub-stacks (cut
= 200 frames) to calculate baseline fluorescence (F0) through a moving average filter
(movAvgWin = 25 frames). In case of effects like photobleaching AQUA can remove
the baseline trend of an event intensity curve and fit it with a polynomial curve (of
order correctTrend = 1). Unmentioned parameters were set to default. The same
parameters were used for all single-astrocyte membrane microdomain calcium signal
analysis. Different parameters were used for axon-astrocyte interactions analysis to
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match the recording characteristics of the preparation (see axon-astrocyte interaction
section).
AQUA was used to extract four event characteristics: size, amplitude duration and
frequency of events. Size refers to the maximum spatial extent of the Ca2+ signal
(in µm2), amplitude refers to maximum ∆F/F of the signal, duration refers to the
maximum temporal extent of the signal (in seconds) and frequency refers to the num-
ber of events detected over time. Each event is described as a 2D binary footprint,
whose area (basic.area) represents the event size (µm2). The peak ∆F/F of each event
(curve.dffMax2) was used a s measure for amplitude (∆F/F). Duration was calculated
as the time between the starting (loc.t0) and stopping frames (loc.t1) of each event.
Statistics
All statistics were performed using Matlab (2015b) or Python (3.7). The normality
of the distributions was assessed using the Kolmogorov-Smirnov test (kstest) with a
significance threshold set at p = 0.05, and a straight line of the quantile-quantile (QQ)
plot (qqplot). Normal distributed data was analysed using an unpaired t-test (ttest2;
two independent groups), paired t-test (ttest; two paired groups), one-way ANOVA
(anova1; multiple independent group comparison) for multiple groups comparison).
Non-parametric data was analyzed using the Mann-Whitney U test (ranksum; two in-
dependent groups), Wilcoxon signed-rank test (signrank; two paired groups), one-way
Kruskal-Wallis (kruskalwallis; multiple independent groups) or Friedman test (fried-
man; within-group design, multiple groups comparison). To counteract the problem of
multiple comparisons I used Tukey’s honestly significant difference (HSD) for normally
distributed data. For the rest I used the more conservative Bonferroni correction. I
sometimes used effect size comparisons between means to give a quantitative assess-
ment about the magnitude of an effect. For parametric data I used Cohen’s d (with
pooled standard deviations). For nonparametric data I used Cliff’s delta. Data was
generally plotted as mean ± 95% confidence interval. A non-linear least squares func-
tion (Levenberg–Marquardt algorithm) was used to fit exponential functions to data. In
all relevant cases, two-tailed tests were used (I never assumed the direction of change)
and the significance threshold was set to p < 0.05 (p < 0.05 = *, p < 0.01 = **, p <
0.001 = ***).
Astrocyte membrane calcium microdomain signal analysis
I analyzed the membrane calcium activity of 6 astrocytes. Three of these astrocytes
were recorded again 1 or 3 days later. For the analysis I included all 9 recordings unless
otherwise stated. Mice transitioned between rest and run states during all recordings
(Figure 3.1 D). Mice during 3 out of 9 recordings didn’t stop to explore the whisker
stimulus. Therefore no-data was gathered during whisker exploration state for these
astrocytes.
I compared four calcium event characteristics: maximum amplitude(∆F/F), maxi-
mum duration (s), maximum size (µm2) and frequency (number of events/s) during the
four behavioural states: rest, run, whisker stimulation (WS) and whisker exploration
(WE). I compared the means of event characteristics (between group analysis) for all
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events (n = 50787) from all astrocyte recordings (n = 9) during rest (n = 29637), run
(n= 15123), whiskers stimulation (n=2906) and whisker exploration (n = 3121). To
compare frequency of events per voxel, the number of events were normalized to the
size of each astrocyte in space (x, y) and time (t). A voxel refers to a 3D cube with x,
y, t coordinates. The number of events was divided by the number of voxels in order
to assess change in the frequency of events during different states (Figure 3.2 E). 3 as-
trocyte recordings were excluded when comparing event characteristic during whisker
exploration state because the mouse was never in that state. I also compared the mean
event characteristics per astrocyte (within group design, paired t-test, Figure 3.3 B,
C, D) to control for variability between astrocyte recordings and recording time. All
astrocyte recordings (n=9) were used to investigate the probability distributions of
event characteristics (amplitude, duration, size) during different states.
To compare event characteristics during state transitions, all recordings were aligned
to a transition point. The transition points used were, rest to run (226 transitions: 9s
intervals, 4263 Ca2+ events), run to rest (177 transitions: 9s intervals, 3089 Ca2+
events) and whisker stimulation during run (279 transitions: 6s intervals, 5333 Ca2+
events). Transition events were only selected if the behaviour state was stable dur-
ing the pre and post transition period. For example, during a rest to run transition
the animal was at rest for at least 3s continuously followed by at least 6s of contin-
uous running. The onset time (loc.t0) of each event was used to determine the Ca2+
characteristics in relation to state transition.
Astrocyte activity maps (heatmaps)
Astrocyte activity maps refer to overall activity patterns observed in astrocytes during
long recording times (35 - 106 mins) represented in the form of a heatmap. A heatmap
represents the proportion of events in space detected by summing the number of event
2D footprints detected by AQUA in time.
Heatmap generation
Motion corrected, two-photon Ca2+ signal recordings of single astrocytes were pro-
cessed by AQUA. The Ca2+ signals were summarized as 2D footprints and binarized
to 1. All binarized events were summed in time while maintaining their spatial co-
ordinates to develop activity heatmaps for each astrocyte recording. Some heatmaps
were limited to Ca2+ events occurring during specific behavioural states (rest, run or
all states). In such cases, only frames associated with the respective behavioural state
were considered. Real heatmaps (generated from real astrocyte recordings in contrast
to random simulations, see below) were normalized to 1 minute and to their respective
maximum pixel value unless otherwise stated.
Random Simulations
Simulations of activity heatmaps were created by randomly distributing binarized Ca2+
signals onto a mask corresponding to the real, recorded astrocyte. Calcium signals
were approximated as ellipses of random orientation, center and eccentricity. These
ellipses were incrementally added within the bounds of the astrocyte previously imaged
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(binarized maximum projection mask). The area of each ellipse was randomly sampled
from the corresponding real astrocyte list of event areas. The total area of all ellipses
in each random simulation was equal to the total area of real calcium events of their
respective astrocyte recording. For example, when the total area of ellipses added to
the simulation was equal to the total area of real event 2D footprints then no more
ellipses were added to the simulation.
Heatmap comparison
Heatmap hotspot patterns were compared using the total continuous recording, video
segments associated with the state of the animal, or subsequences of the respective
video recording (splits) for within day or between day comparisons.
Within day: To compare activity heatmaps within same day (i.e. splits, see below)
and between their respective random simulations, 2D image cross correlation (Mat-
lab, xcorr2; 512×512 pixels; Pearson’s correlation) was used. One of the images was
translated to a position (translation vector) of maximum correlation. The maximum
correlation coefficient was used as the correlation metric between the images.
Between days: To correlate activity heatmaps between days we created an activity
mask to establish the boundaries of cell activity throughout the whole recording. The
mask array had binary x, y values where 1 represents an event taking place. 2D cross
correlation was used to find the maximum correlation between a stationary sample
mask and one translated by a move vector. This allowed us to align the masks of the
sample pairs and use 2D correlation between the heatmap pairs.
Splits: Subsequences of continuous video recordings as referred to as splits. 2D
correlation between heatmaps generated from 70 minute long recordings and their
shorter sub-sequences (split size = 2, 5, 10, 15, 25, 30, 35, 70 minutes) were used to
determine what is a reasonable recording time to capture an accurate Ca2+ activity
map. 70 minute videos were created by trimming out frames beyond the first 70 minutes
in 5, >70 minute long recordings.
Similarly, 2D correlation between the activity heatmaps of rest state sequences
(splits) of the same astrocyte (within day) were used to determine the stability of
heatmaps over individual recordings. The splits were created from 5, 70-minute long
astrocyte videos. Each video was split into 3 sequences of equal duration corresponding
to the rest state of the animal. Their respective heatmaps were 2D correlated to each
other (3 splits/astrocyte correlated, 5 astrocytes, 15 correlations). Alternatively, splits
were correlated with the total running activity heatmap of their respective astrocyte
(state comparison, 3 correlations / astrocyte, 5 astrocytes). Between day correlation
of split heatmaps (n = 12) was obtained from the same astrocytes (n = 2) but during
different day recordings (day 0 and day 1, 18 correlations between days).
Axon-astrocyte interactions
To study axon - astrocyte interactions I recorded the calcium activity of thalamocor-
tical axon boutons (n = 8) labelled with GCaMP6f and TurboRFP in contact with
individual astrocytes (n = 3 pairs) labelled with GCaMP6f in 3 different mice. Two
regions of interest were manually drawn around axon boutons and astrocyte areas with
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approximately equal size at increasing distance from an axon bouton center (<3 µm,
<6 µm) and another one far away from the bouton (>18 µm). The axon-boutons were
identified based on their morphology, signaling characteristics and co-labelling with
TurboRFP. The axon ROI was based on the maximum projection of the full recording
to avoid any possible signal contamination due to uncorrected movement artifacts. As-
trocyte territories were selected in the gliapil, avoiding to include axon boutons. The
cell body and thick astrocyte processes were ignored in this study. The calcium ac-
tivity was processed using AQUA. Some AQUA parameters were optimized differently
for this preparation. The minimum event size cutoff threshold was set to >0.74 µm
(minSize = 4), the spatial smoothing level was set to 1 SD (SmoXY = 1), the active
threshold scale was set to 6 SD of noise (thrARScl = 6). Also 50 pixels close to the
image border (regMaskGap = 50) were removed. Pearson’s cross correlation (xcorr)
was used to calculate the maximum correlation coefficient and correlation delay be-
tween axon bouton and local astrocyte Ca2+ activity initiated within ROIs within a
predefined time window from axon signalling (1 and 1.5s) or from astrocyte signalling
(1.5s). For correlation delay calculations we used the delay of maximally correlated
events per trial. We then calculated the mean of all maximum correlation coefficients
and correlation delays for each axon - astrocyte pair.
The axon signals outside the region of the astrocyte were used to investigate changes
in axon calcium signalling during behavioural state transitions. These signals were also
extracted with AQUA and they represent distinct points of [Ca2+]i elevation, not dis-
tinct axons. The behavioural state transitions investigated and their respective axon
Ca2+ signals were: rest to run (174 intervals, 8613 events), run to rest (52 intervals,
2274 events) and whisker stimulation during run (756 intervals, 28232 events). I also
investigated astrocyte calcium signalling (constrained within ROIs to minimize con-
tamination from axon signalling) changes during whisker stimulation (756 intervals,
6091 events).
3.3 Results
3.3.1 Single-astrocyte Ca2+ microdomain 2-photon imaging in
awake mice
To achieve sparse astrocyte labelling I leveraged the ability of AAVs to transfer an-
terogradely via thalamocortical axons to cortical cells (see chapter 2). I injected
AAV1.CMV.Cre in the VPM and AAV5.GFaABC1D.Flex.lck.GCaMP6f in the so-
matosensory cortex (Figure 3.1 A left). This allowed selective labelling of astrocyte
membranes because of the GFaABC1D promoter (astrocyte specificity) and lck tag
(membrane tagging). Following AAV injections, mice were left to recover for at least
a week. I then introduced the mice to the vertical treadmill apparatus with embedded
whisker stimulus so they habituate to the setup. When GCaMP6f expression was suf-
ficiently high (typically ≈3 weeks post injection) I used in vivo two-photon microscopy
to record the membrane Ca2+ activity of single astrocytes in layer 2/3 of S1 at 30.9
Hz (Figure 3.1 A). Astrocyte microdomain Ca2+ activity was automatically extracted
using the event based software AQUA (Figure 3.1 B). AQUA enabled us to study astro-
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Figure 3.1: Experimental design. A) Double rAAV injection strategy used for
sparse labelling of cortical (S1) astrocyte membranes with GCaMP6f. Mice were left
to recover and habituate to head-fixation on a cylindrical treadmill embedded with a
pole positioned to intersect with whiskers contralateral the injected cortex and VPM.
Long duration 2-photon microscopy was used to record single astrocyte calcium signals
in the awake mouse free to run on the treadmill. B) Examples of single astrocyte
membrane labelling and AQUA processed calcium events represented as coloured 2D
footprints. C) Example ∆F/F traces of astrocyte calcium events (black, extracted with
AQUA during locomotion (red) and whisker stimulus (orange). D) Total recording
duration (over each pie chart) and percentage of time mouse was at rest (gray) and run
(black) state (n = 9). Each astrocyte (n = 6) is represented by a different colour pie
chart outline. Same astrocytes recorder on consecutive days (n = 3) are represented
by dashed lines of the same colour as their first recording.
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cyte microdomain calcium activity without using predefined regions of interest (ROIs)
in an unbiased way (examples of Ca2+ traces extracted shown in Figure 3.1 C). AQUA
also enabled us to capture different characteristics of these Ca2+ signals such as their
frequency, amplitude, duration and size. Since the animal was head-fixed on a rotating
treadmill with an embedded whisker stimulus I was able to relate the characteristics
of astrocyte Ca2+ activity to the behavioural state of the animal.
I investigated Ca2+ activity during 4 behavioural states: rest, run, rest with whisker
stimulus (whisker exploration) and run with whisker stimulus (whisker stimulation)
(Figure 3.2 A). I performed long duration (22 - 106 min) two-photon recordings of 6
astrocytes (3 mice). Three of these astrocytes were recorded again 1 or 3 days after
the first recording. I studied the Ca2+ activity of all 9 astrocyte recordings while the
animal was resting or running (Figure 3.1 D).
3.3.2 State dependent astrocyte Ca2+ activity
To get a general understanding of astrocyte Ca2+ activity I investigated the mean
amplitude, duration, size and frequency (Figure 3.2 B-E) of all microdomains extracted
during rest (n = 29637), run (n= 15123), whisker exploration (n= 3121) and whisker
stimulation (within 1.5s of whisker stimulus during run, n = 2906) states. I used the
Mann–Whitney U test to compare calcium event characteristics (amplitude, duration,
size; Figure 3.2 B - D). I also estimated the effect size in order to give a quantitative
measure of the magnitude of the change using Cliff’s delta (delta). I compared calcium
signal characteristic changes between rest vs run, rest vs whisker exploration and run
vs whisker stimulation. I considered changes significant when p < 0.05.
There was a significant (p < 0.001) but small (delta = 0.10) decrease in the mean
event amplitude (Figure 3.2 B), duration (Figure 3.2 C, p < 0.001, delta = 0.09)
and size (Figure 3.2 D, p < 0.05, delta = 0.03) of events during whisker exploration
compared to rest. There was a small (delta = 0.03) but significant (p < 0.05) increase
in the mean event amplitude and size but not duration during whisker stimulation
compared to run states. A significant increase was also observed in the duration (p <
0.001, delta = 0.09) and size (p < 0.001, delta = 0.12) of events during run compared
to rest state. The size and duration of events were correlated (Figure 3.2 F) to each
other (Pearson’s product moment r = 0.42).
I next asked how the probability distribution of the event amplitudes, durations
and sizes differ during different states (Figure 3.2 G-I). There appears to be no pro-
nounced difference (confidence interval overlay) in the probability distribution of event
amplitudes and durations during the four states (Figure 3.2 G ,H). However, we can
observe a small increase in the probability of finding longer duration Ca2+ events (>
1.2 s) during run compared to rest where we are more likely to find smaller events.
The probability distribution of event durations seems to be composed of two distinct
distributions. The probability distribution function of the natural logarithm of event
sizes indicates that it is more likely to find larger (> 5µm2) events during run compared
to rest where it is more likely to find smaller (< 5 µm2) events (Figure 3.2 I). The event
size probability function during rest and run can be approximated using exponential
functions (Figure 3.2 J). The exponential function approximations for loge event sizes
indicate a higher time constant of decay during rest (0.54s) compared to run (0.60s).
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Figure 3.2: State dependent modulation of astrocyte membrane Ca2+ signal
characteristics. A) Schematic of four behavioural states investigated, rest (blue) = no
wheel rotation, whisker exploration (green) = whiskers intercepted by pole while animal
is at rest, run (red) = wheel rotation triggered by mouse running, whisker stimulation
(orange) = whisker interception by pole while animal is running. B-D) Differences in
astrocyte calcium signal characteristics: B) Amplitude (∆F/F), C) duration (s), D)
size (µm2) during the four behavioural states (mean ± CI, Mann Whittney U test). E)
Total number of events per voxel (x,y,t) per astrocyte (connected dots) during the 4
states (black dots = mean number of events per voxel of all astrocytes ± CI; paired, two
tailed t-test). F) Pearson’s product moment correlation between loge event sizes and
their durations. G- I) Probability distributions of event: G) amplitudes, H) durations
and I) loge sizes. Each line represents the distribution of the event characteristic during
the 4 behavioural states: rest (blue), run (red), whisker stimulation (orange), whisker
exploration (green). Dotted lines represent ± CI. J) Exponential fit of the probability
distribution of loge event sizes during rest (gray) and run (black). CI = 95% confidence
interval. p < 0.05 = *, p < 0.001 = ***.
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Figure 3.3: State dependent astrocyte Ca2+ event characteristics. A)
Schematic of astrocyte recordings and behavioural state comparison. Pie chart colour
outlines represent individual astrocyte recordings that correspond to lines in B, C and
D. B) Mean frequency of events per minute, amplitude (∆F/F), duration (s) and size
(µm2) changes per astrocyte recording (coloured lines) during rest vs run, C) rest
vs whisker exploration (WE), and D) run vs whisker stimulation (within 1.5s from
whisker stimulation onset) (WS). Mean of all astrocyte recordings (black line). Dotted
lines represent recordings of the same astrocyte (same colour line) on consecutive days.
Paired, two tailed t-test, p < 0.01 = **, n.s. = non significant (p > 0.05).
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I then calculated the mean Ca2+ event characteristics of each astrocyte during
different states. I did that in order to give equal weighting to each astrocyte instead
of emphasizing the contribution of longer recordings, like in the previous analysis.
Grouping the data this way shows the contribution of individual recordings to the event
characteristic mean (Figure 3.3). I compared the mean event characteristics (paired,
two tailed t-test) of all the astrocyte recordings to assess general effects of behavioural
states on astrocyte Ca2+ signalling. I found a large (d = 1.72), significant (p = 0.001)
increase (≈166%, 58 to 154 events/minute) in the mean frequency of events during run
compared to rest state (Figure 3.3 B). There was a non-significant increase (≈3.9%,
1.54 to 1.60 ∆F/F, p = 0.14) of the mean amplitude of events during run compared to
rest. The mean duration of events (1.11 to 1.12, p = 1) remained unchanged during rest
compared to run state. In contrast, the mean size of events in all astrocytes increased
significantly (≈32%, 6.3 to 8.3µm2, p = 0.003, d = 1.89) during run compared to rest
state. Therefore, there was a large (d > 0.8) increase in the number of Ca2+ events and
their size, but not in their amplitude and duration during run compared to rest. In
contrast, there was no significant change (p > 0.05, paired two-tailed t-test) in mean
event characteristics during rest compared to whisker exploration (Figure 3.3 C) or run
compared to whisker stimulation (within 1.5s of whisker stimulation) (Figure 3.3 D).
3.3.3 Astrocyte Ca2+ event changes during state transitions
I then asked how event characteristics change during 3 state transitions (Figure 3.4 A):
rest to run (226 intervals, 4263 events), run to rest (177 intervals, 3089 events) and
run to whisker stimulus (279 intervals, 5333 events). In all cases the event onset was
used to align calcium event characteristics in time. The onset of event characteristics
was plotted in time relative to the trigger onset (Figure 3.4) where the trigger was:
beginning to run (red lines), stop running (blue lines), or whisker interception during
run (orange lines). To compare the frequency of events (number of events/s) over time
I used the Friedman test for within-group non-parametric analysis comparing event
frequency between 1s time bins before (-1s from onset) and after (all) trigger onset
Figure 3.4 B, C, D). To compare event amplitude, duration and size changes I used the
Kruskal Wallis test (non-parametric, between-group). I compared the mean magnitude
of all events before the trigger condition (representing the baseline) and each individual
1s bin after the trigger onset (Figure 3.4 E-M). Bonferroni post-hoc correction was used
in all cases and the significance threshold was set to p < 0.05.
The mean frequency of events increased by ≈290% (0.95 to 3.7 events/s) following
rest (baseline) to run state transition (Figure 3.4 B). The frequency of events de-
creased by ≈54% (2.4 to 1.1 events/s) following run (baseline) to rest state transition
(Figure 3.4 C). There was a small increase (≈17%, from 2.9 to 3.4 events/s) in the
frequency of events following whisker stimulation during run state (Figure 3.4 D). In
contrast I found no change in the mean amplitude of events following rest to run (Fig-
ure 3.4 E), run to rest (Figure 3.4 F) and whisker stimulation during run (Figure 3.4
G) states. The mean duration of events increased (≈13%, 1.10 to 1.25s) only during
rest to run state transitions (Figure 3.4 H) but not during run to rest (Figure 3.4 I)
or following whisker stimulation (Figure 3.4 J). Similarly, the mean size of events in-
creased (≈65%, 6.6 to 10.8µm2) during rest to run (Figure 3.4 K) but not during run
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Figure 3.4: Astrocyte Ca2+ signal changes during state transitions. A)
Schematics of state transitions investigated and their corresponding average running
speed traces (gray = raw average, black = 0.5s binned average ± CI): Rest to run (red
line), run to rest (blue line) and whisker stimulation (WS) during run (orange line). B)
Mean frequency of Ca2+ events (number of events/s) during rest to run, C) run to rest
and D) whisker stimulation during run (two-tailed, paired Friedman test, bonferroni
post hoc). E) Mean (right) amplitude (∆F/F) of individual Ca2+ event maximum
amplitudes (left, raw data) during rest to run, F) run to rest transition, G) whisker
stimulation during run. H) Mean duration (right) of individual Ca2+ event maximum
durations (left, raw data) during rest to run, I) run to rest and J) whisker stimulation
during run. K) Mean size (right) of individual Ca2+ event maximum sizes (left, raw
data) during rest to run, L) run to rest transition and M) whisker stimulation during
run (two-tailed, unpaired, Kruskal Wallis test, bonferroni post hoc). p < 0.05 = *, p
< 0.01 = **, p < 0.001 = ***. Data is represented as mean ± CI. Gray trace = raw
average, black trace = 1s bin average. CI = 95% confidence interval.
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to rest (Figure 3.4 L) or whisker stimulation (Figure 3.4 M).
3.3.4 Astrocyte Ca2+ signals are not random
I then asked whether Ca2+ microdomains are randomly distributed in the space of the
astrocyte. It is possible that the Ca2+ activity of astrocyte processes is heterogeneous
allowing microdomains to act as specialized subcellular units. To answer this question
all events detected by AQUA were summerd in time while maintaining their spatial
characteristics (position and maximum size). If the probability of Ca2+ elevation is
equal among processes, it should result in a homogeneous distribution of events given
an infinite number of events. In other words, given that the probability of a calcium
“puff” occurring at any x, y coordinate within the astrocyte territory is equal for all
coordinates, then given infinite time (and thus infinite events) all x, y coordinates
of the astrocyte should be exposed to the same number of events. Given a limited,
but sufficiently large number of events, an approximately homogeneous distribution
of calcium events within the astrocyte territory is expected. In contrast, if there are
specific parts of the astrocyte that are more active than others, then hotspots of activity
within the astrocyte territory are expected.
To test if astrocyte calcium activity is random, I performed >30 minute recordings
of astrocyte Ca2+ activity in awake animals as previously described. All Ca2+ signals
extracted (AQUA) were given a value = 1, and their duration was set to 1 frame.
The spatial characteristics (i.e maximum size and x, y coordinates) of the Ca2+ events
were maintained. The values of these signals were summed in time to give an activity
heatmap and normalized to one minute and to their respective maximum pixel value.
The heatmaps tell us how the number of events are distributed in space. Hotspots of
greater activity (Figure 3.5 D, E, left) can be clearly seen, strongly suggesting that
astrocyte Ca2+ microdomain activity is not random.
To test how astrocyte activity heatmaps should look assuming calcium signalling is
random we built random simulations of astrocyte calcium activity. The random simu-
lations were based on the real calcium signal characteristics of the respective astrocyte
simulated. The shape of calcium events was approximated as ellipses whose size (µm2)
was randomly selected from a list of all real event sizes of the respective astrocyte
recording simulated. Ellipses were positioned randomly (random x, y vector) within
the astrocyte territory mask until they reached a combined size equal to the total size
of real events. The sum of overlaying ellipse territory binary values was used to con-
struct the random activity heatmap. These values were then divided by the respective
real astrocyte’s recording time and normalized to a period of one minute (Figure 3.5 D,
E, right). We can observe that the random simulation heatmap pixel values are more
homogenous (Figure 3.5 D, E, right) compared to real astrocyte activity heatmaps
(Figure 3.5 D, E, left). I then asked how the frequency of normalized heatmap (real
and random) pixel intensity values is distributed (Figure 3.5 F; area under the graph
= 1, n = 9 astrocyte recordings). The frequency of pixel intensity percentile in real
heatmaps can be approximated by an exponential (time constant of decay = 0.18). The
maximum pixel intensity values observed in random simulation heatmaps were <45%
(Figure 3.5 F, top) of the maximum pixel intensity values observed in real heatmaps
(Figure 3.5 F, bottom). Pixel values above the 45% intensity threshold can be classified
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Figure 3.5: Astrocyte calcium activity is not random. A) Single astrocytes were
recorded using two photon microscopy in mice free to move on a treadmill (schematic,
left). The x, y coordinates of single astrocytes were mapped in relation to the blood
vessel pattern obtained using wide-field microscopy (right). B) Z-plane alignment of
the same astrocyte between days by aligning morphological features: astrocyte perime-
ter, blood vessels passing through the astrocyte (white pointers) and autofluorescent
puncta patterns (yellow pointers). C). 50s maximum projection of Ca2+ signals ex-
tracted with AQUA of the same astrocyte recorded over 1 day. D) Astrocyte activity
heatmap (all states) during day 0 (top left) and day 1 (bottom left) compared to their
respective random simulation heatmaps (right). E) Activity heatmap of a different
astrocyte during day 0 (top left) and day 3 (bottom left) compared to their respective
random simulation heatmaps (right). All heatmaps are saturated to their 70% maxi-
mum pixel value. Random simulation heatmaps are normalized to the same range of
pixel values as their respective real heatmap. F) Distribution of normalized heatmap
(real: top, random simulation: bottom) mean pixel intensity value frequency (n = 9 as-
trocyte recordings, mean ± CI = black solid line ± black dashed line) and exponential
distribution approximation (red line).
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as hotspots, or Ca2+ activity patterns that aren’t attributed to randomness.
3.3.5 Astrocytes display Ca2+ activity hotspots that are stable
over time
I then asked whether hotspot patterns are stable over time. To test this I recorded
again the Ca2+ activity of the same astrocytes (n=3) at the same z-plane over one
(n=2) or three (n=1) days. To find the same astrocyte over days I used a combination
of approaches. I used wide field microscopy to capture the blood vessel pattern of the
brain surface above the astrocyte of interest (Figure 3.5 A). Since I knew the approxi-
mate depth of astrocytes (z) and position (x, y) relative to the blood vessel pattern on
the surface, I could broadly locate the same astrocyte on consecutive days. To find (and
align) the same plane of imaging I used the outline of the astrocyte, blood vessel per-
foration pattern through the astrocyte cloud, and autofluorescent background puncta
patterns (Figure 3.5 B). I then performed long duration two-photon imaging of these
astrocytes and extracted their Ca2+ signals using AQUA (Figure 5 C). Looking at the
hotspot patterns of these astrocyte activity heatmaps (whole recording activity pat-
tern) I noticed that the pattern had distinct similarities both between day 1(Figure 3.5
D left) and day 3 (Figure 3.5 E left) recordings.
Given the above observations I wanted to investigate in more detail the stability
of this activity pattern (hotspots). First I asked how long a recording should approxi-
mately be to accurately capture the heatmap hotspot pattern. This is important since
doing continuous, very long (hours) recordings can be an experimental limiting factor.
To do that, the activity map was split into temporal segments of increasing duration
(split size). Therefore a “split” refers to Ca2+ activity heatmap derived from segmented
2P recording. The split heatmaps generated from increasing duration segments (split
size) were correlated (pearson’s correlation) with their respective 70 minute recording
heatmap (Figure 3.6 B). From the average correlation values obtained (5 astrocyte
recordings) it can be estimated that ≈20 minute recordings are needed to obtain a
heatmap pattern with ≈85% similarity to the full 70 minute long recording heatmap.
If the Ca2+ activity pattern of an astrocyte is similar over time and a ≈20 minute
recording time is enough to capture this activity map with ≈85% accuracy, then split-
ting each long recording (> 70 mins) into 3 shorter segments (≈20 mins splits each
during rest state) and correlating them to each other should yield a high correlation
between them if hotspots stable over time. To test that, astrocyte Ca2+ recordings
(> 70 mins) during rest state were split into 3 equal size (> 17 mins) heatmaps and
compared to each other. Common hotspot patterns could be clearly observed between
single recording split heatmaps (Figure 3.6 A, white numbered arrows). Interestingly,
similar hotspot patterns were also observed with splits between day recordings (Fig-
ure 3.6 A, Rest (split x/3), Day 0 - Day 1) as well as between rest to run (Figure 3.6 A,
Rest - Run) and between run states (between days) (Figure 3.6 A, Run, Day 0 - Day
1). The heatmaps of interest were aligned, and their activity profiles were correlated.
First, the split heatmaps were correlated with their individual random simulations (n
= 15) to get an approximate baseline of the expected correlation coefficient (Figure 3.6
C, random, mean = 0.11, SD = 0.12, CI = 0.06), assuming correlation between random
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Figure 3.6: Astrocyte activity heatmaps are stable over time. A) Normalised
activity heatmaps of the same astrocyte during day 0 (top) and day 1 (bottom) during
rest and run states. Activity heatmaps during rest state were split in 3 equitemoral
splits (Rest split 1 - 3, ≈20 minutes each). Similar hotspot pattern can be observed
between different splits, days and states (numbered white pointers indicate examples
of these hotspots). All heatmaps were normalized to their maximum pixel value. B)
Pearson’s correlation between the activity heatmap of astrocyte recordings (n=5, 70
mins each) and different size temporal splits (2-70 mins). C) Pearson’s correlation
between rest state splits (3 per astrocyte, 5 astrocytes) with: their respective random
simulation heatmaps (gray), other splits of same day recordings during rest state (red),
run heatmap of same day recordings during run (black) and splits of same astrocyte
recordings a day later during rest (blue). Mean ± SD, One-way ANOVA with Tukey’s
HSD, p < 0.05 = *, p < 0.01 = **, p < 0.001 = ***. D) Pearson’s correlation between
heatmaps when the mouse is at rest or run state during different days (black dots, D0-
1, D0-3) and between 25 random simulations of each recording (total 75 simulations,
gray dots, black rhombus = mean ± CI). The correlation value between real heatmaps
and their respective random simulations is linearly scaled so the random simulation
mean correlation value = 0.
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heatmaps. We then quantified the correlation coefficients between real heatmap splits
of the same astrocytes (5 astrocytes, 3 splits each, n = 15 comparisons) during single
recordings (Figure 3.6 C, Self splits, mean = 0.61, SD = 0.10, CI = 0.06). We then
quantified the correlation coefficients of heatmap splits during rest with their respective
recording’s overall activity heatmap during run state (Figure 3.6 C, state splits, mean
= 0.50, SD = 0.11, CI = 0.06). Finally, I correlated the split heatmaps (rest state)
of the same astrocyte (2 astrocytes, 3 splits/ astrocyte, day 0 - day 1 recordings, n
= 18 comparisons) between days (Figure 3.6 C, Day splits, mean = 0.28, SD = 0.06,
CI = 0.03). I used one-way, between-group ANOVA (two-tailed, with Tukey’s HSD)
to compare the above correlation coefficient values. There was a significantly greater
mean Pearson’s correlation coefficient for all map comparisons: self splits (p < 0.0001,
state splits (p < 0.0001) and day splits (p = 0.0001) compared to random. There was
a significant decrease in the mean correlation coefficient (≈0.6 to ≈0.5) of state splits
compared to self splits (p < 0.03). There was a significant decrease in the correlation
between day splits compared to both self splits (≈0.6 to ≈0.3, p < 0.0001) and state
splits (≈0.5 to ≈0.3, p < 0.0001). These results suggest a high correlation between
the activity pattern within a recording day that decreases between states and between
recording days.
In order to get a better approximation of heatmap similarities between days I
compared the total recording heatmap (more averaging in time and therefore a more
accurate heatmap pattern) of each astrocyte (n=3) during the same state (Figure 3.5
D) but between different days. For example, the rest state heatmap of day 0 recording
vs the rest state heatmap of day 1 recording of the same astrocyte. We compared the
correlation values between real heatmaps and 25 random simulations per astrocyte (75
total/ comparison). The correlation values between real heatmaps was calibrated so
the mean correlation coefficient of their respective random simulations was = 0. For
example, if the mean correlation coefficient of the random simulation for astrocyte 1
was equal to 0.1 and the actual correlation between rest states during different days was
0.5 it would calibrate to mean random simulation correlation = 0 and real correlation =
0.4. This calibration was performed to control for factors other than Ca2+ activity that
could contribute to an increase in correlation coefficient values (i.e. size of mask). I
found that the calibrated correlation coefficient between real heatmaps of all astrocytes
during rest (mean r = 0.43) and run (mean r = 0.39) states (mean r between all states =
0.46) was higher than the full range of random simulation with real heatmap correlation
coefficient values above the mean (r > 0.2). This observation suggests that there is
high similarity between activity heatmaps during either rest or run states between
consecutive days of recording.
Together the above findings suggest that astrocyte Ca2+ activity is not random.
The probability of having a calcium event is higher in some parts of the astrocyte than
others. These activity patterns can be extracted over long durations and summarized
as activity heatmaps. Heatmaps are stable between days and states suggesting the
existence of astrocyte activity maps in the brain.
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3.3.6 Axon-astrocyte interaction
Next, I wanted to investigate if astrocyte Ca2+ microdomains are correlated to nearby
thalamocortical axon activity. To do that, I injected AAV1.CMV.Cre, AAV1.CAG.Flex.
GCaMP6f and AAV1.hSyn.TurboRFP in the mouse VPM (Figure 3.7 A). This injection
strategy leads to thalamocortical axon labelling with TurboRFP and GCaMP6f (for
more details see chapter 2) while cortical astrocytes are labelled only with GCaMP6f.
An important feature of this strategy is that there is no injection in the cortex thus
alleviating any possible pathological effects triggered by local AAV injections. This
strategy also allows for general astrocyte labelling instead of focusing only on mem-
brane calcium activity (no lck tag). Using in vivo 2P microscopy in awake mice free
to move on a vertical treadmill apparatus embedded with whisker stimuli, I was able
to study axon-astrocyte interactions (n= 3 astrocytes, 3 mice) during different states.
Axons within astrocyte territories were clearly distinguishable because only axons ex-
pressed the TurboRFP marker (Figure 3.7 B). Also the axon bouton calcium activity
profile (functional puncta) was starkly contrasting the cloud like morphology of astro-
cytes.
If axon bouton Ca2+ activity (which is associated with neurotransmitter release)
triggers Ca2+ elevation in nearby astrocytic processes, their Ca2+ signals should be
correlated to each other. I thus hypothesised that there should be a higher correlation
between the Ca2+ activity of an axon and its local (near, < 6 µm from bouton cen-
ter) astrocyte processes compared to processes far away from that axon. To test this
hypothesis, ROIs were manually drawn around the maximum z-projection of 8 axon
boutons within the astrocyte territory (n = 3 astrocytes). 2 concentric ROIs were man-
ually drawn around each axon bouton with ≈3 µm and < 6 µm radius from its center.
A third, control ROI of approximately the same size far (>9 µm) from the selected
bouton (Figure 3.7 C) was also drawn. Care was taken to avoid selecting axons within
astrocytic ROIs to avoid signal contamination. AQUA was then used to extract Ca2+
signals initiated within these ROIs (example traces shown in Figure 3.7 D).
Thalamocortical axon and astrocyte Ca2+ signalling during behavioural
state transitions
First I tested how thalamocortical axon activity changes with state transitions and
whisker stimuli. To do that I used all the axons outside the astrocyte territory (Fig-
ure 3.7 C, white arrows) so the signal is not contaminated by astrocyte Ca2+ activity. I
found that during rest to run state transitions (n = 174 intervals) the mean frequency
of axon Ca2+ events (n= 8613 events) started increasing from rest baseline (mean = 3.8
events / s ± 0.4 SD, 0.3 CI) ≈0.5s before the animal started running, reaching a peak
event frequency ≈0.3s (129% increase; 8.7 events / s) after run onset quickly decaying
(within ≈0.3s from peak) to the average event frequency (events/ s) during run (5.9 ±
0.6 SD, 0.2 CI; Figure 3.7 E). During run to rest state transitions (n = 52 intervals)
the mean frequency of axon Ca2+ events (n = 2274 events) started decreasing from run
baseline (mean = 7.2 ± 0.9 SD, 1.0 CI) ≈1s before the animal stopped running (during
deceleration period) down to the baseline resting frequency (47% decrease; mean =
3.8 ± 0.4 SD, 0.2 CI) at t = 0 (Figure 3.7 F). The mean event frequency increased
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by ≈97% from mean run baseline frequency (5.8 events/s), to 11.4 events/s, 0.2s after
the onset of whisker stimulation (WS) during run (754 intervals, 28232 events). Mean
run baseline event frequency = 5.8 ± 0.8 SD, 0.2 CI; Figure 3.7 G. A sinusoidal event
frequency pattern in time was observed (Figure 3.7 G) presumably because of the re-
peating whisker stimulation triggered by the rotation of the treadmill (Figure 3.7 I).
In contrast, the mean frequency of astrocyte events extracted from all ROIs (n = 35)
selected didn’t change with whisker stimulation during run state (Figure 3.7 H). These
results suggest that thalamocortical axons respond to whisker stimuli and locomotion.
Figure 3.7: Axon-astrocyte interactions (caption next page.)
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Figure 3.7: (previous page.) A) Schematic of injection strategy (top) used to study
neuron-astrocyte interactions in the somatosensory cortex (S1). I used two photon
microscopy in awake mice to study thalamocortical axon - astrocyte interactions in 3
astrocytes from 3 mice (bottom) undergoing rest (gray) and run (black) state transi-
tions with whisker stimulation. B) Layer 2/3 somatosensory cortex astrocyte labelling
(green: GCaMP6f) and thalamocortical axons (red: TurboRFP, green: GCaMP6f). C)
Schematic of ROI selection for calcium activity extraction with AQUA: Axon (green),
nearby astrocyte processes (purple, <3 µm) and light blue (3-6 µm) and far astrocyte
processes (yellow, >9 µm). Axons outside astrocyte territory (white) were used to
extract axon activity without contamination from astrocyte signals. D) Example of
axon (green) and astrocyte signals extracted using AQUA from selected ROIs during
locomotion (red) and whisker stimulation (orange). E) Mean number of axon Ca2+
events/second (8613 events, outside astrocyte territory during rest to run (red, 174
intervals), F) run to rest (2274 events, 52 intervals) and G) whisker stimulation dur-
ing run (28232 events, 756 intervals). Mean running speed (Red trace), number of
whisker stimuli/ second (orange trace). H) Mean number of astrocyte Ca2+ signals
seeds per second (6091 events) inside all ROIs (n = 35) during whisker stimulation
(orange dotted line, 156 intervals) while the animal is running (red trace). I) Distri-
bution or all whisker stimuli during whisker stimulation trials (run - ws - run). WS
= whisker stimulation. Raw Ca2+ event number/s average = gray, 1s binned average
± CI = black. J) Mean of maximum cross correlation values and K) mean correlation
delay (s) between Ca2+ signals in selected axon (n = 8) and astrocyte process ROIs
(n = 35) at increasing distance from the selected axon within 1.5s after axon signal
onset during different states (rest, run, all states). L) Mean of maximum xcorr. and
M) mean xcorr. delay between astrocyte ROIs (at increasing distance from selected
axon) and selected axon Ca2+ signals within 1.5s following the onset of an astrocyte
signal. N) Mean of maximum xcorr between axon and astrocyte signals within a 1s
time window from axon signal onset instead of 1.5s like J-M. O) Mean of maximum
xcorr. between astrocyte and axon signals within a 1s time window of astrocyte signal
onset. All plots are represented as raw means for each axon - astrocyte ROI pair (dots)
and their group means (black dots ± CI). Different colour dots represent ROI distance
from the selected axon (red = <3 µm: n = 8, black = 3-6 µm: n = 8, gray = >9 µm:
n = 19). Between groups comparison, two-tailed Kruskal-Wallis test with bonferroni
correction. Significance threshold set at p < 0.05.
Correlation between axon and astrocyte calcium signalling at fast timescales
(≤1.5s)
Direct observation of simultaneous axon and astrocyte recordings did not reveal obvious
correlation between axon and nearby astrocytic process Ca2+ activity. In order to give
a quantitative description I asked if Ca2+ signals in astrocytic processes near (<6 µm)
manually selected axon boutons (punctated morphology, co-express TurboRFP) within
the astrocyte territory, were more highly correlated than Ca2+ signals in processes
distant (>9 µm) from the respective bouton. Distal astrocytic processes were used as
a control to avoid misinterpretation of correlation values deriving from random Ca2+
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signals. Cross-correlation between Ca2+ signals of axon boutons (n = 8) to Ca2+
signals initiated within (detected by AQUA) nearby (<3 µm, 3-6 µm, n = 8 each) and
distal (>9 µm, n = 19) astrocytic process ROIs from the respective bouton revealed no
significant difference (Kruskal-Wallis test with bonferroni correction, p > 0.05) between
their mean correlation values (Figure 3.7 J, all) and correlation delay from the onset of
axonal Ca2+ signal (Figure 3.7 K, all). Correlations were restricted within a 1.5s time
window from the onset of axonal Ca2+ signals to account for fast astrocytic responses
and to minimize dilution of possible evoked signals with random astrocyte activity.
Similarly, there was no significant difference between the mean cross-correlation value
(Figure 3.7 N, all) in near and far astrocytic Ca2+ microdomains from axon boutons
within 1s time window from axon Ca2+ signal onset. Similar results were obtained
using a range of time windows from axon Ca2+ signal onset (not shown). To test if
the behavioural state of the animal influences the correlation between active axons
and nearby astrocytic process, the same analysis was repeated in data taken during
rest or locomotion (run) of mice (Figure 3.7 J, K: rest, run). There was no significant
difference (p > 0.05) in the mean of maximum correlation value (Figure 3.7 J, rest,
run) or cross-correlation delay (Figure 3.7 K, rest, run) in nearby or distant astrocytic
Ca2+ microdomains to active axon boutons (within 1.5s time window). These results
suggest that astrocyte (L2/3, barrel cortex) processes do not reliably respond to nearby
(<6 µm) thalamocortical axon Ca2+ signals.
I then asked if astrocyte Ca2+ signals precede nearby axon Ca2+ activity to inves-
tigate the possibility of astrocyte signalling triggering presynaptic calcium responses
(within <1.5s). I found no significant difference (p > 0.05) in the mean of maximum
xcorr. values (Figure 3.7 L, O) or mean xcorr. delays (Figure 3.7 M) between astrocyte
processes at increasing distance from the bouton of interest. Additionally, no significant
change in these correlation values was observed during rest or run states (Figure 3.7 L,
M: rest, run). Overall, these findings suggest no clear, microscale, bidirectional Ca2+
signalling between thalamocortical axon boutons and nearby astrocyte processes.
3.4 Discussion
3.4.1 Anterograde axo-astrocytic rAAV transfer can be used
for functional studies in barrel cortex astrocytes
First, I showed that anterograde axo-astrocytic rAAV transfer can be used for func-
tional studies of astrocytes embedded in the thalamocortical circuit. The sparse la-
belling of L2/3 cortical astrocytes allows high-contrast and long duration (>1hr), in
vivo two photon imaging of single astrocytes (Figure 3.1). The next step will be to
investigate whether other neuron-astrocyte circuits can be probed with axo-astrocytic
rAAV transfer or if it is a special property of a subset of circuits including thalamocor-
tical projections. While I focused on astrocyte calcium signalling, it will be interesting
to combine axo-astrocytic rAAV transfer with the delivery of other genetically en-
coded indicators, such as glutamate (i.e. iGluSnFr [219], voltage (GEVIs) [167] and
noradrenaline (GRABNE [109] sensors for future investigations in neuron-astrocyte in-
teractions. Combinations of such sensors and/or dyes (i.e. voltage sensitive dyes such as
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ANNINE-6plus [304]) has the potential to refine our understanding of astrocyte-neuron
interactions embedded in specific circuits in vivo. However, while I tried to use a com-
bination of GECIs (i.e. GCaMP6f & jRGECO delivered by AAVs) to simultaneously
label and record Ca2+ activity in thalamocortical axons, cortical astrocytes and corti-
cal neurons I observed a “repulsion effect” (not shown in this thesis) between expressed
fluorophores that made such a study not possible. Better understanding of rAAV biol-
ogy, including the interactions between multiple rAAVs, AAV capsid engineering [184]
and astrocyte subtype (i.e. take into account the heterogeneity of astrocytes) specific
promoters can enhance the potential of axo-astrocytic AAV transfer in functional stud-
ies. Studying circuit specific neuron-astrocyte interactions [216] [217] [215] given the
functional heterogeneity of astrocytes in distinct circuits [67] has potential to refine our
understanding of their bidirectional communication. Axo-astrocytic AAV transfer in
combination with in vivo functional imaging offers a new way to study circuit specific,
neuron astrocyte interactions under physiological conditions.
3.4.2 Unbiased investigation of astrocytic Ca2+ microdomains
during behaviour
Two photon imaging of single, L2/3 S1 astrocytes labelled with membrane bound
GCaMP (lck.GCaMP6f) combined with event based Ca2+ signal detection software
(AQUA [388]) allowed unbiased extraction of the detected [Ca2+]i signals. Astrocytes
exhibit highly localized microdomain Ca2+ signals in their thin astrocytic processes
that can be readily investigated using membrane tethered (lck) GCamP [332] [333] [334]
[129] [341] [345]. These fast Ca2+ microdomains operate at a timescale that may be
relevant for subsecond information processing by astrocytes [47] [92] [261] [345]. With
these exciting discoveries came the novel challenge of analyzing these signals. Because
of the complex spatiotemporal dynamics of these Ca2+ signals, ROI based analysis
is insufficient in capturing their characteristics. An elegant solution to this problem
came with the development of AQUA [388], that enables ROI independent, event based,
automatic and unbiased extraction of Ca2+ dynamics. Two photon microscopy enables
the study of astrocyte signalling in the living animal, under physiological conditions.
This is important as many of the earlier findings may have confused physiological
responses with pathological ones because of the experimental conditions used [111]
[314]. The most physiologically relevant experiments are done in awake conditions
since anesthesia is known to disrupt Ca2+ signalling in astrocytes [359]. Combination
of these innovations with state of the art surgical procedures [303] and fast imaging
(30.9Hz) and sparse labelling allowed us to capture single-astrocyte Ca2+ microdomain
dynamics with a spatiotemporal resolution of 2µm2 and 0.2s in awake mice even during
locomotion.
Head fixed mice on a wheel can be used with 2P to study brain activity in behaving
mice. A fundamental questions is whether astrocytes respond to sensory stimuli with
fast transient elevation in [Ca2+]i at their fine processes. I chose the somatosensory
circuit as a model system to answer this question because it is well studied [284], it is
considered an important, well organized sensory modality in dark dwelling mice (un-
like vision) [204] and whisker stimulation was reported to trigger both neuronal [23]
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[284] and astrocyte microdomain [345] [Ca2+]i signals. I developed a simple intermit-
tent whisker stimulation system involving a rod embedded in a cylindrical treadmill
mice were free to move on. I avoided air puff stimulation or removal of whiskers to
avoid startle (and possibly sound) induced neuronal modulation or a disturbance to
the somatosensory system respectively. I avoided any type of artificial stimulation (i.e.
electrical stimulation, optogenetics or chemogenetics) since I am not convinced astro-
cytic responses to such stimuli is physiological (even when delivered to neurons). The
intermittent whisker stimulus delivered by the pole contacting whiskers as the mouse
run on the cylindrical treadmill provides a transient, natural stimulus the mouse could
have experienced in nature. Since there was no sound or visual cues associated with it
(experiments were performed in darkness), cross modal interaction was limited. Mice
occasionally stopped at their own volition to explore the pole with their whiskers pro-
viding another possible state of whisker exploration. Considering that locomotion is
thought to increase the gain of astrocytes to sensory stimuli [274] I wanted to inves-
tigate if and how astrocyte Ca2+ microdomain activity is associated with behaviour
state and sensory stimuli. Maybe astrocyte responses to sensory stimuli are situational
to the behavioural state of the animal.
3.4.3 Diversity of astrocyte Ca2+ microdomain signals
A combination of all of the above techniques revealed a range in amplitude, duration
and size (Figure 3.2 G, H, I) of astrocyte [Ca2+] signals. The amplitude of the majority
of signals ranged from ≈0.5 to 3 ∆F/F in a skewed probability distribution centered
at ≈1 ∆F/F (Figure 3.3 G). The duration of the majority of signals ranged from
0.2s (cutoff point) to ≈2.5s with short duration (< 1s) events being more probable
(Figure 3.2 H). Note, a mean Ca2+ signal duration of ≈1s is ≈4 times shorter than
reported by recent studies investigating Ca2+ signals in microdomains reported by lck-
GCaMP6f [344] [345]. Also the distribution of event sizes seems to be composed of
two distinct distributions (Figure 3.2 H) suggesting that different microdomains may
exhibit heterogeneous duration of activity. This may be explained by different sources
of calcium elevation, i.e. fast entry through opening of channels allowing extracellular
calcium into the cell or release from internal stores. An other explanations might
involve different distribution of Ca2+ sinks within the cell. The size of the majority of
events were at the cutoff point of 2µm2 with the probability of larger events occurring
decreasing exponentially (Figure 3.2 I) suggesting a power law distribution in event size,
a characteristic of scale free systems. Thus smaller events are most frequent. If the
event size probability distribution follows the same trend for unresolved, nanodomain
Ca2+ signals then we should expect them to be exponentially more frequent than
microdomain Ca2+ signals. I believe the reason we observe shorter duration signals than
other reports is because I take into account very small events (>2µm2). Since event
duration is positively correlated (r = 0.42) to event size (Figure 3.2 F), it is expected
that missing smaller events underestimates the lower range of Ca2+ signal duration. I
therefore show that astrocyte Ca2+ microdomains are faster (shorter duration) than
generally believed. It would be interesting to assess how these event characteristics
change by disturbing specific Ca2+ sources or sinks such as ER (IP3R), mitochondria or
mobile buffers. The dynamics of single-astrocyte Ca2+ signals should aid computational
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modeling and understanding of the astrocyte Ca2+ code.
3.4.4 Locomotion modulates astrocyte Ca2+ microdomain sig-
nals
I found that during voluntary locomotion, the frequency (number of events/time) size
and duration of Ca2+ microdomains are increased compared to when the animal is at
rest (stationary). Comparing the average of individual calcium signal characteristics I
found significant differences between different behaviour states (Figure 3.2 B, C, D).
However, when looking at the variability in event characteristics between recordings I
realized that the differences shown in Figure 3.2 (B, C, D) can be explained by the vari-
ability between recordings. Since Figure 3.2 (B, C, D) shows a biased representation
of the data I will refrain from drawing conclusions based on it. To alleviate this bias
I gave equal weight to each astrocyte recording and compared the mean event charac-
teristics of each recording during different states to assess general trends (Figure 3.3).
I observed the biggest change in the frequency of events. There was approximately a
threefold increase in the average number of events/minute and ≈32% increase in the
average size of events during run compared to rest The average event amplitude and
duration was unchanged (Figure 3.3 B). Interestingly, I observed a shift in the probabil-
ity distributions of event sizes. The probability of having smaller, and shorter duration
events is higher during rest, while it is more likely to have larger, longer duration events
during locomotion (Figure 3.2 H, I, J). There was no shift in the event amplitudes dur-
ing different states (Figure 3.2 G). To further assess the effect of locomotion on event
characteristics I investigated their changes during state transitions (Figure 3.4). In
agreement with my previous findings, I found a sharp increase in the number of Ca2+
events/s following the onset of locomotion (peak ≈290%, 6s after onset) (Figure 3.4
B). The frequency of events likely decreases to ≈2.4 (54%) following a slow onset peak
≤6s from run which decreases slowly (≈6s from rest onset) down to a baseline of ≈1.1
events/s. I also observed an increase (≈65%) in the mean size of events, reaching
a peak ≈4s after run onset (Figure 3.4K). Interestingly, the duration of signals also
increased (13%) briefly 3-4 seconds following the onset of running (Figure 3.4H). In
contrast, there was no change in the mean amplitude of events with the onset or off-
set of locomotion. Increase in the frequency, duration and amplitude of events starts
increasing ≈1s from run onset (Figure 3.4 B, H, K). The frequency of events keeps
increasing over a longer period of time than the event duration and size. While event
duration (with duration decreasing to baseline earlier than size) (Figure 3.4 H, I) and
size (Figure 3.4 4 K, L) decrease back to baseline following the initiation of running,
the number of events/s decreases but remains 54% higher than baseline during running
(Figure 3.4 B, C).
Locomotion is known to be correlated with synchronised global Ca2+ activity in
cortical astrocytes [93] [274] as well as local synchronization of Ca2+ microdomains [2].
Astrocytes exhibit stronger responses to neuromodulators such as noradrenaline com-
pared to sensory stimuli [34] [93] [274] and acetylcholine [356]. Since astrocytes exhibit
a variety of GPCRs that bind neuromodulators [59] astrocytes could be targeted di-
rectly by these volume transmitters to trigger GPCR mediated Ca2+ signals. The large
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increase in the number of microdomain events/s observed during the onset of voluntary
locomotion is similar to the startle induced, fast Ca2+ component observed by Srini-
vasan et al. [341]. Srinivasan et al. [341] found that the fast component (but not the
slow component) of Ca2+ elevation in astrocyte processes is blocked in IP3R2KO mice
and with application of the a1-blocker, prazosin. Similarly, Stobart et al., [345] showed
that prazosin and DSP4 (a locus coeruleus neurotoxin) reduced the number Ca2+ mi-
crodomain activity. It is thus likely that at least the first component in the increase of
event frequency observed during voluntary locomotion is mediated by noradrenaline.
However that does not exclude synergy with local neuron circuit activity or other neu-
romodulators. For example, during locomotion the activity of barrel thalamocortical
(Figure 3.7 E) and cortical neurons is increased [23]. However the Ca2+ activity onset
and offset is slower in astrocytes compared to neurons. Increase in neuronal activ-
ity is associated with increased metabolic demand and K+ release in the extracellular
fluid. This can trigger Ca2+ release from mitochondria in astrocytes [2] and engage
in Ca2+ mediated K+ uptake [385]. Also atropine (muscarinic receptor antagonist) is
known to decrease Ca2+ microdomain activity [345] and cholinergic neurons display
increased activity during locomotion [300]. A combination of these factors is likely to
modulate changes in the frequency, duration and size of events observed. These slow
(multiple seconds) Ca2+ responses are unlikely to be involved in fast modulation of
neuronal circuits but are better poised in reducing extracellular [K+] [385], mediate
neurotransmitter uptake [237] [333] or be involved in plasticity [38] [356] over longer
timescales. Overall, my results are in agreement with previous studies showing that
astrocytes reliably respond with slow, transient and synchronized elevations of Ca2+ to
arousal and locomotion [274] [2]. One notable difference is that I found no change in
the amplitude of microdomain Ca2+ signals in contrast to Agarwal et al. [2] who found
a 20% increase during locomotion. This might be because of the analysis methods used
to extract the signals or perhaps there are region specific differences in astrocyte Ca2+
dynamics during locomotion (i.e. visual cortex vs somatosensory cortex).
3.4.5 Whisker stimulation does not modulate microdomain Ca2+
signals in L2/3 S1 astrocytes
It is well accepted that astrocytes respond with large [Ca2+]i elevations to neuromodula-
tors during arousal in vivo. However, whether astrocytes respond with fast, micrometer
scale, Ca2+ responses to wired transmission and sensory stimuli in awake animals is
not well explored yet [344] [345] [18]. Neuronal activity was shown to trigger astrocyte
Ca2+ microdomain activity in slices [47] [92] [261], in vivo (under anesthesia) in re-
sponse to optogenetic stimulation of inhibitory interneurons [215], in response to long
(8s) high frequency (90Hz) single whisker stimulation in awake animals [345] or air puff
and electrical stimulation of the trigeminal nerve [258] [201] during anesthesia. If astro-
cytes respond to minimal neuronal stimulation (as suggested by [47] [92] [261]) in vivo
under physiological conditions, using a realistic whisker stimulus should elicit reliable
Ca2+ responses in astrocyte fine processes. For example, Stobart et al., [345] reported
a subpopulation (≈8%) of Ca2+ microdomains in S1, L2/3 lck.GCaMP6f labelled as-
trocytes that respond to whisker stimulation with a short onset latency (≈300ms). On
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the other hand, Asada et al., [18] reported an increase in the size but not frequency
of V1 astrocyte Ca2+ microdomains in response to visual stimuli. The (controversial)
role of astrocytes as active participants in (ms-s) information processing of the brain
should be reflected in fast astrocyte responses to neuronal activity.
I used an intermittent whisker stimulus delivered by a rod attached on a vertical
treadmill, whose rotation was determined by the locomotion the mouse. I wanted
to avoid stimuli that may evoke cross modal responses (i.e. sound) or startle the
animal (air puff). I also wanted to avoid high frequency, single whisker stimuli since
they are not an ethologically relevant stimulus to the mouse (as it wouldn’t encounter
such a stimulus in nature). In combination with the high spatiotemporal resolution
and fully automated event based analysis approach should have revealed the response
characteristics of S1, L2/3 astrocyte Ca2+ microdomains.
Surprisingly, I found no changes in the frequency (number of events/time), ampli-
tude, size or duration of events within 4s of whisker stimulation. First, the probability
distribution of event characteristics (amplitude, duration, size) didn’t change with
whisker stimulation during rest or run (Figure 3.2 G, H, I). Second, the mean number
of events/minute, amplitude, duration and size of Ca2+ events was unchanged during
periods of rest compared to rest with whisker stimulus (Figure 3.3 C) or during pe-
riods of run compared to run with whisker stimulus (1.5s) (Figure 3.3 D). The latter
was particularly surprising since I expected locomotion to increase the gain to sensory
input in the S1 like in V1 [274]. Perhaps the change in astrocytic [Ca2+]i was very
brief and was averaged out in the previous analysis. Third, I didn’t find any changes in
event size, amplitude or duration (Figure 3.4 G, J, M) in response to whisker stimuli. I
found a slow increase in the frequency of events. However, this increase started before
the whisker stimulus (Figure 3.4 D) which may be explained by changes in movement
speed (see Figure 3.4 A, Run-WS-Run). In addition, since the rate of frequency in-
crease was slow, I support the conservative interpretation that the ambiguous change
observed is an artifact of running rather than a genuine response to whisker stim-
uli. A less conservative interpretation might be that whisker stimuli enhanced the slow
Ca2+ activity of astrocytes observed during locomotion. Fourth, to ensure that whisker
stimulation induces neuronal activity in S1 and to investigate whether the activity of
individual thalamocortical axons correlates with local astrocyte Ca2+ microdomains
I used a new preparation (Figure 3.7). Briefly, I injected a combination of AAV1
vectors only in the VPM (Figure 3.7 A) that I previously showed (Chapter 2) could
label both thalamocortical axons and cortical astrocyte with GCaMP6f (Figure 3.7 B).
Thalamocortical axons co-expressed TurboRFP, however it was easy to separate them
from astrocytes based on their punctated morphology, contrast differences and activ-
ity pattern. Extracting Ca2+ signals outside the astrocyte territory revealed a sharp
increase in thalamocortical axon Ca2+ activity with a peak 200ms following whisker
stimulation. Correlation between the Ca2+ activity of axon boutons with Ca2+ signals
in astrocytic processes at increasing distance from the selected bouton (Figure 3.7 C)
revealed no difference in the mean correlation values or correlation delay between these
regions. The time window of correlation was restricted to 1-1.5s since I expect fast
astrocytic responses to be within this timeframe. I also investigate a broad range of
time windows with the same results (not shown in this thesis). One major limitation
of the axon-astrocyte experiment is the use of a single Ca2+ indicator that can lead to
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signal contamination in claimed astrocytic or neuronal signals. Effort has been made
to avoid this contamination by choosing sparse boutons and drawing ROIs, but it is
still a suboptimal way of performing this analysis. Dual colour GECIs can alleviate
this limitation and allow for ROI independent analysis of axon bouton and astrocyte
process Ca2+ activity at increasing distance from each other, including the overlay to
the axon bouton that we ignored. Besides these limitations, visual inspection of the
recordings didn’t reveal any obvious correlation in their activity. Dual colour GECI la-
belling didn’t work in my hands. In summary, the combined evidence suggest that L2/3
S1 astrocytes do not respond with transient changes in [Ca2+]i elevation or dynamics
to sensory stimuli induced by a pole in awake mice under physiological conditions and
are likely not correlated to spontaneous neuronal activity.
One explanation for the conflicting findings might lie in the mode of neuronal stimu-
lation. Perhaps a stronger stimulus is needed to drive micrometer scale Ca2+ responses
in astrocytic processes of awake animals. For example Stobart et al., [345] used a long,
high frequency whisker stimulus (8s, 90Hz, single whisker) to elicit Ca2+ microdomain
activity. Another possibility is that astrocytes respond with Ca2+ nanodomain signals
to neuronal activity. Considering the scale of the tripartite synapse is nanoscopic, min-
imal neuronal stimulation might induce astrocytic [Ca2+]i elevation contained within
nanodomains. Advancements in super resolution microscopy might enable this inves-
tigation. Perhaps astrocytes respond with Ca2+ signals when their local environment
deviates from homeostasis (i.e. thorough abnormal neuronal activity) and it is inter-
preted as a physiological astrocytic response involved in information processing. It
will also be interesting to use different whisker stimuli. For example using wall touch
of increasing length to engage whiskers for progressively longer periods. Such exper-
iments can reveal if astrocytes respond to integrated sensory stimulation over time.
Interestingly, S1 L2/3 neurons, display sustained activity to wall touch while layer 5
neurons display transient activity in moving mice, suggesting that L2/3 neurons might
be integrating tactile stimuli during locomotion [23]. Considering that astrocytes might
display circuit-specific functional heterogeneity [216] [217] [67] [215] [404], different sen-
sory conditions might elicit different responses in different astrocytes. It will thus be
important to study astrocyte Ca2+ microdomain responses to different neuronal circuit
modulation.
3.4.6 Thalamocortical axon Ca2+ activity increases with whisker
stimulation and locomotion
I showed that S1 L2/3 astrocytes respond with Ca2+ microdomain characteristic changes
to locomotion but not to whisker stimulation. In contrast, thalamocortical axons re-
spond both to whisker stimulation and locomotion. The axonal activity recorded (out-
side of astrocyte territory) might be slightly contaminated by cortical neurites since
cortical neurons are also sparsely labelled with GCaMP6f (but not TurboRFP) using
this protocol. Because of sparse labelling cortical neuron neurites are rare in compari-
son to thalamocortical axons (see example Figure 3.7 B). I found that thalamocortical
axons respond with biphasic [Ca2+] elevation to locomotion (Figure 3.7 E) composed of
a transient increase from baseline starting before (≈0.5s) the onset of locomotion and
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reaching a peak ≈0.3s (≈129% increase from rest) after mice started running, followed
by a sharp decrease to a sustained running baseline activity ≈44% higher than during
rest. VPM axon activity starts decreasing ≈1s before the animal stops running (dur-
ing deceleration phase) reaching baseline activity approximately as soon as the animal
stops (Figure 3.7 F). The animal likely enters a state of higher arousal when it decides
to run, leading to neuronal activity preceding the onset of locomotion. These observa-
tions are similar to Ca2+ activity in S1, L2/3 and L5 neurons in response to the onset
of running [23]. Thalamocortical axons respond to whisker stimuli during locomotion
with fast, (peak ≈0.2s after whisker stimulus onset) transient increase in Ca2+ activ-
ity (Figure 3.7 G) similar to what is observed in S1 neurons [23]. The Ca2+ activity
of axons in the whisker stimulation trace was oscillatory, most likely because of the
combined effect of changes in running speed (Figure 3.7 G, red trace) and periodicity
in whisker stimuli (Figure 3.7 I). In contrast, astrocytes did not respond with [Ca2+]
transients (Ca2+ signals initiated in ROIs inside astrocytes devoid of axon boutons) to
whisker stimulation (Figure 3.7 H).
3.4.7 Astrocyte Ca2+ microdomain activity is not random
Recent work alluded to possible heterogeneity in the Ca2+ activity of astrocytic pro-
cesses [2] [47]. Considering the plethora of inputs, sources and sinks associated with
Ca2+ signalling, it is unlikely that Ca2+ microdomain activity in astrocytes is random.
If Ca2+ signalling is random then astrocyte process should be equally likely to exhibit
Ca2+ elevation.
To find if Ca2+ signalling is random, I performed long recordings (≈1hr) of Ca2+
microdomain activity in lck.GCaMP6f labelled astrocytes, automatically (AQUA) ex-
tracted the microdomain signals, binarize their amplitude and duration and summed
up all events in time while preserving their maximum size and spatial position. This
resulted in activity heatmaps exhibiting high activity hotspots (Figure 3.5, Figure 3.6).
This suggested that some parts of the astrocytic territory are more active than others.
To visualize and assess how the overall activity profile of an astrocyte would be as-
suming Ca2+ microdomain activity was random we created random simulations using
the event characteristics of the real astrocyte simulated (Figure 3.5 D, E right). The
distribution of pixel intensity was different between real activity heatmaps (Figure 3.5
F) compared to random simulation heatmaps (Figure 3.5 G). No hotspots are observed
in the random simulations of activity. These results thus suggest heterogeneous Ca2+
microdomain activity within the territory of a single astrocyte.
This heterogeneity might be associated with the distribution of Ca2+ storing or-
ganelles such as mitochondria, ER-plasma membrane contacts or lysosomes. Alter-
natively, hotspot regions might represent areas with increased concentration of Ca2+
channels, exchangers and transporters or decreased concentration of Ca2+ buffers. An-
other possibility is that astrocyte Ca2+ activity hotspot regions are associated with
higher local neuronal circuit activity, thus exhibiting proportional Ca2+ responses.
This could involve increased uptake of K+ [385]; gliotransmitter release [16]; metabolic
support [252] [2]; neurotransmitter uptake [237] [333] or any combination of the above
among others.
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3.4.8 Astrocyte Ca2+ activity maps in the brain
Since astrocytes exhibit hotspots of higher Ca2+ activity, the natural next question
was whether the position of activity ‘hotspots’ is stable over time. First we approxi-
mated how long a recording should be to exhibit the characteristic hotspot pattern of
a long (<1hr) recording by cutting (splits) recording videos into increasingly shorter
segments and comparing it to the total recording heatmap. ≈20 minutes of recording
could capture the heatmap pattern with ≈85% accuracy (Figure 3.6 B). Comparing
the split heatmaps (during rest state) of the same recordings to each other and the
total astrocyte recordings when the animal is at rest or locomotion (Figure 3.6 A)
revealed remarkable similarity between hotspot patterns within individual recordings
(Figure 3.6 A, C). This suggested that astrocyte hotspot patterns are stable within
timescales of minutes to 1 hour. Then I asked if this similarity persists between days.
To achieve that I recorded the same astrocyte again 1-3 days after the first recording.
I could find the same astrocyte using the blood vessel pattern on the brain surface,
the shape of the astrocyte and using autofluorescent signal and blood vessel patterns
landmarks at the z-plane of interest. This step is extremely difficult using this method,
and virtually impossible to completely control for z-movement artifacts. I could min-
imize such artifacts through the surgery protocol, an elongation of the PSF to ≈4µm
by underfilling of the back aperture of the objective, use of heavy optomechanical com-
ponents for the construction of the treadmill apparatus and training of the animal.
Despite these difficulties I was able to record Ca2+ activity from the same astrocyte
at the same z-plane between days (Figure 3.5 B, D; Figure 3.6 A). I found similarities
in the activity heatmaps of the same astrocytes between days (Figure 3.6 A, C, D).
The hotspot pattern was more highly correlated in astrocytes within days compared
to between days (Figure 3.6 C, D). This is likely because of smaller z-plane offsets in
within day recordings and not necessarily because of physiological changes in astrocyte
signalling over days. Any z-offset is likely to result in decreased correlation between
heatmaps. Future studies should repeat these experiments with 3D imaging (i.e. [47])
or using calcium integrators such as CaMPARI [113] instead of GECIs. These ap-
proaches will solve the main problem of z-plane orientation, minimize artifacts and
give a more accurate representation of these activity maps. A simpler but less optimal
approach might be to use a bessel beam [289] [207]. Despite the limitations of our meth-
ods I found that astrocyte calcium activity patterns are stable within single recordings
or between day recordings. They are more highly correlated to each other compared to
their respective random simulations (Figure 3.6 C, D) and the hotspot pattern can be
clearly observed (Figure 3.6 A). Future work should reveal if these hotspots are differ-
entially regulated by different neurotransmitters and neuromodulators. While many of
the hotspots were similar between states, there were also notable hotspots that were
similar only during locomotion, between days (i.e. arrow 9, Figure 3.6 A). This is line
with previous findings ex vivo showing that noradrenaline and ATP modulate distinct
Ca2+ microdomains [2]. Local drug application through a chronic cranial window ac-
cess port [303] can greatly facilitate this endeavor. It will also be interesting to assess
if it is easier to trigger Ca2+ signals in these hotspots and if different hotspots mediate
heterogeneous functions (i.e. release different gliotransmitters). This might be possi-
ble using a combination of light activated calcium channels and holography [136] to
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stimulate specific parts of the astrocyte at different intensities of illumination.
3.4.9 Summary of findings
• Anterograde axo-astrocytic AAV transfer can be used to study single-astrocyte
Ca2+ microdomains in behaving mice.
• Astrocytes display rich repertoire of Ca2+ microdomain characteristics in vivo.
• Barrel cortex astrocytes did not respond to whisker touch stimulation with tran-
sient elevation in Ca2+ microdomains in awake mice.
• Barrel cortex astrocyte Ca2+ microdomains were not correlated to thalamocorti-
cal axon activity.
• Thalamocortical axons respond to whisker touch and locomotion with transient
and biphasic [Ca2+]i elevation respectively.
• Barrel cortex astrocytes respond to locomotion with prolonged, synchronized
elevation in Ca2+ microdomains that exhibit larger size and duration compared
to rest state.




This work provides new methods for studying neuron-astrocyte interactions within
specific brain circuits and provides insight about the Ca2+ code of astrocytes and its
relationship to behaviour, sensory stimuli and neuronal activity under physiological
conditions.
First. AAV1 injected in the VPM can transfer anterogradely to S1 astrocytes and
neurons. This provides a new toolkit for studying neuron-astrocyte interactions and
reinforces the idea that AAV1 can transfer anterogradely to neurons. Also care should
be taken when using AAVs to induce local changes in the brain as these viruses may
transduce both astrocytes and neurons at projection sites of the injection area. Future
studies, focusing on different AAV serotypes injected in different brain regions, should
clarify the limits and universality of AAV transfer to astrocytes.
Second. AAV1 anterograde intercellular transfer can be used to sparsely label
cortical astrocytes and neurons with fluorescent indicators. Intersectional approaches
using combinations of AAVs carrying cell type specific promoters can be leveraged to
target astrocytes or neurons with higher specificity. Based on the pattern of fluorescent
expression, AAV1 most likely transports to astrocytes and neurons through the ’tripar-
tite synapse’. Sparse labelling enabled by axo-astrocytic AAVs transfer can be used to
study single astrocytes within specific neuronal circuits. Future studies should reveal
in more detail if axo-astrocytic AAV transport takes place at the tripartite synapse
and focus on elucidating the mechanisms of transport. AAV capsid engineering should
enhance the efficiency of AAVs to transport to astrocytes.
Third. Anterograde axo-astrocytic AAV transfer can be combined with membrane
tagged genetically encoded calcium indicators and in vivo two photon microscopy to
enable high contrast, long duration (>1 hour) imaging of Ca2+ microdomains in single
astrocytes of awake mice under physiological conditions. This provides a platform for
studying the Ca2+ code of single astrocytes under physiological conditions and has the
potential of resolving many of the controversies in the field.
Fourth. Astrocytes display rich repertoire of Ca2+ microdomain characteristics in
vivo. Automated, event based analysis of Ca2+ microdomains allows unbiased quan-
tification of their characteristics: frequency, amplitude, duration and size. It revealed
a rich repertoire of localized, subsecond, µm scale Ca2+ signals. Characterization of
Ca2+ microdomains should help guide computational modeling of astrocyte signalling.
Fifth. Barrel cortex astrocytes respond with Ca2+ microdomain signalling to lo-
comotion but not to whisker touch. Analysis of Ca2+ microdomain signals of barrel
cortex astrocytes in mice free to run on a wheel apparatus embedded with a whisker-
touch stimulus revealed an increase in the number, size, and duration of events during
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locomotion but not with whisker stimulation. This suggests that astrocyte Ca2+ mi-
crodomains respond to neuromodulators but not to sensory driven, neurotransmitter
release. Therefore, these results support the critiques of sensory driven astrocyte re-
sponses and add to the growing consensus that astrocytes are responsive to locomotion
and arousal. Future studies should clarify under what conditions astrocytes respond
to sensory stimuli taking into account possible heterogeneity.
Sixth. Thalamocortical axons respond to whisker touch and locomotion with tran-
sient and biphasic [Ca2+]i elevation respectively. Barrel cortex astrocyte Ca2+ mi-
crodomains were not correlated to thalamocortical axon activity. Axo-astrocytic AAV
transfer can be used to co-label thalamocortical axons and astrocytes with GECIs.
Two photon microscopy revealed that thalamocortical axons respond to whisker stim-
uli with a transient increase in Ca2+ activity, and to the onset of locomotion with a
biphasic response that starts before the animal begins running. I did not find signifi-
cant correlation between the Ca2+ signals of thalamocortical axon boutons and nearby
astrocyte processes. These finding support our previous observations and suggest that
barrel cortex astrocytes do not reliably respond with transient Ca2+ microdomains to
thalamocortical input. Further developments should enable simultaneous recording of
axon bouton, dendritic spine and astrocytic process activity with a more diverse array
or molecular tools to supplement or disprove our findings.
Seventh. Astrocyte fine processes exhibit heterogeneous Ca2+ activity hotspots
that are stable over time. This alludes to subcellular specialization and the existence
of astrocyte activity maps in the brain. 3D imaging should provide a more accurate
and complete representation of these activity maps. Future studies should determine
the mechanisms and functional role of these hotspots.
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